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ABSTRACT 
 
KUN WANG 
Classifier Design to Improve Pattern Classification and Knowledge Discovery for 
Imbalanced Datasets 
(Under the direction of Prof. Alexander Tropsha) 
 
Imbalanced dataset mining is a nontrivial issue. It has extensive applications in a 
variety of fields, such as scientific research, medical diagnosis, business, multiple industries, 
etc. Standard machine learning algorithms fail to produce satisfactory classifiers: they tend to 
over-fit the larger class but ignore the smaller class.  
Numerous algorithms have been developed to handle class imbalance, and limited 
progress has been achieved in improving prediction accuracy for the smaller class. However, 
real world datasets may have hidden detrimental characteristics other than class imbalance. 
Those characteristics usually are dataset specific, and can fail otherwise robust algorithms for 
other imbalanced datasets. Mining such datasets can only be improved by algorithms tailored 
to domain characteristics (Weiss, 2004); therefore, it is important and necessary to do 
exploratory data analysis before classifier design. On the other hand, unmet needs in 
knowledge discovery, such as lead optimization during drug discovery, demand novel 
algorithms. 
In this study, we have developed a framework for imbalanced dataset mining tailored 
to data characteristics and adapted to knowledge discovery in chemical datasets. First, we 
explored the dataset and visualized domain characteristics, and then we designed different 
classifiers accordingly: for class imbalance, active learning (AL), cost sensitive learning 
 iv 
(CSL) and re-sampling methods were designed; for class overlap, Class Boundary Cleaning 
(CBC) and Class Boundary Mining (CBM) were developed. CBM was also designed for lead 
optimization: ideally it would detect fine structural differences between different classes of 
compounds; and these differences could be options for lead optimization.  
Methods developed were applied to two datasets, hERG and CPDB. The results from 
imbalanced hERG liability dataset showed that CBC, CBM and AL were effective in 
correcting class imbalance/overlap and improving the classifier’s performance. Highly 
predictive models were built; discriminating patterns were discovered; and lead optimization 
options were proposed. The methodology developed and knowledge discovered will benefit 
drug discovery, improve hazard test prioritization, risk assessment, and governmental 
regulatory work on human health and the environmental protection.  
 
Keywords: QSAR, applicability domain, outliers, data mining, data visualization, class 
imbalance, class overlap, sampling, cost sensitive learning, class boundary cleanining, class 
boundary minng and active learnining. 
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CHAPTER I 
 
INTRODUCTION 
Introduction of Imbalanced Dataset Mining 
A dataset is imbalanced if at least one of the classes is represented by a significantly 
smaller number of instances, observations, examples or cases than others (Japkowicz, 2002; 
Abe, Naoki et al, 2003, Ertekin et al, 2007). Mining an imbalanced data set is a nontrivial 
issue. It has extensive applications in numerous fields that are essential for human life, for 
instance, rare disease or mutation diagnosis, credit card or insurance fraud detection (Fawcett 
and Provost, 1997), insurance risk modeling (Pednault, Rosen et al, 2000), airline no-show 
prediction (Lawrence, Hong et al, 2003), targeted marketing (Zadrozny & Elkan, 2001), 
intrusion detection and virtual high-throughput screening (HTS) in drug discovery. In the 
literature, the problem of imbalance is also known as dealing with rare cases or skewed data 
(Visa, 2005). 
However, many standard machine learning algorithms fail to produce satisfactory 
classifiers for imbalanced datasets. They tend to over-fit the larger class and ignore the 
smaller class, of which the cost of misclassification can be extremely high, even fatal. The 
classifiers are poor partly because of the way they were designed, partly because of 
inappropriate performance measurements or evaluation metrics they used (Weiss, 2004; Visa, 
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2005). With regard to algorithm design, (i) standard machine learning algorithms are 
designed to maximize overall accuracy while minimizing overall error rate; (ii) many 
standard classification algorithms assume even distribution, while class distributions in 
whole datasets, training, or test sets are not necessarily the same (Provost, 00; Weiss et al, 
2001); (iii) misclassification costs for different classes are different, and may be unknown at 
learning time (Visa, et al, 2005). From the perspective of performance evaluation, overall 
prediction accuracy (the ratio of correctly classified instances over total number of instances 
in the dataset) might be inadequate because class distributions and misclassification costs are 
rarely uniform (Provost & Fawcett, 1997); and the use of such measures might lead to 
misleading conclusions. Accuracy or error rate assumes equal misclassification costs 
(Fawcett & Provost, 1997; Kubat, et al, 1997), which are not true in an imbalanced dataset. 
Evaluation metrics that take imbalance into account can improve classifier searching and 
selection (Weiss, 2004). Alternative measurements include ROC analysis*
                                                 
*  ROC analysis: receiver operating chacteristic analysis, which can access trade off 
between precision and recall; AUC: Area under the ROC curve (AUC), which is not biased 
against the minority class; Precision: which is the percentage of times the predictions 
associated with the rule(s) are correct; Recall: is the percentage of all examples belonging to 
X that are covered by these rule(s); Geometric mean: the square root of precision times recall, 
reaching high value only if both precision and recall are high and in equilibrium; F-measure: 
parameterized weighted harmonic mean which can be adjusted to specify the relative 
importance of precision vs. recall; Precision Recall Break Even Point (PRBEP): the accuracy 
of positive class (smaller class) at the threshold where precision equals recall, it is another 
commonly used performance metric for imbalanced data classification; Matthews Correlation 
Coefficient (MCC):  a measure of the quality of binary classifications, it is generally 
regarded as one of the best measures since it takes into account true and false positives and 
negatives, and can be used even if the classes are of very different sizes. 
, AUC, precision, 
( )( )( )( )FNTNFPTNFNTPFPTP
FNFPTNTPMCC
++++
×−×
= , where TP is the number of true 
positives, TN the number of true negatives, FP the number of false positives and FN the 
number of false negatives. 
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recall, geometric mean, F-measure, Precision Recall Break Even Point (PRBEP) (Visa, 2005; 
Elkan, 2003; Ertekin et al, 2007), Matthews Correlation Coefficient (Matthews, 1975).     
Numerous algorithms have been developed for mining imbalanced datasets (Table 
1.1). Depending on where imbalance is handled, current algorithms fall into two main 
categories:  re-sampling or re-balancing methods, which correct class imbalance at data level; 
and cost sensitive learning, which deals with imbalance at algorithm level (Abe, 2003; 
Chawla, 2003; Weiss, 2004).  
Re-sampling or rebalancing algorithms in turn fall into two sub-categories: up/over 
sampling the minority class, or down/under sampling the majority class to approach balanced 
class ratio. Re-sampling can be done randomly or in more sophisticated ways. For example, 
random under-sampling randomly chooses a subset of the overrepresented class (or classes) 
to approach the same number as the underrepresented class (or classes) for inclusion in the 
training dataset. Random oversampling randomly duplicates records from the 
underrepresented class (or classes) for inclusion in the training set. Resampling can be done 
in more sophisticated ways: e.g., cluster-based resampling (Jo, et al, 2004) and Principal 
Direction Divisive Partition (PDDP)-guided resampling (Nickerson & Milios, 2001) correct 
imbalance caused by small disjuncts or clusters among classes; Synthetic Minority Over-
sampling Technique (SMOTE) (Chawla et al, 2002) creates and interpolates new minority 
class examples to reduce within-class imbalance (small disjuncts); Query learning gets more 
data for rare classes or more data near the decision boundary (Provost and Kolluri, 1999; 
Mamitsuka and Abe, 2000); Uncertainty sampling queries examples for which its prediction 
so far is uncertain to maximize information gain; Adaptive resampling selects instances from 
a labeled training set that were misclassified by classifier ensemble with the goal
  
4 4 
Table 1.1: Survey of current algorithms for imbalanced dataset mining. 
Category Methods Algorithms References Pros Cons 
Data 
Level 
Over Sampling 
 
SMOTE 
Cluster-based resampling 
Ling et al, 1998 
Chawla et al, 2002 
Jo et al, 2004 
Effective in correct  
class imbalance  
Probability localized 
Computational Cost↑ 
Over-fitting Risk↑ 
No information gain 
Down Sampling 
Random down-sampling Kubat et al, 1997 Japkowicz, 2001 
Effective in correct  
class imbalance  
Probability localized 
Lost information 
Active Learning 
Adaptive Sampling 
Importance Sampling 
Selective Learning 
Query Learning 
Abe, 2003 
Iyengar et al, 2000 
Breiman et al, 1999 
Ertekin et al, 2007 
Provost, 1997 
More efficient 
No information lost 
No increase of comp. cost  
 
Algorithm 
Level 
Imbalance 
Insensitive 
Recursive Partition 
SVM 
Japkowicz, 2002 
Visa et al, 2003 
Insensitive to class 
imbalance  
Imbalance ratio 
limitation 
Cost Sensitive 
Learning 
Cost 
Penalty 
Decision Threshold 
Moving 
Weiss, 2007 
Zadrozny et al, 2001 
Pazzani et al, 1994 
Kubat et al, 1998 
Do well in big set 
Effective than random 
sampling 
Cost not known 
Bad estimation 
No local control 
TM ↑statistics only 
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of improving the classification accuracy (Iyengar, et al, 2000); Selective sampling uses only 
a small subset of labeled data for learning given a large number of (possibly unlabeled) data; 
Importance sampling concentrates on the examples near the classification boundaries. 
(Breiman, 1999) emphasized that Importance sampling pays off in terms of reduced 
generalization error, and it is better than query by bagging empirically. 
Although resampling methods are popular because they are straightforward in 
correcting class imbalance, they have known drawbacks: 1) random over/up-sampling 
increases the training set size, computational cost and risk of over-fitting without any 
information gain, by adding exact copies of the smaller class examples (Provost 2000; 
Chawla, et al, 2002; Dummond, et al, 2003; Visa, 2005); 2) random down/under-sampling 
may suffer information loss by discarding potentially useful data (Japkowicz, 2001), thus it 
may degrade rather than improve classifier performance; 3) best class distribution is usually 
unknown and needs to be investigated (Chan & Stolfo, 1998; Estabrooks & Japkowicz, 
2004) prior to the subset generation; (Weiss & Provost 2003) showed that neither a balanced 
distribution nor the natural distribution is necessarily best for the learning task. 4) 
controversial results imply that inappropriate class ratio or other issues may involved. It 
has been reported that up-sampling or down-sampling solved the "problem" of imbalanced 
data sets in some studies, but didn’t help at all for other studies (Provost, 2001; Dummond et 
al, 2003; Kubat et al, 1997). Possible reasons are: the corrected class ratio after re-sampling 
is not appropriate for the dataset; other data structure features that degraded classifier’s 
performance have not been detected nor handled.  
On the contrary, Query/Active Learning methods are designed to correct class 
imbalance without inducing information loss or increasing computational cost (Mamitsuka 
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and Abe, ICML’00). In active learning, learners actively select each individual instance to 
train rather than take class distribution as given. While this principle of active learning 
(Provost, 2000) remains that same, the implementation of active learning varies. For example, 
Zheng used minimum number of compounds but kept the maximum diversity of the bigger 
class when balancing the two classes (Zheng et al, 2002); Kubat only removed majority class 
examples that are redundant, or bordering on minority class examples, which may be noise 
(Kubat et al, 1997). In many formal problems, active learning is provably more powerful 
than passive learning from randomly given examples (Cohn, 1994).  
In contrast to aforementioned intrusive approaches that correct imbalance by 
changing data, other methods remedy imbalance at the algorithm level by adjusting 
classification costs, reweighting different classes, moving decision threshold/probability 
(Zadrozny & Elkan, 2001), or being insensitive to imbalance. For instance, some cost-
sensitive learning algorithms factor in misclassification costs when building the classifier; 
others assign error penalties to different classes that favor the smaller class. Cost-sensitive 
learning assumes that a cost-matrix is known for different types of errors, which can be used 
at classification time. In fact, we often do not know the cost matrix (Chawla et al, 2003); and 
costs are not necessarily the same for the entire dataset, or consistent across training set and 
test set. Weiss demonstrated that the cost-sensitive learning algorithm does consistently yield 
the best results for the large data sets, but performs poorly for small data sets, in which very 
little training data are available for classifier to estimate cost information accurately then 
properly assign the correct classification (Weiss, 2007).  Unless the misclassification cost is 
implemented to adapt to local density or small disjuncts, cost sensitive learning will not 
improve the classifier’s performance as expected. Some algorithms are claimed to be 
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insensitive to class imbalance (but to a certain extent) such as recursive partitioning, or SVM.  
Japkowicz showed that their SVM implementation is not sensitive to class imbalances up to 
imbalance ratio of 1/16 (Japkowicz & Stephen, 2002). The sensitivity of recursive 
partitioning to class imbalance increases with the domain complexity and the degree of 
imbalance, but decreases with training set size (Japkowicz et al, 2002).  
            Right issues It is often assumed that class imbalance is responsible for significant 
loss of performance in standard classifiers; and all aforementioned algorithms focus on 
correct class imbalance directly or indirectly. However, Weiss and Provost demonstrated that 
neither a balanced distribution nor the natural distribution is the best for the learning task 
(Weiss & Provost, 2003). Japkowicz showed that the classifier’s performance for imbalanced 
data set related to three factors: concept complexity, training set size and degree of the 
imbalance (Japkowicz et al, 2000, 2002, 2003). They found that linearly separable domains 
are not sensitive to imbalance independently of the training size; as the degree of concept 
complexity increases, so does the system’s sensitivity to imbalance; with very large training 
data, the imbalance does not hinder the classifier’s performance too much. They concluded 
that class imbalance is a relative problem depending on both the complexity of the concept 
represented by the data and the overall size of the training set; class imbalance does not 
directly cause deterioration of classifier performance; the small disjuncts created by the class 
imbalance in highly complex and small-sized domains do. Moreover, Japkowicz indicated 
that his study did not cover all the characteristics a data domain may have (Japkowicz & 
Stephen, 2002). 
Not the one and only issue  Class imbalance is the one and only issue that most of 
the current algorithms deal with, with a few exceptions. However, real-world datasets have 
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other domain features that may hinder the performance of the classifiers. (Prati et al, 2004) 
demonstrated that the problem is not directly caused by class imbalances but the degree of 
overlap among classes. (Garcia et al, 2006) demonstrated that imbalance by itself will not 
strongly affect the classifier’s performance; performance deteriorates greatly when overlap 
increases. (Visa & Ralescu, 2003, 2004) showed that the overlap affects the fuzzy based 
classifier more than the imbalance; and the fuzzy classifier is affected by the imbalance only 
when data are of high complexity and small size, in which case the true problem is the lack 
of information, rather than imbalance ratio. (Weiss 2003) and (Jo & Japkowicz 2004) 
identified small disjuncts (subclusters in the minority class) as another hurdle in the 
classification of imbalanced datasets due to being poorly represented in the training set. 
(Weiss, 2004; Visa, 2005) elucidated that the following data chacteristics can all degrade 
classifier performance: improper evaluation metrics, lack of data (absolute or relative rarity), 
data fragmentation, noise and inappropriate inductive bias, which is the set of assumptions 
that the learner uses to predict outputs given inputs that it has not encountered (Mitchell, 
1980). Therefore, it is not surprising to see an algorithm that only corrects class imbalance 
succeed in certain cases but fail in others (Provost, 2001; Dummond et al, 2003; Kubat et al, 
1997). (Japkowicz, 2003) suggested that an algorithm should consider all fundamental 
domain characteristics that degrade classification, which necessitates carrying out 
exploratory data analysis and visualization before classifier design.  
Beyond Accuracy – Be Knowledge-Discovery & Application-Minded  All above 
mentioned algorithms have a few things in common: the minority (or so-called positive) class 
is the interest or target; misclassification of the minority class is rare but very costly; the goal 
is to improve performance for the minority class, even sometimes at the expense of the 
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majority class; most of current algorithms deal with the pattern of minority class only, while 
overlooking the consequence of overlap between classes (Garcia, et al, 2006). However, real-
world imbalanced datasets usually have unique characteristics: 1) the status of 
positive/minority or negative/majority class might not be fixed. For instances, in current 
hERG liability dataset, hERG blockers are the majority class comparing with hERG 
activators, but the minority class relative to inactives; 2) misclassification cost for the 
majority class can be very high as well. In this hERG liability study, both blockers and 
activators can cause fatal arrhythmia, but by different mechanisms; misclassification cost of 
either is forbiddingly high. However, each of them can be a potential cure for familiar SQTS 
or LQTS (Raschi et al, 2008), respectively. Therefore, for the sake of drug safety or 
therapeutic efficacy, we need to predict each and every class accurately; for the purpose of 
drug discovery and lead optimization, we need to discover structural features that can be used 
to tune out unwanted toxicity in lead compounds. However, current algorithms tailored to 
prediction accuracy of the minority class only are not sufficient for either of the purposes. 
Thus, beyond prediction accuracy, classifiers design shall adapt to data mining needs to 
maximize knowledge discovery and application.  
If hERG is the primary therapeutic target, the process of drug discovery and design 
can stop once highly predictive models are built, which are sufficient for virtual screening of 
databases for blockers or openers. However, more often than not, hERG is an antitarget, and 
hERG liability is an inadvertent activity. Therefore, the next step of drug design will be the 
lead optimization, which is more appealing than throwing out a potential blockbuster 
prematurely. The question is: how to tune out hERG liability in a lead compound? The 
answer is most likely buried in compounds that are close to the class boundary – where 
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compounds are structurally similar to each other but have different activities. The fine 
differences in structures between these compounds should explain the difference in their 
activities, and hence can be used to guide drug optimization – tuning out undesired toxicity 
without compromising the primary therapeutic efficacy. To find answer for this question, we 
need a new algorithm that mining data at class boundary; current algorithms that tailored to 
improving prediction accuracy of the minority class only are not suitable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
Overview of Chapter II Methodology 
 Our central hypothesis is that in addition to class imbalance, other data domain 
characteristics such as class overlap (Figure 1.1), small disjuncts or clusters, and outliers all 
can contribute to deterioration of classifier performance. The only way to detect all those 
hidden characteristics is to do exploratory data analysis and data visualization. Problems 
detected within the data should be used as guidance for classifier selection and classifier 
 
 
 
 
 
 
 
 
 
 
a b 
Figure 1.1. Principal components analysis (PCA) of hERG dataset showed class imbalance, 
class overlap, outliers and small disjuncts. a (left): Blockers (red) and openers (blue); b(right): 
Blockers (red), openers (blue) and inactives (green). 
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design. On the other hand, classifier design shall meet the ultimate goal of data mining – 
knowledge discovery and application. Unmet needs in drug discovery, such as lead 
optimization by tuning out hERG liability, require development of new algorithms. Keeping 
data structure and data mining needs in mind, to improve the performance of classifiers and 
knowledge discovery, we designed classifiers as follows:    
Class Boundary Cleaning (CBC)  
The method is designed to clean up class overlap as well as reducing class imbalance. 
This is done by identifying compounds from the majority class that are within a certain 
distance of the minority class in high dimensional descriptor space, then removing them 
temporarily from the model building. The optimal distance can be defined by sampling 
different distance thresholds and consequent model building. Since the cleaning is only 
executed for the majority class, it reduces the class imbalance at the same time.  
Class Boundary Mining (CBM)  
The method is developed to searche, define, optimize and learn from class boundary – 
the region where compounds from different classes are structurally similar and geometrically 
close to each other, yet have different activities. By sampling different distance thresholds, 
different compounds are pooled and learned; ideally the fine structural differences between 
two classes of compounds should be picked up by distinguishing models; and that shall give 
us clues about how to reduce or remove undesired activity of a drug. 
Active Learning (AL)   
The method is created to select most relevant, most interesting and most informative 
samples to learn, rather than taking database or class distribution as given. Those samples are 
structurally similar compounds from different classes. They are presumed to be located close 
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to class boundary. The difference between CBM and AL is that AL keeps all the rare cases, 
thus using the information of rare instances in a somewhat better way.  
Cost Sensitive Learning (CSL)   
The method assigns a greater cost to each case of misclassification of the minority 
class than those of the majority class. This approach improves performance with respect to 
the positive (minority) class (Weiss, 2004). It is done by including decision thresholds, 
weights for different classes, and misclassification costs into standard QSAR procedures, in 
our case, kNN QSAR category algorithm that developed in our laboratory. Ideally, these 
parameters should be optimized, i.e. the values should be found which give models with 
highest predictivity.  
Outlier Removal (OR)  
The method is designed to identify and remove outliers that may degrade 
performance of classifier. It is done by searching compounds in the dataset that have no 
nearest neighbors within different distance thresholds (i.e. outliers are defined by a distance 
threshold). 
Resampling   
The method is designed to correct class imbalance, by resampling the original 
training dataset to create more balanced classes. This is done either by oversampling the 
minority class or under-sampling the majority class until the classes are approximately 
equally represented. 
Figure 1.2 represents the overall study design that interlinked aspects of this project 
that are different from current algorithms for imbalanced dataset classification: (i) data 
domain diagnosis by data visualization tool such as principal component analysis; (ii) design 
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of classifiers targeting domain characteristics detected in the first step; (iii) design of 
classifiers that incorporate data mining goals. Without data domain diagnosis, it will be 
impossible to find out hidden detrimental domain characteristics other than class imbalance; 
using algorithms that correct class imbalance only will generate mixed results – which work 
in certain cases but fail in others as reported in literature (Provost, 2001; Dummond et al, 
2003; Kubat et al, 1997). 
 
For comparison, we studied the performance of in-house kNN QSAR classification 
algorithm with and without combination with aforementioned algorithms; we also studied the 
performance of WEKA algorithms before and after data preprocessing with the algorithms 
we developed.  
Overview of Chapter III Pattern Classification and Knowledge Discovery in QSAR 
Studies of Imbalanced Data Set of hERG Liability  
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Figure 1.2. Framework of imbalanced dataset classifier design that integrated data chacteristics 
analysis (domain diagnosis) and adapted to knowledge discovery and application needs. 
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The human ether-a-go-go related gene (hERG) K+ channel can be both antitarget and 
target in drug discovery. As antitarget, drug induced blockade of hERG K+ channel can 
cause QT prolongation, TdP and fatal arrhythmia, thus it is important to screen out hERG 
channel blockers at early stage of drug discovery. As target, hERG blockers can be potential 
class III anti-arrhythmics, or possible therapeutics for congenital short QT syndrome (Raschi 
et al, 2008). hERG openers shorten QTS, and can work as potential therapeutics for 
congenital LQTS (Fermini and Fossa 2003). On the other hand, the inactive compounds, 
especially those located at class boundary, may contain valuable chemical information that 
can be used to tune out hERG liability from lead compounds for other non-cardio 
therapeutics at the stage of drug optimization. Therefore, all three classes in this particular 
dataset are very important in their own terms to drug discovery.  
The hERG liability dataset contains 1878 compounds, which include 54 activators, 
193 blockers, and 1630 inactives after dataset cleaning. It is a diverse, imbalanced dataset 
with class overlap and outliers. All these domain characteristics may deteriorate the 
performance of classifiers (Figure 1.1). Standard QSAR algorithms generated unsatisfied 
classifiers, which had poor prediction accuracy for minority class. To remedy those 
detrimental data features, we combined the k-nearest-neighbor (kNN) QSAR classification 
algorithm with the class boundary cleaning (CBC), class boundary mining(CBM) and active 
learning(AL) techniques, then built models for (i) blockers vs. activators, (ii) blockers vs. 
inactives, (iii) activators vs. inactivates (iv) actives (openers & blockers) vs. inactives. 
Models with prediction accuracy about 90% each were obtained for training, test and external 
validation sets; false positive/negative rates were about 10%. Our results compared favorably 
with those generated using algorithms implemented in WEKA, such as, kNN, Naïve 
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Bayesian, Support Vector Machine (SVM), Decision Tree, Random Forest, Multilayer 
Perceptron (MLP), AdaBoost, and Classification Via Clustering (CVC), etc. As further 
comparison, we performed the same studies using those WEKA algorithms combined with 
CBC, CBM and AL, the results showed that CBC, CBM and AL can improve WEKA 
classifier’s performance.  
We performed frequent descriptor analysis of those highly predictive models, and 
discovered chemical structural patterns that either promote or demote hERG liability with 
different levels of confidence. Those promoting or demoting structural features can be used 
to alert or tune out hERG liability, respectively. In addition to drug screening or lead 
optimization, that knowledge can extend application of hERG liability prediction in 
governmental regulatory work. 
Overview of Chapter IV Classification and Knowledge Discovery for Mutagenicity 
andCarcinogenicity in Carcinogenic Potency Database (CPDB) 
Accurate prediction of the chemical carcinogenicity is a scientific issue of 
unquestionable importance. Cancer is the most feared disease in the modern world, the 
second largest cause of death. It affects one person in three at all ages (American Cancer 
Society, December 2007), and costs hundreds of billions of dollars in medical expenses each 
year. Accurate prediction of carcinogenicity potential of compounds is crucial for the 
prevention of chemically-induced cancer.  
Rodent carcinogenicity bioassay, the gold standard to test chemical carcinogenicity, is 
known to be expensive in terms of labor, animals, compounds, and time consumed (Zeiger, 
2004). Alternative short term genotoxicity tests, such as Ames Salmonella mutagenicity 
assay (Ames, et al, 1973), mouse lymphoma tk assay (MLA), in vivo mouse bone marrow 
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chromosome aberration (CA), sister chromatid exchanges (SCEs) etc, are fast and cost-
effective but currently insufficient to accurately and reliably predict the outcome of long-
term carcinogenicity studies (Kirkland et al, 2008; Ashyby, 1993). SAR methods overall 
produced a higher concordance frequency and a lower percentage of false negatives than the 
overall genetic toxicity test methods (Ashyby, 1988). Structural alerts (SAs) qualitatively 
point to the potential of a compound to induce cancer by direct DNA damage, but not by 
epigenetic mechanisms. Compared with SAs, QSAR models are preferred in virtual 
screening as more powerful, efficient and reproducible. However, for in silico toxicity 
prediction software such as MCASE, DEREK, OncoLogic and TOPKAT, HazardExpert etc 
(Benigni, 1997; Ashyby and Tennant, 1991), high false negative rate and false positive rate 
have always been problems. Many studies have been carried out to reduce false positive and 
false negative rates, such as threshold moving to correct statistical prediction errors. 
Consequently, sensitivity was improved at the price of specificity or vice versa. Very little 
systematic research has been done to elucidate the chemical mechanistic information behind 
the phenomena, and to differentiate false negatives and false positives from genotoxic 
carcinogens better.  
To address the problem, we used Berkeley Carcinogenic Potency Database (CPDB). 
The CPDB provides a systematic and unifying source of outcomes from in vivo animal 
chemical carcinogenicity studies. The most recent release of the CPDB includes experimental 
data for 1,481 diverse chemicals obtained for one or both sexes of rats and mice and other 
species, and reports outcomes for 35 possible target organ/tissue sites. Endpoints used for 
category modeling are mutagenicity and carcinogenicity. We preprocessed the data by 
excluding those entries that had missing structures or mutagenicity readings, and inorganic 
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chemicals (salts and metals). Chiral compounds were removed as well. We took into account 
both mutagenicity and carcinogenicity simultaneously, and created working sets for different 
studies shown in Table 4.1.  
Working sets have different levels of class imbalance. They will be a good source for 
cross-references. The models will be examples of how class imbalance affects the 
performance of classifiers. We expect models built and chemical patterns found will be 
useful for reducing the risk of hidden hazards, animals sacrificed for toxicity tests, and undue 
concerns as well.  
Overview of Chapter V Summary and Future Studies 
 In the last chapter of this dissertation, I summarized the novel methodology I 
developed for the important, challenging issue in the data mining field – imbalanced dataset 
classification, plus its potential significant application in drug discovery and development. 
Two supporting research projects were also reviewed for the results, knowledge discovered 
and potential application, and future studies.  
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
CHAPTER II  
METHODOLOGY 
 Novel algorithms were developed based on core technology – kNN QSAR 
classification that was developed in the lab – to improve the performance of classifiers for 
imbalanced dataset and improve knowledge discovery. These new algorithms outperformed 
WEKA algorithms in mining the imbalanced hERG liability dataset. What’s more, the new 
algorithm demonstrated unique edge in discovering chermical patterns for lead optimization 
during drug discovery. In this chapter, the background information about QSAR will be 
briefly introduced first, and then methodology developed will be presented, followed by 
explaining WEKA algorithms in comparison. 
Background Information of QSAR   
QSAR, which  stands for Quantitative Structure-Activity Relationship, is a statistic 
learning methodology of searching, optimizing and validating the best possible mathematic 
equations that quantitatively correlate a set of chemical structures with their experimentally 
defined biological or chemical activities, such as inhibition or activation of hERG K+ 
channel, being mutagenic or carcinogenic or not, etc. QSAR's most general mathematical 
form is: 
Activity = f(physiochemical properties and/or structural properties)  
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Once established, the mathematical expression can be used to predict the biological response 
of other similar chemical structures.  
As its name and equation suggest, QSAR has three core components: chemical 
structures, activity and the mathematical relationship between the two. Chemical structures 
were quantitatively expressed by descriptors, such as functional groups, as well as their 
physicochemical properties etc. We will review QSAR methodology by structural descriptors 
first, and then the development and validation of the mathematic relationship.  
Descr iptors Used 
There are many types of chemical structural descriptors. Three types of descriptors 
used in this dissertation project are listed as follows: 
 Molconn-Z Chemical Descriptors: 
The Molconn-Z software (eduSoft LC, Ashland, VA, USA) affords the computation 
of a wide range of topological indices for molecular structures. These indices include, but are 
not limited to, the following descriptors: simple and valence path, cluster, path/cluster and 
chain molecular connectivity indices, kappa molecular shape indices, topological and 
electrotopological state indices, differential connectivity indices, graph’s radius and diameter, 
Wiener and Platt indices, Shannon and Bonchev-Trinajstić information indices, counts of 
different vertices, counts of paths and edges between different kinds of vertices (Hall et al, 
1991; Kier 1986; Kier 1987; Kier and Hall 1991). In all, Molconn-Z (eduSoft LC) produces 
over 800 different descriptors. Those with zero variance were removed. The remaining 
descriptors were range-scaled since the non-scaled Molconn-Z (eduSoft LC) descriptors are 
in different units and/or can differ by orders of magnitude. Therefore, descriptors with 
significantly higher ranges will not be weighted disproportionally upon distance calculations 
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in multidimensional descriptor space as well as in feature selection during kNN model 
building procedure (see below). 
 Dragon Descr iptors 
A set of 843 theoretical molecular descriptors was computed using DRAGON 
software (Talete s.r.l. Dragon, 2007). The descriptors were generated from the SMILES 
strings available for each compound. The descriptors includ the following types: 0D 
constitutional (atom and group counts); 1D functional groups; 1D atom centered fragments; 
2D topological descriptors; 2D walk and path counts; 2D autocorrelations; 2D connectivity 
indices; 2D information indices; 2D topological charge indices; 2D Eigenvalue-based 
indices; 2D edge adjacency indices; 2D Burden eigenvalues and molecular properties. 
Dragon descriptors were range-scaled. Variables which had the same value for all 
compounds were deleted. If two descriptors were at least 98% correlated one of them was 
deleted. The final sets used in QSAR studies included about 350 descriptors. The definition 
of these descriptors and related literature references are reported elsewhere (Todeschini et al, 
2007). 
 Frequent Subgraph Descr iptors 
Frequent Subgraph Descriptors have been recently developed in our lab (Khashan 
dissertation, 2007). The principle of this method is to represent molecules by graphs, then use 
subgraph mining tools to facilitate exploring the information encoded in data. This method 
can be used to find the frequent subgraphs (chemical fragments) that are above a certain 
threshold of support (percentage of presence in the dataset). These chemical fragments can be 
used as molecular descriptors for the quantitative structure-activity relationship (QSAR) 
studies. They can also be used to identify the pharmacophores that are responsible for the 
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activity, or the toxicophores for the toxicity, of molecules in different datasets. Compared to 
descriptors with fixed types and sizes of built-in functional group library in commercial 
software, descriptors generated by this method is more dataset specific, and more likely to 
catch novel structural features that are unique for particular activity. 
kNN QSAR Methodology 
Model Development and Validation   
Training, Test and External evaluation set     After preprocessing, the datasets were 
randomly divided into modeling and external evaluation sets which included about 85% and 
15% of compounds of entire datasets, respectively. Modeling sets were further divided into 
multiple training and test sets of different sizes (see below). Training sets were used for 
building QSAR models. Test sets were used for validation of QSAR models. External 
evaluation sets were used for additional validation of QSAR models which had high 
predictive accuracy of the training sets in the leave-one-out cross-validation procedure (see 
below) and the test sets. Consensus prediction was applied for external validation. Thus, 
external evaluation sets were used as an objective evaluation of prediction of compounds not 
included in the original dataset. In validation of QSAR models using test and external 
evaluation sets, predictions were made for compounds within rigorously defined applicability 
domains (AD). High prediction accuracy for external evaluation sets would confirm the 
predictive power of QSAR models and their applicability for classification of other 
compounds.  
Selection of Training and Test Sets   The modeling sets were divided into multiple 
pairs of training and test sets using the Sphere Exclusion program developed in this 
laboratory(Golbraikh, Shen et al, 2003). The procedure implemented in this study starts with 
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the calculation of the distance matrix D between points that represent compounds in the 
descriptor space. Let Dmin and Dmax be the minimum and maximum elements of D, 
respectively. N probe sphere radii are defined by the following formulas. Rmin = R1 = Dmin, 
Rmax = RN = Dmax/4, Ri = R1 + (i-1)*(RN-R1)/(N-1), where i = 2, ..., N-1. Each probe sphere 
radius corresponds to one division into the training and the test set. A sphere-exclusion 
algorithm used in this study consisted of the following steps: (i) randomly select a 
compound. (ii) include it in the training set. (iii) Construct a probe sphere around this 
compound. (iv) select compounds from this sphere and include them alternately into the test 
and training sets. (v) exclude all compounds from within this sphere from further 
consideration. (vi) if no more compounds are left, stop. Otherwise, let m be the number of 
probe spheres constructed and n be the number of remaining compounds. Let dij (i=1,...,m; 
j=1,...,n) be the distances between the remaining compounds and the probe sphere centers. 
Select a compound corresponding to the lowest dij value and go to step (ii). This algorithm 
guarantees the following for the entire descriptor space: (i) representative points of the test 
set are close to representative points of the training set (test set compounds are within the 
applicability domain defined by the training set); (ii) given the size of the test set, as many of 
the representative points of the training set as possible are close to representative points of 
the test set; (iii) the training set represents the entire modeling set (i.e. there is no subset in 
the modeling set which is not represented by a similar compound in the training 
set)(Golbraikh, Shen et al, 2003). As a result, the sphere-exclusion algorithm could maximize 
the diversity of the training/test sets in the descriptor space used for modeling. In addition, 
step (iv) of the algorithm guarantees that the local densities of representative points in the 
descriptor space are at least partially taken into account. Due to the stochastic nature of the 
 23 
 
 
algorithm, the composition of training and test sets is different for different original dataset 
divisions.  
kNN QSAR Method  The kNN QSAR method employs the kNN pattern recognition 
principle and a variable selection procedure. Initially, a subset of nvar (number of selected 
variables) descriptors is selected randomly. Then the selected subset of descriptors is 
modified based on the values of prediction accuracy (see below) in the leave-one-out cross-
validation procedure, in which each compound in turn is eliminated from the training set and 
its biological activity is predicted as the weighted-by-distance average activity of k most 
similar molecules (k=1 to 5) in the selected nvar descriptor subspace. (The molecular 
dissimilarity was characterized by the Euclidean distance between compounds in the nvar-
subspace of the multidimensional descriptor space.) In general, the Euclidean distances in the 
descriptor space between a compound and each of its k nearest neighbors (k>1) are not the 
same. Thus, the neighbor with the smaller distance from a compound was given a higher 
weight in calculating the predicted activity as follows (Eq. 1 & 2):  
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where dij is the Euclidean distance between compound i and its k-th nearest neighbor; wij is 
the weight for every individual nearest neighbor; yi is the observed activity value for nearest 
neighbor i; and ŷi is the predicted activity value of compound i. If k=1, 1ˆ yyi = . In case of 
classification QSAR, ŷi value is rounded to the closest integer. A method of simulated 
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annealing with the Metropolis-like acceptance criteria is used to optimize the variable 
selection. The optimization criterion (prediction accuracy), or correct classification rate 
(CCR) is defined as: 
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where 0 and 1 are class numbers (e.g., non-carcinogenic and carcinogenic, Nicorr and Nitotal 
are the number of correctly predicted and total number of compounds of class i. The ratio 
total
i
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N
N
 is also called specificity and sensitivity, respectively, for class i=0 and i=1. For truly 
predictive models, both sensitivity and specificity should be close to one. For compounds not 
included in the training set prediction is made using the same formulas [1] and [2], and 
nearest neighbors are taken from the training set. For all the training, test and external 
evaluation sets, CCR are used as criteria of prediction accuracy.  
In summary, the kNN-QSAR algorithm generates both an optimal k value and an 
optimal nvar subset of descriptors, that afford a QSAR model with the highest training set 
model accuracy as estimated by the CCR value. Further details of the kNN method 
implementation, including the description of the simulated annealing procedure used for 
stochastic sampling of the descriptor space, are given in our previous publications (Roberts, 
Myatt et al, 2000; Shen, Xiao et al, 2003; Ng, Xiao et al, 2004). 
Applicability Domain (AD) of kNN QSAR Models   Theoretically, a QSAR model 
can predict the target property for any compound, where chemical descriptors can be 
calculated. However, this compound can be very far from all compounds of the training set in 
the descriptor space, i.e. it can be dissimilar to all compounds in the training set. In this case, 
reliable prediction for this compound is impossible. Thus, a model AD (i.e. the dissimilarity 
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threshold) should be introduced to avoid making predictions for compounds that differ 
substantially from the training set molecules. Suppose that a model includes M descriptors, 
i.e. each compound can be represented by a point in the M-dimensional descriptor space with 
the coordinates Xi1, Xi2, ..., XiM, where Xis are the values of individual descriptors. The 
molecular dissimilarity between any two molecules was characterized by the Euclidean 
distance between their representative points. The Euclidean distance dij between two points i 
and j (which correspond to compounds i and j) in M-dimensional space is calculated as 
follows (Eq. 4): 
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Compounds with the smallest distance between one another are considered to have the 
highest similarity. Let y and σ be the mean and standard deviation of distances between 
compounds and their K nearest neighbors in the training set, then the applicability domain 
threshold, ADT, is defined as follows (Eq. 5): 
    ADT = y +  Zσ        [5] 
Here, Z is an arbitrary parameter called Z-cutoff. Based on previous studies (Shen, LeTiran et 
al, 2002), we set the default value of this parameter to 0.5, but other values such as 1.0 or 1.5 
can be used as well. Thus, if the distance of the external compound from the closest of its k 
nearest neighbors in the training set exceeds this threshold, the prediction is not done.  
Robustness of QSAR models Y-randomization (randomization of response) is a 
widely used approach to establish the model robustness. It consists of rebuilding the models 
using randomized activities of the training set and subsequent assessment of the model 
statistics. It is expected that models obtained for the training set with randomized activities 
should have significantly lower predictive accuracy for the test and external evaluation sets 
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Algorithm 1: Class Boundary Cleaning 
Input: S (data set with n instances) 
Parameters: Z (applicability domain) 
Output:  Az (clean data set)  
S1 = DataPartition S (class 1) 
S0 = DataPartition S (class 0) 
S01 = SimilarityMatrix_EuclidianDistance (S0, S1) 
If size(S0) > size(S1) 
for Z = 0 to 3.0 do  
  A01 = RemoveInstancesSimilarToClass 1 AtThreshold Z (S0 – S01) 
      Az = A10 U A01  
      Z += 0.5 
end for 
return Az 
# Az is ready to input standard kNN QSAR Classification workflow 
end if 
 
Figure 2.1: Algorithm of Class Boundary Cleaning (CBC). 
than the models built using the training set with real activities, or the total number of 
"acceptable" models based on the randomized training set satisfying the same cutoff criteria 
(CCR (train) > 0.7 and CCR (test) > 0.7) should be much lower (at least one order) than 
those based on the training set with real activities. If this condition is not satisfied, models 
built with real activities for this training set are not reliable and should be discarded. This test 
was applied to all data divisions considered in this study. 
Methodology Developed 
Class Boundary Cleaning (CBC) This method is designed to reduce class overlap 
(Fig. 2.1). Cleaning could be done in two classes. To avoid worsening class imbalance, it was 
performed for the majority class only, i.e. com-pounds from the majority class that are close 
to those of the minority class (within certain distance thresholds) were removed, then the rest 
of the majority class was combined with the minority class to form a working dataset input 
for the kNN QSAR workflow (Figure 1.2). Since only compounds from the majority class 
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 Algorithm 2: Class Boundary Mining Input: S (data set with n instances) Parameters: Z (applicability domain) 
Output:  A (clean data set)  
S1 = DataPartition S (class 1) 
S0 = DataPartition S (class 0) 
S10 = SimilarityMatrix_EuclidianDistance (class 1 to class 0) 
S01 = SimilarityMatrix EuclidianDistance (class 0 to class 1) 
for Z = 0 to 3.0 do  
 A10 = CollectInstancesSimilarToClass 0 AtThreshold Z (S1 – S10) 
 A01 = CollectInstancesSimilarToClass 1 AtThreshold Z (S0 – S01) 
 Az = DataFusion (A10+A01) 
 Z += 0.5 
end for 
return Az 
feed Az to standard kNN QSAR Classification workflow 
 
Figure 2.2 Algorithm of Class Boundary Mining (CBM). 
were removed, class imbalance was alleviated along with the class overlap, and the effect 
increased with the distance threshold.  
Class Boundary Mining (CBM) This method is developed to search, define, 
optimize and learn from the class boundary – the region where compounds from different 
classes are structurally similar and geometrically close to each other, yet have different  
activities labels (Fig. 2.2). By sampling different distance thresholds, different compounds 
are pooled and trained; ideally the fine structural differences between two classes of 
compounds should be picked up by distinguishing models; and that can be used to guide drug 
optimization – reduce or tune out undesired activity. For example, by learning the boundary 
between hERG blockers and inactives (see Chapter III), this algorithm discovered some 
patterns that account for structural similarity, and other patterns explained the activity 
difference. Modifying a compound with those patterns may turn a blocker to an inactive 
compound, or vise versa, if needed. Mining the boundaries between activators vs. the 
inactives, blockers vs. activators, the actives vs. the inactives are likewise.  
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Algorithm 3: Active Learning 
Input: S (data set with n instances) 
Parameters: Z (applicability domain) 
Output:  A (clean data set)  
S1 = DataPartition S (class 1) 
S0 = DataPartition S (class 0) 
if S0 > S1 
S01 = SimilarityMatrix EuclidianDistance (class 0 to class 1) 
for Z = 0 to 3.0 do  
  A01 = RemoveInstancesSimilarToClass 1 AtThreshold Z (S0 – S01) 
  Az = DataFusion (S1+A01) 
  Z += 0.5 
end for 
return Az 
feed Az to standard kNN QSAR Classification workflow 
end if 
 
Figure 2.3: Algorithm for Active Learning (AL).  
Active Learning (AL)  The main idea of active learning is to actively select 
training examples rather than passively taking input as given (Cohn, 1994). The principle of 
active learning is to reduce the number of training examples needed while maintaining the 
quality of resulting classifiers. AL is designed to enhance data mining efficiency, especially 
for the scenario where not every example is equally important or informative. (Breiman, 
1999) demonstrated that in classification, concentrating on the examples near the 
classification boundaries pays off in terms of reduced generalization error. The paradigm of 
active learning falls into two major subfields: membership queries and selective sampling 
(Lindenbaum, 1999). In this study, Active Learning was implemented as Fig. 2.3 to select 
majority class objects that are close to the minority class boundary. Ideally this sampling step  
will correct class imbalance, reduce classification error without inducing information loss or 
increasing computational cost (Mamitsuka and Abe, 2000). In many formal problems, active 
learning is provably more powerful than passive learning from randomly given examples 
(Cohn, 1994). 
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 Cost Sensitive Learning (CSL) kNN QSAR   To make the learning function of 
aforementioned kNN QSAR category method cost sensitive, we introduce decision threshold 
and misclassification penalty into evaluation metrics for imbalanced dataset classification as 
follows:   
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where iy
 is the predicted activity value of compound i; t is the decision threshold, instead of 
0.5 for rounding to the closest integer; iy
  is rounded to 0 if it is smaller than t, or 1 if it is 
higher; CCRi is correct classification rate for imbalanced dataset; wi is weight for class i; 
tot
iN and
corr
iN are correctly predicted and total number for class i; P is misclassification 
penalty; Pc is misclassification penalty coefficient. Ideally, optimal parameters t, w0, w1 and 
Pc could be found that would be sensitive to high misclassification cost of the minority class 
and enable equal or higher tot
corr
N
N
0
0 and tot
corr
N
N
1
1 despite high class ratio. 
Outlier Removal (OR) This algorithm consists of following steps: 1) calculate 
pair-wise distances among all compounds in a dataset, and output the distance matrix, mean 
and standard deviation; 2) build a list of nearest neighbors within certain distances for each 
compound in the dataset; 3) sample this list of of nearest neighbors, starting from z cut-off 
value 0, increasing by 0.5 at each step, untill reaching maximum distance or distance of 
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choice; 4) remove those compounds that have no neighbors within certain z cutoff thresholds, 
keeping the rest of compounds as the working set for the next step.  
Inter-class Rare Instance Over-Sampling (RIOS_Inter) This method was done in 
a similar way as above, except that rather than removed those compounds with no neighbors 
at certain z cut-off, we simply duplicated those compounds.  
Intra-class rare Instance Over-Sampling (RIOS_Intra) This method was also 
done in a similar way; just the first step was done within each class, and then duplicated the 
“loner” compounds either in both classes or only the minority class, respectively, depending 
on whether small clusters or class imbalance is the main concern of that particular dataset.   
WEKA Software and Algor ithms Used 
WEKA stands for the Waikato Environment for Knowledge Analysis, which was 
developed at the University of Waikato in New Zealand. It was written in Java and 
distributed under the GNU Public License (Witten and Frank, 2005). It is a comprehensive 
software package that includes data pre-processing tools, machine learning algorithms and 
evaluation methods for data mining tasks. The algorithms can either be applied directly to a 
dataset or called from your own Java code. WEKA machine learning tools contains 
algorithms for classification, regression, clustering, association rules, and visualization. It is 
well-suited for comparing learning algorithms, as well as developing new machine learning 
schemes.  
It was claimed that algorithms such as Naïve Bayesian, Decision trees, and SVM are 
not sensitive to class imbalance (Japkowicz et al, 2002), and AdaBoost can improve a weak 
classifier (Freund and Schapire, 1999). Therefore, in this study, we compared performance of 
the WEKA implementation of these algorithms with the performance of algorithms that we 
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developed, as well as comparing performance of these algorithms before and after combining 
them with approaches we developed. Herein, we briefly introduce these algorithms and 
corresponding parameters used as follows. 
IBk This algorithm is the WEKA implementation of K-nearest neighbors (kNN) 
classifier based on Aha and Kibler’s work on instance-based learning algorithms (Aha and 
Kibler, 1991). Optimal parameters we selected for this algorithm are: three nearest neighbors, 
inverse-distance-weighting, ten-fold cross-validation and linear nearest neighbor searching 
algorithm. 
NaïveBayes  This algorithm is WEKA implementation of Naive Bayes classifier 
using estimator classes based on John and Langley’s work (John and Langley, 1995). 
Numeric estimator precision values are chosen based on analysis of the training data. In this 
study, the following parameters are used for this algorithm: useKernelEstimator as true for 
using a kernel to estimate numeric attributes instead of using normal distribution; 
useSupervisedDiscretization as false for not using supervised discretization to convert 
numeric attributes to nominal ones. 
SMO This algorithm is the WEKA implementation of John Platt's sequential 
minimal optimization algorithm for training a support vector (SVM) classifier (Platt, 1998; 
Keerthi et al, 2001). In this study we use following parameters: buildLogisticModels as false 
for not fit logistic models to the outputs (for proper probability estimates); c as 2.0 for 
complexity; checksTurnedOff as false; epsilon as 1.0E-12 for round-off error; filterType as 
normalized training data; kernel used is RBF kernel: K(x,y) = e^-(0.02* <x-y,x-y>^2); 
numFolds as 10 for ten-fold cross-validation;  randomSeed as 1; toleranceParameter as 0.001. 
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J48 This algorithm is the WEKA implementation of C4.5 decision tree based on 
work by Quinlan (Quinlan, 1993). The optimal parameters we selected for this algorithm are: 
use binary Splits on nominal attributes when building the trees; confidence Factor of 2.5 for 
pruning; the minimum number of instances per leaf as 2; counts at leaves are smoothed based 
on Laplace. 
RandomForest This algorithm is the WEKA implementation of a classifier for 
constructing a forest of random trees based on work of (Breiman, 2001). In this study, we 
used the following parameters: maxDepth as 0 for unlimited maximum depth of the trees; 
numFeatures as 50 for the number of attributes to be used in random selection; numTrees as 
250 for the number of trees to be generated; seed as 10 for the random number seed to be 
used. 
MLP This algorithm, Multi-Layer Perceptron, is the WEKA implementation of a 
back-propagation neural network classifier. This network can be built by hand, created by an 
algorithm, or both. The network can also be monitored and modified during training time. 
The nodes in this network are all sigmoid (except for when the class is numeric in which case 
the output nodes become unthresholded linear units). We used the following parameters: 
autoBuild as true to add and connect up hidden layers in the network; decay as true to set the 
learning rate to decrease; hiddenLayers as ‘a’ to define the hidden layers of the neural 
network by 'a' = (attribs + classes) / 2; learningRate as 0.3 for the amount the weights are 
updated; momentum as 0.2 to apply to the weights during updating; nominalToBinaryFilter 
as false; normalizeAttributes as true to normalize the attributes to between -1 and 1; 
normalizeNumericClass as true to transform class range to be between -1 and 1 (note that this 
is only internally, the output will be scaled back to the original range); randomSeed as 0 to  
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initialize the random number generator; Random numbers are used for setting the initial 
weights of the connections between nodes, and also for shuffling the training data; reset as 
true to allow the network to reset with a lower learning rate to restart training again if the 
network diverges from the answer; trainingTime as 500 epochs to train through; 
validationSetSize as 0 for the network to train for the specified number of epochs; 
validationThreshold as 20 to terminate validation testing when the validation set error is 
worse 20 times in a row before training is terminated.  
AdaBoost  AdaBoost stands for adaptive boosting. It is the WEKA 
implementation of Adaboost M1 method for boosting a nominal class classifier based on 
work of Freund and Schapire (Freund and Schapire, 1996). Only nominal class problems can 
be tackled by this method. It often dramatically improves the performance of a weak 
classifier, but sometimes over-fits. Parameters we optimized and set are: Decision Stump as 
classifier to use; numIterations as 100 iterations to perform; seed as 1 for random number 
generation; useResampling as false; weightThreshold as 100 for weight pruning. 
Classification via Clustering (CVC)  This algorithm is the WEKA implementation of 
a simple meta-classifier that uses a clusterer for classification based on ‘clusters to classes' 
functionality of the weka.clusterers.ClusterEvaluation class by Mark Hall. We selected 
Simple EM (Expectation Maximization) as clusterer with the following parameters: 
maxIterations – maximum number of iterations as 100; minStdDev – minimum allowable 
standard deviation as 1.0E-6; numClusters – number of clusters as -1 to select number of 
clusters automatically by cross validation; seed – The random number seed to be used as 100. 
EM assigns a probability distribution to each instance which indicates the probability of it 
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belonging to each of the clusters. EM can decide how many clusters to create by cross 
validation, or you may specify a priori how many clusters to generate.  
Toxicophores and Toxicophobes Identification and Validation 
General Procedures The first step towards the identification of toxicophores or 
toxicophobes was generation of highly predictive models, followed by examination of the 
models with test sets and external validation sets; The second step is frequent descriptor 
analysis over the models that showed high prediction accuracy for the training, test and 
external validation sets; The third step is association rule learning of the significant structure 
feature/descriptors detected in step two. The support, confidence and p-value will show 
whether the structures were an interesting or significant (p <= 0.05) pattern that is capable of 
promoting (confidence > 0.5, toxicophores) or demoting (confidence < 0.5, toxicophobes) 
specific toxicity in the dataset.  
Support The support suup(X) of a substructure (or toxicophore) is the 
percentage of compounds in the dataset D that contain this substructure. 
DXcountXsuup /)()( =                                                                    [9] 
Confidence The confidence of a substructure (or toxicophore) is the percentage of 
experimentally determined toxicants in the subset of compounds that contain this 
substructure 
                                               ( )XsuupPXsuupYXconf /)()( ∪=⇒                                     [10] 
p-Value  Given a subset of compounds containing a substructure (or 
toxicophore), the p-value is the chance that a random selection of an equal number of 
compounds from the assembled dataset will have an accuracy that equals or exceeds the 
accuracy of this substructure (Kazius et al, 2005). 
  
 
 
 
 
 
CHAPTER III  
Pattern Classification and Knowledge Discovery in QSAR Studies  
of Imbalanced Data Set of hERG Liability 
Introduction 
Importance of hERG -- function and dysfunction  The human Ether-a-go-go 
Related Gene (hERG) encoded K+ channel plays a key role in repolarization of the cardiac 
action potential and maintenance of the normal cardiac rhythm (Fermini and Fossa 2003; 
Pearlstein, Vaz et al, 2003; Recanatini, Cavalli et al, 2005). The dysfunction of hERG, 
congenital or acquired, can cause prolongation of the QT interval in surface 
electrocardiogram (ECG), abnormal T waves and fatal ventricular arrhythmia. Thus hERG 
has elicited intense scientific interest from academia and industry, and concern from 
regulatory agencies, especially because of the increased incidences of sudden death caused 
by non-cardiac drugs. hERG liability is the most common reason for drug withdrawal from 
the market during the last 16 years (Shepard, Canavier et al, 2007). It has become a practice 
for the pharmaceutical industry and a requirement of Food and Drug Administration (FDA) 
to test hERG liability for compounds (Sanguinetti and Tristani-Firouzi 2006; Guth 2007; 
Perrin, Subbiah et al, 2008). 
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Implication for drug design & current status of research    Because of 
aforementioned inadvertent lethal toxicity, hERG K+ channel was mainly taken as an 
antitarget in drug development; current research on hERG liability prediction has 
overwhelmingly focused on screening out potential hERG blockers at the earliest stage of 
drug discovery (Fermini and Fossa 2003). However, the recent identification and functional 
characterization of hERG K+ channels, not only in the heart but also in several other tissues 
(e.g. neurons, smooth muscle and cancer cells), suggests that hERG can also be a possible 
target for antipsychotic, muscle atrophy, oncology and cardiology drugs (Witchel 2007; 
Raschi, Vasina et al, 2008). As hERG blockers, Class I antiarrhythmics can be promising 
therapeutics for short QT syndrome (SQTS) (Gaita, Giustetto et al, 2004; Milberg, Fleischer 
et al, 2007); Class III antiarrhythmics can prevent reentry arrhythmia and be second-line 
therapy for SQTS (Wolpert, Schimpf et al, 2005; Antzelevitch 2007). hERG activators 
shorten QT interval and can be potential new therapeutics in the treatment of delayed 
depolarization conditions, which may happen in patients with inherited and acquired LQTS 
(Zhou, Augelli-Szafran et al, 2005; Raschi, Vasina et al, 2008). Therefore, to make drug 
discovery process more safe, efficient and cost effective, it is important to distinguish and 
screen out potential hERG blockers and activators at early stage of drug discovery, if hERG 
is the primary therapeutic target. Otherwise, tuning-out hERG liability without compromising 
its primary therapeutic efficacy should be considered before throwing out a promising lead 
from drug discovery pipeline. For that purpose, sound and practical medicinal chemistry 
strategies are needed (Aronov 2006; Stansfeld, Gedeck et al, 2007; Judd, Souers et al, 2008; 
Lagrutta, Trepakova et al, 2008).  
Because of the undesired activity, hERG liability evaluation has become a routine 
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practice in the early stage of drug discovery. Among all assays for hERG blockade 
evaluation, conventional patch-clamp electrophysiology remains the ‘gold-standard’. It 
directly measures the current passing through hERG channels, and provides the most 
complete and reliable data about the interaction between a drug and the various 
conformational states (e.g. open, closed, and inactivated states) of a channel, but it is costly, 
labor-intensive, technic-demanding, time-consuming and low throughput (Fermini and Fossa 
2003; Jamieson, Moir et al, 2006; Hancox, McPate et al, 2008; Lagrutta, Trepakova et al, 
2008). Recently planar-patch-clamp such as IonWorks Quattro, PatchXpress, Q-Patch, etc. 
reported improved throughput (Kiss, Bennett et al, 2003), but with new issues, for instance, 
artifacts related to compound loss during delivery (Lagrutta, Trepakova et al, 2008), and 
variable and compound-specific potency shift (Sorota, Zhang et al, 2005). Some other higher 
throughput methods that do not measure functional hERG current but act as surrogates for 
prediction of hERG blockade have been developed, such as radio-ligand binding assay, 
rubidium (Rb+) efflux assay, etc, but each of them has drawbacks. Radioligand binding assay 
(Chiu, Marcoe et al, 2004; Diaz, Daniell et al, 2004) detects compounds that compete for the 
same binding site of the labeled ligands, not their activity on ion channel function – it   can’t 
distinguish agonists from antagonists, nor detect weaker compounds or compounds binding 
to different sites (Fermini and Fossa 2003; Jamieson, Moir et al, 2006);  Rubidium (Rb+) 
efflux assay exhibited a right shift in inhibition potency of the hERG channel as compared to 
those measured using electrophysiological techniques (Chaudhary, O'Neal et al, 2006), so it  
lacks the sensitivity required to accurately determine the potency of blockade under high 
concentration of K+,  thus it can generate false negatives. Functional in vitro assays such as 
depolarization assays utilize voltage-sensitive fluorescent dyes to measure actual changes in 
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the membrane potential of cells. However, depolarization is not linearly correlated with 
current inhibition, and fluorescence artifacts of compounds can confound interpretation of 
results (Lagrutta, Trepakova et al, 2008). Thus the methods are prone to generate false-
negative results with less potent inhibitors (Murphy, Palmer et al, 2006).  Considering the 
pros and cons of experimental assessment of hERG inhibition, reliable, efficient and cost-
effective in silico predictive tools are needed for the screening and optimization of drug 
candidates (Witchel, Hancox et al, 2003; Gavaghan, Arnby et al, 2007).  
Survey of hERG blockade In Silico Predictions  Approaches for in silico prediction 
of hERG blockade fall into two major categories: target-based or ligand-based (Recanatini, 
Poluzzi et al, 2005). A typical, target-based approach that employed homology modeling, 
docking and sometimes molecular dynamics (Witchel, Dempsey et al, 2004; Osterberg and 
Aqvist 2005; Rajamani, Tounge et al, 2005; Choe, Nah et al, 2006; Farid, Day et al, 2006; 
Du, Li et al, 2007) provides an insight into molecular interactions between drugs and key 
binding-site residues that are identified by mutagenesis (Pearlstein, Vaz et al, 2003; 
Rajamani, Tounge et al, 2005; Farid, Day et al, 2006; Coi, Massarelli et al, 2008). As such, 
these models have been largely qualitative and descriptive rather than predictive (Sanguinetti 
and Mitcheson 2005). This in conjunction with the time cost limits its application for 
screening large databases. On the other hand, one needs to be aware that ligand binding to 
hERG channel is site and gating state dependent (De Ponti, Poluzzi et al, 2002); thus the 
assumption beneath homological approaches that test compounds share binding modes with 
known hERG inhibitors in a given state (closed, open, inactive) at known crucial binding 
sites with similar orientation may not necessarily hold; otherwise controversial conclusions 
could be reached (Pearlstein, Vaz et al, 2003). Compared with homology model,
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Table 3.1. Summary of current studies of in silico prediction of hERG liability. 
Reference 
 
Data Descriptor Methods Accuracy Patterns Observations 
Endpoint Source Size 
Nisius et al, 
2009 IC50 L 242 MACCS 
Cluster 
SVM 85% 
Ring-6m 
HBA 
R-N+-Ar 
 
Chekmarev 
et al, 2008 IC50 L 83 
Shape 
signature 
kNN 
SVM 
SOM 
69-73%  
shape + 
polarity 
works better 
Jia & Sun, 
2008 IC50 E 
977 
655+/322- 
Atom 
Types SVM 
90% Trn 
94% Test 
Al-N+-Al 
Ar Ring 
H- 
+ ↑ 
−↓ 
Thai & Ecker, 
2008 IC50 L 285 
MOE-2D 
VSA 
CPG-NN 
PLS 
93% Trn 
83% Test 
Hyd 
SlogP 
Diameter 
VSA 
QuaSAR 
Contingency 
--Feature 
Selection 
Gavaghan et al, 
2007 IC50 E 8832 
DRONE 
Selma 
VolSurf 
Fragment 
Hierarchical 
PLS 78~96% 
Fragments 
Table 3 
IonWork 
HTS 
Gepp & Hunter, 
2006 
TdP 
QTc 
L 339 2D SMART 
Decision 
Tree 71% 
SMART 
Ar-N+-Ar  
Song & Clark, 
2006 IC50 L 90 Fragment 
SVR 
PLS 
RF 
0.91% Trn 
0.85% Test 
Fragments 
Table 3 
Sparse 
Linear 
SVR--FS 
H. Sun 
2006 IC50 E 1979 
Universal, 
FCFP-6 Bayesian 88% 
Atom types 
Table 3 Patch clam 
Seierstad & 
Agrafiots, 06 IC50 E 439 
Kier-Hall 
Atom Type 
Neural 
Network ~70% 
20 
Descriptors Patch clam 
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Reference 
 
Data Descriptor Methods Accuracy Patterns Observations 
Endpoint Source Size 
ISIS Keys 
Atom Pairs 
EState 
MOE 
Table 2 
Dubus et al, 
2006 IC50 E 203 2D MOE RP 81% 
LogP, VSA 
SMR 
 
Ekins 
et al, 06 IC50 L 99 
Smart 
Mining® 
SOM 
Sammon 
RP 
81-95% 
Hdy 
HBD 
S(=CH) 
S(>N-) 
 
AM Aronov 
2006 IC50 E 194 MOE 
Pharmacophore 
MOE 
5pt: 
70%~ 80% 
6pt: 
21%~44% 
Hyd, HBA 
ClogP 
Pharmaco 
-phores 
(2x5pt, 1x6pt) 
Neutral 
blocker; 
T623, S624 
Partial fit is 
sufficient 
Cianchetta et al, 
2005 IC50 E 882 GRIND 
HQSAR 
PLS 
r2=0.76 
q2=0.72 
N+--HBD 
HBA 
Hyd 
Charged & 
Neutral 
Blockers 
Aronov & 
Goldman, 2004 IC50 E 
414 
85+/329- 
Topology 
Pharmacophore 
Pharmacophore 
ensemble 82% 
CLogP 
MR, pKa 
 
 
Bains et al, 
2004 
IC50 
 
L 
 
124 Fragment GA EP 85-90% 
2 Hyd 
1 Ar 
1 N+ 
 
Roche 
et al, 2002 IC50 E 472 
TSAR 
CATS 
VolSurf 
Dragon 
SOM 
PLS 
PCA 
NN 
71% Blockers 
93% Non- 
Blockers 
2 motifs 
(1/0) 
Ar-N+-Ar 
Under-
represented 
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Reference 
 
Data Descriptor Methods Accuracy Patterns Observations 
Endpoint Source Size 
3D 
Cio et al,2008 EC50 E 18  
Homology 
MD 
Docking 
 
N+ 
Ar-G657/S624 
Hyd~F656/T652 
ECG 
g/kg?! 
C-State? 
Farid et al, 2006 IC50 C 11  
Homology 
Docking  
{N+-
F656/T652, 
Polar-S624, 
HB} 
KvAP 
(open) 
Rajamani et al, 
2005 IC50 L 32  
Homology 
LIE 
RMSD=0.5 
r2=0.82 
∆vdw 
outweighs 
∆ele 
Dual states 
KcsA (close) 
MthK(open) 
Pearlstein et al, 
2003 IC50 E 32  
Homology 
Docking 
CoMSiA 
q2=0.57 
Ar/Hyd-F656 
N+-T652 
Pore Diameter 
Loop Depth 
MthK 
(open) 
Cavali 
et al, 02 IC50 L 31  CoMFA 
r2=0.95 
q2=0.77 
2 Ar 
1 3rd N  
L: literature; E: experiment; HB(A/D): hydrogen bond acceptor/donor; Ar : Aromatic; Al: aliphatic; GA: genetic algorithm; EP: evolutional programming; kNN: k 
nearest neighbor; SVM: support vector machine; SOM: self organized map; Trn: training set; H-: acidic hydrogen; VSA: van der Waals surface area; CPG-NN: counter-
propagation neuron network; PLS: partial least square; Hyd: hydrophobic; SlogP: Log of the octanol/water partition coefficient (including implicit hydrogens); HTS: 
high throughput screening; TdP: torsade de piontes; QTc: QTcorrected; RF: recursive partition; SVR-FS: support vector regression feature selection; FCFP-6: Functional 
Connectivity Fingerprints with a neighborhood size of six bonds; EState; electrotopological state; SMR: Molecular refractivity (including implicit hydrogens); HQSAR: 
Hologram QSAR; NN: neural network; MD: molecular dynamics; ECG: electrocardiograph; KvAP/KcsA/MthK: the open/close/open state of K+ channel; LIE: linear 
interaction energy; ∆vdw: the change of van de walls energy; ∆ele: the change of electrostatic energy; CoMSiA: Comparative Molecular Similarity Indices Analysis; 
CoMFA: comparative molecular Field analysis
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pharmacophore model can be both descriptive and predictive (Cavalli, Poluzzi et al, 2002; 
Ekins, Crumb et al, 2002; Pearlstein, Vaz et al, 2003; Aronov and Goldman, 2004; Bains, 
Basman et al, 2004; Peukert, Brendel et al, 2004; Sanguinetti and Mitcheson 2005; Aronov, 
2006; Johnson, Yue et al, 2007; Leong 2007), thus it can have extensive applications to 
database screening. However, the application can be tricky: depending on the size and 
diversity of the dataset the pharmacophore is derived from, it could be too general for a huge, 
diverse dataset, or too specific for a small series of molecules; besides, considerable variation 
of pharmacophore features within or accross chemical series can be tolerated without 
significant reduction in potency of hERG blockade (Pearlstein, Vaz et al, 2003).  
Numerous QSAR studies on hERG blockade have been carried out using different 
collected or experimental datasets, different types of descriptors and various algorithms. 
Results at different levels of accuracy were achieved, and concordant or unique patterns were 
discovered (Table 3.1). Nisius et al used MACSS keys as descriptors and performed 
clustering followed by support vector machines (SVM) for a dataset of 242 compounds, and 
achieved 85% accuracy. They found essential patterns of 6-membered rings, hydrogen bond 
acceptors, etc. in hERG blockers (Nisius, Goller et al, 2009). Chekmarev and colleagues used 
shape signatures as descriptors with k nearest neighbors (kNN) QSAR, SVM and self-
organizing map (SOM) for a dataset of 83 compounds and demonstrated that shape and 
polarity worked better than shape alone (Chekmarev, Kholodovych et al, 2008). Jia and Sun 
used atom pairs as descriptors and the SVM for an experimental dataset of 977 compounds, 
and achieved above 90% accuracy for training and test sets (Jia and Sun 2008); Using 
SMART keys as descriptors (http://www.daylight.com) and the decision tree algorithm, 
Gepp and Hunter developed a pharmacophore model of basic nitrogen center with aromatic 
 43 
 
 
moeties based on a dataset of 339 compounds (Gepp and Hutter 2006). Cianchetta  and 
Aronov independently built predictive models and found that hydrophobicity and hydrogen 
bond acceptors are critical pharmacophore features for neutral hERG blockers (Cianchetta, Li 
et al, 2005; Aronov 2006). Dubus and Aronov separately found that LogP and molecular 
refractivity are critical for decision tree models to be highly predictive (Aronov and Goldman 
2004; Dubus, Ijjaali et al, 2006). However, the hERG liability screening used in the 
pharmaceutical industry can have positive rates as high as 60% (Zhou, Augelli-Szafran et al, 
2005; Shah 2006), which implies that the false positive rate is high. This necessitates more 
accurate and reliable in silico methods.  
Massive efforts have been made to elucidate molecular characteristics that indicate 
hERG blockade and use them to screen out blockers (Pearlstein, Vaz et al, 2003); only a few 
works have been published on eliminating hERG blockade or liability (Aronov 2008; Judd, 
Souers et al, 2008); even less research has been done on hERG activators. However, these in 
conjunction with the following questions deserve no less attention: what chemical 
characteristics of these two groups of compounds enable them to bind to the same target? 
what chemical characteristics decide them to have different activities? what chemical 
features can be modified to tune out hERG liability? Driven to tackle those interesting 
problems, we found these seemingly straightforward classification tasks have many 
challenging technique issues. 
Drugs that induce hERG blockade are known for their diversity   hERG K+ 
channel is known to be promiscuous – the binding ligands encompass diverse structural and 
therapeutic classes, which include antiarrhythmics, psychiatric, antimicrobial, antihistamine, 
etc. This unpredictability has frustrated conventional drug-design approaches to circumvent 
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the arrhythmia side effect (De Ponti, Poluzzi et al, 2002; Sanguinetti and Tristani-Firouzi 
2006). This promiscuous nature lies in the architecture of the channel: i) hERG is a 
homotetramer with each subunit containing six trans-membrane domains, in which S1-S4 are 
voltage sensors, S5 is pore helix, and S6 is pore region; ii) the presence of Y652 and F656 in 
S6 domain of each subunit are critical; high-affinity blocking drugs may form hydrophobic 
interactions with F656, or cation-π, or π stacking interaction with Y652, within or between 
different subunits, by basic tertiary nitrogen or aromatic groups (Mitcheson, Chen et al, 
2000; Farid, Day et al, 2006; Masetti, Bellei et al, 2007; Myokai, Ryu et al, 2008); iii) the 
spatial arrangement of the residues change with channel gating (Perrin, Subbiah et al, 2008); 
iv) the inner cavity is sufficiently large for big and structurally diverse compounds. The 
complexity of the drug-hERG interaction is a principal reason for the difficulty in providing 
an accurate assessment of hERG affinity from chemical structure (Recanatini, Cavalli et al, 
2008). 
hERG data set is imbalanced The impact of class imbalance on standard data 
mining algorithms and the reasons have been reviewed in depth (Provost 2000). Standard 
machine learning algorithms produce unsatisfactory classifiers for the following reasons: (i) 
standard machine learning algorithms are designed to maximize overall accuracy while 
minimizing overall error rate; (ii) class distribution in test set and training set are not 
necessarily the same, and the true misclassification costs may be unknown at learning time 
(Provost 2000; Weiss and Provost 2003); (iii) misclassification costs for different classes are 
different (Visa and Ralescu 2003), while many standard classification algorithms assume 
even distribution among classes. In such cases, standard classifiers tend to over-fit the larger 
class and ignore the smaller class (Chawla, Lazarevic et al, 2003). Numerous algorithms 
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have been proposed and their performance was demonstrated for imbalanced datasets (Abe 
2003; Chawla, Lazarevic et al, 2003; Ertekin, Huang et al, 2007). However, real world 
datasets may have unique data domain characteristics, such as class overlap, small 
disjuncts/clusters, outliers etc (Fig. 3.1), which all deteriorate performance of a classifier in 
addition to class imbalance; yet most algorithms address imbalance as the one and only issue, 
except for a few (Prati, Batista et al, 2004; Garcia, Alejo et al, 2006). What’s more, most 
currently available algorithms for imbalanced datasets presume that minority class is the 
target/interest class with the highest misclassification cost. This assumption may not always 
hold. In this study, both minority and majority classes are important, especially those 
instances from both classes that are close to a class boundary. On the other hand, unmet 
needs of knowledge discovery in real world datasets and its application set new goals for data 
mining, and they can only be achieved by algorithms that are fine tuned to domain 
characteristics and well adapted to data mining goals (Weiss 2004). For example, in the 
current study we wanted to learn from class boundary of the fine structure differences 
between blockers and inactives. Those structure features will give us clues about how to tune 
out hERG blockade in a lead.  
To the best of our knowledge, this is the first time hERG K+ channel blockers, 
inactives, and activators were included explicitly in QSAR modeling to address the 
aforementioned questions. We built highly predictive models and searched for distinguishing 
structural features that either promote or demote the inhibition or activation of hERG 
channel. The models retained and knowledge discovered will be useful in many areas: 
screening out hERG blockers or activators, lead optimization, the design of hERG-safe 
drugs, exploration of therapeutic potential of hERG openers for LQTS, and blockers for  
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SQTS, as well as govermental regulatory work. The challenge is to gain a better 
understanding of channel-drug interactions and use current drug series to identify the options 
of modifications that will successfully decrease hERG channel affinity. Herein, we present 
our study of building distinguishing models for blockers, activators and the inactives, and 
searching for patterns that promote or demote hERG liability.  
Methods 
Data The hERG assay that implemented by our collaborator – Dr Roth’s group uses 
a FlexStation II 96-well fluorescence plate reader and a proprietary membrane potential dye 
(Molecular Devices) based on a previously published protocol (Dorn, Hermann et al, 2005) 
with slight modification. The principle of the assay is that the membrane potential dye used 
in this assay partitions across cell membranes in a manner dependent on the plasma 
membrane-membrane potential: when the dye binds to cytosolic proteins, its fluorescence 
increases; when cells are depolarized, more dye enters the cells, and the intensity of the 
fluorescent signal increases; when cells expressing the hERG channel are depolarized, the 
Figure 3.1. Principal components analysis (PCA) of the hERG dataset showed outliers, class 
imbalance & overlap and small disjuncts. a(left): Blockers (red) and openers (blue) only. 
b(right): Blockers (red), openers (blue) and inactives (green). 
 
a 
 
b 
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Category Blockade 
Compound Number 
Before Cleaning After Cleaning 
 
Blockers ≥ 20% 203 193 
 
Inactives -20% ~ 20% 1725 1631 
 
Activators ≤ -20% 57 54 
 
Total -70% ~ 134% 1985 1878 
Table 3. 2: Statistics of working dataset hERG. 
fluorescent signal increases; however, when the hERG channel is blocked by a test 
compound, the increase of the fluorescent signal is much smaller.  The dataset contains 1985 
compounds, including 203 inhibitors, 57 activators, and 1725 inactive compounds. After 
cleaning the dataset to remove salts, metals, small fragments and inorganic compounds 193 
inhibitors, 54 activators and 1631 inactive compounds are left in the working set. 
 
Descr iptors:  
Dragon Descriptors   A set of 843 theoretical molecular descriptors was computed 
using DRAGON software (Talete s.r.l. Dragon, 2007). The descriptors were generated from 
the SMILES strings available for each compound. The descriptors include following types: 
0D constitutional (atom and group counts); 1D functional groups; 1D atom centered 
fragments; 2D topological descriptors; 2D walk and path counts; 2D autocorrelations; 2D 
connectivity indices; 2D information indices; 2D topological charge indices; 2D Eigenvalue-
based indices; 2D edge adjacency indices; 2D Burden eigenvalues; molecular properties. 
Dragon descriptors were range-scaled. Variables which had the same value for all 
compounds were deleted. If two descriptors were at least 98% correlated one of them was 
deleted. The final sets used in QSAR studies included about 350 descriptors. The definition 
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of these descriptors and related literature references are reported elsewhere (Todeschini, 
Ballabio et al, 2007). 
QSAR Modeling: 
Workflow The Combi-QSAR modeling workflow has been proved robust in 
many studies (Tropsha and Golbraikh 2007). Yet class imbalance poses big challenge to most 
of standard data mining algorithms and deteriorates their performance, especially when it is 
complicated with other data characteristics, such as class overlap, outliers, small 
disjuncts/clusters, to name a few. Class imbalance is a feature relatively easy to spot, if only 
class ratio were considered; while other data characteristics are less obvious, even hidden. 
Without a data domain analysis, those attributes will not be detected nor corrected therefore 
will degenerate classifiers’ performance. To avoid that, we incorporate data domain 
diagnosis into our standard workflow (Fig. 1.2), and then design classifiers targeting 
problems detected, such as Class Boundary Cleaning (CBC), Class Boundary Mining 
(CBM), Active Learning (AL), Cost sensitive Learning (CSL) etc. We also adapt classifier 
design to meet the needs in knowledge discovery and application, such as CBM for lead 
optimization. Each of the classifiers was explained in detail in methodology section of 
Chapter II.  To avoid redundance yet have enough information to refresh the memory for 
smooth transition, the principle of the methods (Fig. 3.2) will be illustrated briefly first, and 
then the usefulness of these approached will be demonstrated shortly.  
Class Boundary Cleaning (CBC) was designed to reduce class overlap as well as class 
imbalance. It was done by removing compounds of the majority class that close to those of 
minority class within certain distance thresholds. Rests of the compounds from both classes 
were combined as working dataset for kNN QSAR workflow.  
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Class Boundary Mining (CBM) was developed to mine class boundary, where 
compounds from different classes have similar structure but different activities, for fine 
structural differences between compounds from two classes. Replacing one of those structure 
features with another may turn a compound to opposite class. These structural patterns offer 
invaluable information for lead optimization.  
Active Learning (AL) was created to actively select most infrormative data (the 
examples near the classification boundaries) for training, rather than take data or class 
imbalance as it is. Thus, it could correct class imbalance, reduce training time, enhance data 
mining efficiency and still maintain the quality of resulting classifiers.  
Model development and validation Training, Test and External evaluation sets. After 
preprocessing, the datasets were randomly divided into modeling and external evaluation sets 
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AL = C+ + C-SC+
CBC = C+ + C-DC+ 
CBM = C+SC- + C-SC+
 
Figure 3.2 Illustration of some algorithms developed in this work: Class Boundary Cleaning 
(CBC), Class Boundary Mining (CBM) and Active Learning (AL). C-DC+: negative instances 
that are dissimilar to positive instances; C-SC+: negative instances that are similar to positive 
instances; C+DC-: positive instances that are dissimilar to negative instances; C+SC-: positive 
instances that are similar to negative instances 
 
 50 
 
 
which included about 85% and 15% of compounds of entire datasets, respectively. Modeling 
sets were further divided into multiple training and test sets of different sizes (see below). 
Training sets were used for building QSAR models. Test sets were used for validation of 
QSAR models. External evaluation sets were used for additional external validation of 
QSAR models which had high predictive accuracy of the training sets in the leave-one-out 
cross-validation procedure (see below) and the test sets. Consensus prediction was applied 
for external validation. Thus, external evaluation sets were used to simulate the prediction of 
compounds not included in the original dataset. In validation of QSAR models using test and 
external evaluation sets, predictions were made for compounds within rigorously defined 
applicability domains (AD). High prediction accuracy for external evaluation sets would 
corroborate predictive power of QSAR models and their applicability for classification of 
other compounds.  
In summary, the kNN-QSAR algorithm generates both an optimal k value and an 
optimal nvar subset of descriptors, that affords a QSAR model with the highest training set 
model accuracy as estimated by the CCR value. Further details of the kNN method 
implementation, including the description of the simulated annealing procedure used for 
stochastic sampling of the descriptor space, are given in our previous publications (Roberts, 
Myatt et al, 2000; Shen, Xiao et al, 2003; Ng, Xiao et al, 2004). 
Robustness of QSAR models Y-randomization (randomization of response) is a 
widely used approach to establish the model robustness. It consists of rebuilding the models 
using randomized activities of the training set and subsequent assessment of the model 
statistics. It is expected that models obtained for the training set with randomized activities 
should have significantly lower predictive accuracy for the test and external evaluation sets 
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than the models built using training set with real activities, or the total number of 
"acceptable" models based on the randomized training set satisfying the same cutoff criteria 
(CCR (train) > 0.7 and CCR (test) > 0.7) should be much lower (at least one order) than that 
based on the training set with real activities. If this condition is not satisfied, models built 
with real activities for this training set are not reliable and should be discarded. This test was 
applied to all data divisions considered in this study. 
Results 
Blockers vs. Activators 
Imbalance affected classifiers’ performance when modeling hERG K+ channel 
blockers vs. activators (Table 3.3). The in-house standard kNN QSAR category algorithm 
took class ratio as given, and achieved high CCR of 0.97, 0.96 and 0.84 for training, test and 
validation set, respectively; however, high sensitivity of 0.97 and low specificity of 0.71 in 
consensus prediction of the external validation set suggested that the classifier favored the 
majority class (blockers) more than the minority class (activators). CSL performed 
comparably with standard kNN QSAR category algorithm and attained CCR of 0.94, 0.90, 
and 0.76 for training, test and validation set, respectively; high sensitivity of 0.91 and low 
specificity of 0.60 in consensus prediction of the external set indicated that the class 
imbalance favored the majority class (blockers), and it was not compensated by the CSL 
effectly. One possible reason was that when dataset size is small, it is difficult to optimize 
weights and penalties to compensate the difference in true misclassification costs for 
different classes. Over Sampling (OS) performed similarly to standard kNN QSAR category 
algorithm for training and test set, but consensus prediction of external validation set result 
showed lower CCR, same accuracy for the majority class (blockers), lower accuracy for the  
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Table 3.3: Performance comparison for classifiers of hERG Blockers (B) vs. Activators (A) 
kNN + ... IR(B/A) Train. Test 
Validation Set 
CCR Sens. Spec. IR(B/A) CutOff Model# C 
Standard 193/54 0.97 0.96 0.84 0.97 0.71 30/7 0.90 6 1.0 
CSL 193/54 0.94 0.90 0.76 0.91 0.60 32/5 0.90 6 1.0 
OS 159/38 0.99 0.99 0.78 0.97 0.38 34/16 0.90 190 1.0 
RIOS_Inter 201/59 1.0 1.0 0.85 0.97 0.40 36/10 0.90 101 1.0 
RIOS_Intra 163/61 0.99 0.92 0.93 0.90 0.93 30/10 0.85 20 1.0 
OR 143/39 0.99 0.98 0.87 0.92 0.82 27/8 0.80 172 1.0 
CBC 109/41 0.98 0.96 0.95 1.0 0.90 16/10 0.90 124 1.0 
CBM_Z05 59/46 0.98 0.97 0.94 1.0 0.88 17/8 0.85 26 1.0 
AL 52/45 0.99 0.98 0.92 0.94 0.90 9/8 0.90 645 1.0 
IR: imbalance ratio; CCR: correct classification rate; Sens.: sensitivity; Spec.: specificity; C: coverage; CSL: 
cost sensitive learning; OS: oversampling, or up-sampling; RIOS_Inter: inter class rare instance over sampling; 
RIOS_Intra: intra class rare instance oversampling; OR: outlier removal; CBC: class boundary cleaning; CBM: 
class boundary mining; AL: active learning.  Blockers and activators were labeled as class 1 and 0, respectively. 
 
minority class (activators). One possible reason could be class ratio, or misclassification costs 
in training set are not necessary the same as those in the external validation set. Outlier 
Removal (OR) filter at threshold z = 0.5 worked effectively and accomplished CCR of 0.99, 
0.98 and 0.87 for training, test and validation set, respectively, and sensitivity of 0.92 and 
specificity of 0.82 in consens prediction of external validation set. CBC was effective in 
correcting class imbalance and achieved CCR of 0.98, 0.96, and 0.95 for training, test and 
validation set, respectively, and sensitivity of 1.0 and specificity of 0.90 for consensus 
prediction of external validation set. CBM proved useful in improving class imbalance with 
CCR of 0.98, 0.87 and 0.94 for training, test and validation set, respectively, and sensitivity 
of 1.0 and specificity of 0.88 in consensus prediction of the external validation set. AL was 
useful in reducing class imbalance, which was proven by CCR of 0.99, 0.98 and 0.92 for 
training, test and validation set, respectively, and then sensitivity of 0.94 and specificity of 
0.90 for consensus prediction of validation set. 
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Blockers vs. Inactives 
Class imbalance dramatically influenced the performance of classifiers when 
modeling hERG K+ channel blockers vs. inactive compounds (Table 3.4). The in-house 
standard kNN QSAR category algorithm took class ratio as given, and achieved CCR of 
0.81, 0.73 and 0.60 for training, test and external validation set, respectively; high specificity 
of 0.91 and low sensitivity of 0.29 in consensus prediction suggested that class imbalance 
favor the majority calss (the inactives) over the minority class (blockers). CSL improved 
performance compared with the standard kNN QSAR category algorithm, and attained CCR  
Table 3.4: Performance comparison for classifiers of hERG Blockers (B) vs. Inactives (I) 
kNN + ... IR(I/B) Train. Test 
Validation Set 
CCR Sens. Spec. IR(I/B) CutOff Model# C 
Standard 1385/164 0.81 0.73 0.60 0.29 0.91 244/29 0.70 3 1.0 
CSL 1385/164 0.99 0.98 0.72 0.44 1.0 244/29 0.70 4 1.0 
OR 1233/157 0.89 0.86 0.83 0.73 0.93 178/36 0.70 37 1.0 
CBC_Z25 169/163 0.99 1.0 0.96 1.0 0.92 24/35 0.90 185 1.0 
CBC_Z20 302/160 0.98 1.0 0.92 0.93 0.91 49/33 0.90 1000 1.0 
CBC_Z15 401/162 0.96 1.0 0.90 0.89 0.92 63/36 0.90 165 1.0 
CBC_D20 286/158 0.98 1.0 0.94 0.94 0.93 43/35 0.90 67 1.0 
CBM_Z0 200/145 0.95 1.0 0.91 0.87 0.96 33/28 0.80 3 1.0 
AL 266/193 0.87 0.82 0.77 0.68 0.86 35/34 0.70 140 1.0 
IR: imbalance ratio; CCR: correct classification rate; Sens: sensitivity; Spec: specificity; C: coverage; CSL: cost 
sensitive learning; OS: oversampling, or up-sampling; OR: outlier removal; CBC: class boundary cleaning; 
CBM: class boundary mining; AL: active learning. Blockers and inactives were labeled as class 1 and 0, 
respectively. 
 
of 0.99, 0.98 and 0.72 for training, test and validation set, respectively, but the improvement 
of sensitivity – prediction accuracy for the minority class to 0.44 was not significant. One 
possible reason is that weights and penalties used in the algorithm were not optimized to 
make up the difference in true misclassification costs for different classes. Outlier Removal 
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(OR) filter worked effectively and acccomplished CCR of 0.89, 0.86 and 0.83 for training, 
test and validation set, respectively, and sensitivity of 0.73 and specificity of 0.93 in 
consensus prediction of external validation set. CBC was effective in correcting class 
imbalance and achieved CCR of 0.98, 1.0 and 0.96 for training, test and validation set, 
respectively, and sensitivity of 1.0 and specificity of 0.92 for consensus prediction of 
validation set. CBM proved effective in improving class imbalance with CCR of 0.95, 1.0 
and 0.91 for training, test and validation set, respectively, and sensitivity of 0.87 and 
specificity of 0.96 in consensus prediction. AL was useful in reducing class imbalance and 
attained CCR of 0.87, 0.82 and 0.77 for training, test and validation set, respectively, and 
sensitivity of 0.68 and specificity of 0.86 for consensus prediction of external validation set. 
Activators vs. Inactives 
Class imbalance greatly influenced the performance of a classifier when modeling 
hERG K+ channel activators vs. inactive compounds (Table 3.5). The in-house standard kNN 
QSAR category algorithm took class ratio as given and achieved CCR of 0.93, 0.67 and 0.5 
for training, test and validation set, respectively; however, consensus models predicted 
perfectly for the majority class (the inactives) but had no prediction at all for the minority 
class (activators). CSL performed similary as in-house standard kNN QSAR in all aspects. 
OR slightly improved the performance compare with the former two algorithms. CBC was 
effective in correcting class imbalance and achieved CCR of 0.95, 0.98 and 0.89 for training, 
test and validation set, respectively, and sensitivity of 0.83 and specificity of 0.95 for 
consensus prediction of validation set. CBM (Z-cutoff=0) proved effective in attenuating 
class imbalance with CCR of 0.98, 0.98 and 0.83 for training, test and validation set,  
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respectively, and sensitivity of 0.89 and specificity of 0.78 in consensus prediction. The 
performance was better than that of CBM (Dis-cutoff=1.8), which implied z-cutoff may  
Table 3.5: Performance comparison for classifiers of hERG Activator (A) vs. Inactives (I).  
kNN + ... IR(I/A) Train. Test 
Validation Set 
CCR Sens. Spec. IR(I/A) CutOff Model# C 
Standard 1390/41 0.93 0.67 0.5 0 1.0 239/13 0.70 2 1.0 
CSL 1388/42 0.92 0.70 0.5 0 1.0 241/12 0.70 19 0.99 
OR 1013/32 0.96 0.74 0.54 0.13 0.96 177/8 0.70 1 0.89 
CBC_Z15 780/48 0.95 0.98 0.89 0.83 0.95 140/6 0.80 22 0.92 
CBC_Z25 423/43 1.0 1.0 0.89 0.82 0.96 71/11 0.90 161 1.0 
CBM_D18 51/17 1.0 1.0 0.75 0.67 0.83 6/6 0.80 4 1.0 
CBM_Z0 56/44 0.98 0.98 0.83 0.89 0.78 9/9 0.80 3 1.0 
AL_ZC0 56/45 0.95 0.95 0.78 0.78 0.78 9/9 0.80 4 1.0 
IR: imbalance ratio; CCR: correct classification rate; Sens.: sensitivity; Spec.: specificity; C: coverage; CSL: 
cost sensitive learning; OS: oversampling, or up-sampling; OR: outlier removal; CBC: class boundary cleaning; 
CBM: class boundary mining; AL: active learning. Activators and inactives were labeled as class 1 and 0, 
respectively. 
 
outperform distance cutoff as parameter in CBM algorithm, but it needed more investigation. 
AL was useful in reducing class imbalance, which was proven by CCR of 0.95, 0.95 and 0.78 
for training, test and validation set, repsectively, and 0.78 for both sensitivity and specificity 
in consensus prediction of external validation set. 
Actives vs. Inactives 
Class imbalance showed big impact on the performance of classifiers when modeling 
active compounds against inactive compounds for hERG K+ channel (Table 3.6). The in-
house standard kNN QSAR category algorithm took class ratio as given, and attained a 
barely acceptable CCR at 0.75, 0.63 and 0.59 for training, test and validation set, 
respectively; consensus prediction showed higher accuracy for the majority class – higher 
specificity than sensitivity. CBC (Dis-cutoff=2.8) was effective in correcting class imbalance 
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and achieved CCR of 0.96, 0.98 and 0.94 for training, test and validation sets, respectively, 
and sensitivity of 0.95 and specificity of 0.93 in consensus prediction of external validation 
set. CBC (Z-cutoff=1.5, IR=1.88) performed better than CBC (Z-cuttoff=1.0, IR=2.46), 
which suggested that CBC performed better as imbalance ratio decreased. CBM was useful 
in improving class imbalance too, and attained CCR of 0.83, 0.77 and 0.69 for training, test 
and validation sets, respectively, and sensitivity of 0.65 and specificity of 0.73 in consensus  
Table 3.6: Performance comparison of classifier of hERG Actives (A) vs. Inactives (I). 
kNN + ... IR(I/A) Train. Test 
Validation Set 
CCR Sens. Spec. IR(I/A) Cutoff Model# C 
Standard 1397/199 0.75 0.63 0.59 0.40 0.78 232/48 0.70 2 0.98 
CBC_D28 322/206 0.96 0.98 0.94 0.95 0.93 52/41 0.85 126 1.0 
CBC_Z10 578/156 0.92 0.89 0.72 0.70 0.74 91/37 0.80 2 0.94 
CBC_Z15 345/160 0.95 0.94 0.92 0.88 0.95 62/33 0.80 729 1.0 
CBM_D20 248/176 0.83 0.77 0.69 0.65 0.73 38/37 0.70 2 0.95 
AL_ZC0 245/205 0.98 0.94 1.0 1.0 1.0 38/42 0.80 16 1.0 
IR: imbalance ratio; CCR: correct classification rate; Sens.: sensitivity; Spec.: specificity; C: coverage; CSL: 
cost sensitive learning; OS: oversampling, or up-sampling; OR: outlier removal; CBC: class boundary cleaning; 
CBM: class boundary mining; AL: active learning. Actives and inactives were labeled as class 1 and 0 
respectively. 
 
prediction of external validation set. CBM did not outperform CBC probably because of class 
overlap. AL was proved effective in correcting class imbalance and accomplished CCR 
higher than 0.90 for training and test set, and perfect CCR, sensitivity and specificity for 
consensus prediction of external validation set. 
Discussion  
1. Compar ison with other  algorithms  
 To compare with our approaches in handling class imbalance and other factors that 
deteriorate classification, we performed studies with algorithms implemented in WEKA that 
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claimed to be less sensitive to class imbalance, such as Naïve Bayesian, SVM, Decision Tree 
etc, and meta-algorithms that increase performance of a weak classifier such as AdaBoost 
(Parameters for those algorithms were explained in Chapter II where the algorithms were 
first introduced). We took the same working sets as corresponding studies using in-house 
kNN QSAR classification algorithm, then randomly split them into training and test sets at 
the ratio of 85% : 15%.  Training set models were built by 10-fold cross validations, and then 
used to predict the test set. Results are reported and discussed below. 
 Blockers vs. Activators  
In this classification study, blockers were the majority class and activators the 
minority class with imbalance ratio was 193/54. Prediction accuracy (Table 3.7a) for 
majority class were overwhelmingly better than those of the minority classes in both traning  
Table 3.7a: Performance comparison among classifiers implemented in WEKA for study of 
hERG Blockers (B) vs. Activators (A). 
Classifiers 
Training Set Test Set 
TP Rate TN Rate ROCA TP Rate TN Rate ROCA 
kNN 0.85 0.57 0.70 0.88 0.33 0.61 
NB 0.68 0.74 0.76 0.71 0.67 0.73 
SVM 0.85 0.44 0.65 0.94 0.33 0.64 
DT 0.82 0.46 0.63 0.91 0.67 0.78 
RF 0.95 0.35 0.80 0.91 0.33 0.47 
MLP 0.87 0.44 0.78 0.91 0.33 0.59 
AdaBoost 0.91 0.26 0.72 0.94 0.33 0.77 
CVC 0.58 0.69 0.65 0.65 0.33 0.49 
kNN: k Nearest Neighbor; NB: Naïve Bayesian; SVM: Support Vector Machine; DT: Decision Tree; MLP: 
multilayer perceptron; AdaBoost: adaptive boosting; CVC: classification via clustering; TP Rate: true positive 
rate; FP Rate: False positive rate; ROCA: area under receiving operation curve (ROC). Blockers and activators 
were labeled class 1 and 0, respectively. 
 
and test set by all algorithms except Naïve Bayesian and Classification Via Clustering 
(CVC). This demonstrated the impact of imbalance at various degrees for different 
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algorithms. Naïve Bayesian showed much more stable performance across training set and 
test set than CVC. Like Random Forest, AdaBoost showed biggest gap between prediction 
accuracy for different classes, which suggested that boosting improved the performance of 
majority class more than that of minority class. 
 Blockers vs. Inactives 
In this classification study, blockers were the minority class and inactives the 
majority class with imbalance ratio of 193/1361. Except for Naïve Bayesian and CVC, 
prediction accuracies were above 0.90 for the majority class and below 0.30 for the minority 
class (Table 3.7b) by all the remaining algorithms. This demonstrated the impact of class  
Table 3.7b: Performance comparison among classifiers implemented in WEKA for study of 
hERG Blockers (B) vs. Inactives (I). 
Classifiers 
Training Set Test Set 
TP Rate TN Rate ROCA TP Rate TN Rate ROCA 
kNN 0.28 0.92 0.61 0.08 0.91 0.49 
NB 0.70 0.63 0.70 0.62 0.54 0.57 
SVM 0.12 0.99 0.56 0 0.98 0.49 
DT 0.23 0.94 0.56 0.08 0.94 0.58 
RF 0.14 0.98 0.68 0.10 0.98 0.49 
MLP 0.07 0.99 0.62 0.03 0.99 0.52 
AdaBoost 0.06 0.99 0.71 0 0.98 0.50 
CVCluster 0.31 0.42 0.44 0.42 0.42 0.50 
kNN: k Nearest Neighbor; NB: Naïve Bayesian; SVM: Support Vector Machine; DT: Decision Tree; MLP: 
multilayer perceptron; AdaBoost: adaptive boosting; CVC: classification via clustering; TP Rate: true positive 
rate; FP Rate: False positive rate; ROCA: area under receiving operation curve (ROC). Blockers and inactives 
were labeled class 1 and 0, respectively. 
 
imbalance on the performance of different algorithms. CVC seemed relatively less affected; 
Naïve Bayesian was the winner, with stable performance across different classes, training set 
and test set.  
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 Activators vs. Inactives 
In this classification study, activators were the minority class and inactives the 
majority class with imbalance ratio of 54/1361 -- the highest among all working datasets in 
this study. Apparently the impact of imbalance was so high that algorithms such as Support 
Vector Machine (SVM), Decision Tree (DT) and AdaBoost showed no prediction for 
minority class, and barely so in Random Forest (RF) and Multi Layer Perceptron (MLP). 
Except for Naïve Bayesian and CVC, prediction accuracy was above 0.90 for the majority 
class and below 0.30 for the minority class (Table 3.7c) by all the remaining algorithms. This 
demonstrated the impact of class imbalance on the performance of different algorithms. CVC 
appeared relatively less affected, and Naïve Bayesian seemed not affected and showed stable 
performance accross training set and test set, but the prediction accuracy for both classes 
needed to improve. 
Table 3.7c: Performance comparison among classifiers implemented in WEKA for study of 
hERG Activators (A) vs. Inactives (I). 
Classifiers 
Training Set Test Set 
TP Rate TN Rate ROCA TP Rate TN Rate ROCA 
kNN 0.13 0.98 0.70 0 0.96 0.61 
NB 0.76 0.46 0.76 0.6 0.53 0.73 
SVM 0 1 0.65 0 0.99 0.64 
DT 0 0.99 0.63 0 1 0.78 
RF 0.04 0.99 0.58 0.01 0.98 0.47 
MLP 0.01 0.98 0.57 0.01 0.99 0.49 
AdaBoost 0 1 0.72 0 1 0.77 
CVCluster 0.35 0.55 0.65 0.6 0.67 0.49 
kNN: k Nearest Neighbor; NB: Naïve Bayesian; SVM: Support Vector Machine; DT: Decision Tree; MLP: 
multilayer perceptron; AdaBoost: adaptive boosting; CVC: classification via clustering; TP Rate: true positive 
rate; FP Rate: False positive rate; ROCA: area under receiving operation curve (ROC). Activators and inactives 
were labeled class 1 and 0, respectively. 
 
 
 Actives vs. Inactives (Hit vs. Miss) 
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In this classification study, actives were the minority class and inactives the 
majority class with imbalance ratio of 247/1361. Because the actives included both blockers 
and activators, the classification problem was the most complicated among all tasks in this 
study. SVM, DT, RF, MLP and AdaBoost showed prediction accuracy higher than 0.9 for the 
majority class, and lower than 0.25 for the minority class. Compared to these, prediction 
accuracy gap between different classes by kNN and CVC were smaller, and kNN seemed 
slightly more robust than CVC for showing higher prediction accuracy in the majority class.  
Table 3.7d: Performance comparison among classifiers implemented in WEKA for study of 
hERG Actives (A) (B) vs. Inactives (I). 
Classifiers 
Training Set Test Set 
TP Rate TN Rate ROCA TP Rate TN Rate ROCA 
kNN 0.26 0.90 0.59 0.25 0.9 0.58 
NB 0.66 0.55 0.67 0.78 0.55 0.69 
SVM 0.29 0.89 0.59 0.38 0.89 0.63 
DT 0.23 0.93 0.55 0.18 0.93 0.51 
RF 0.14 0.98 0.56 0.11 0.97 0.48 
MLP 0.11 0.98 0.52 0.08 0.96 0.50 
AdaBoost 0 1 0.63 0 1 0.65 
CVCluster 0.33 0.65 0.48 0.65 0.54 0.60 
kNN: k Nearest Neighbor; NB: Naïve Bayesian; SVM: Support Vector Machine; DT: Decision Tree; MLP: 
multilayer perceptron; AdaBoost: adaptive boosting; CVC: classification via clustering; TP Rate: true positive 
rate; FP Rate: False positive rate; ROCA: area under receiving operation curve (ROC). Actives and inactives 
were labeled class 1 and 0, respectively. 
Irrespective of the imbalance ratio, Naïve Bayesian was the better predicter for the minority 
class (Table 3.7d).   
 In summary, the WEKA implementations of kNN, SVM, DT, RF, MLP were as 
sensitive to class imbalance as in-house kNN QSAR category with degraded performance. 
The claim that SVM, DT, etc. are less sensitive to class imbalance did not hold, probably 
because of other data characteristics besides class imbalance. NB did not seem to be 
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influenced by class imbalance; the less than ideal performance suggested that detrimental 
data structures other than class imbalance maybe involved, which necessitate data 
visualization and diagnosis before classifier design. On the other hand, CBC, CBM and AL 
show reasonable effectiveness in handling and correcting class imbalance, building 
predictive models and pattern discovery for applications. 
2. CBC, CBM and AL combined  with WEKA Algor ithms 
Having illustrated the effectiveness of CBC, CBM and AL in correctting class 
imbalance, overlap and improving performance of in-house kNN QSAR category algorithm, 
we performed another set of comparison studies to see whether these approaches would work 
the same for other algorithms. We preprocessed same working dataset with CBC, CBM and 
AL, split the data the same way into training sets and test sets, then built classification 
models with aforementioned algorithms implemented in WEKA with ten-fold cross 
validation, followed by examining the models with test sets. Results were reported in Table 
3.8a-d.  
In the study of Blockers vs. Activators (Table 3.8a), CBC and AL significantly 
improved the performance of each algorithm for both training and test sets in terms of True 
Positive (TP) Rate or sensitivity, True Negative (TN) Rate or specificity, and area under 
ROC when comparing with corresponding results in Table 3.7a. CBM notably improved the 
prediction accuracy for the minority class (activators) in both training and test sets at the 
price of the accuracy for the majority class (blockers) apparently. It is interesting to note that 
the performance of Naïve Bayesian was good and very stable – its performance improved the 
least by any of the three approaches; AdaBoost and kNN were the top two approaches whose 
performance were greatly improved.  
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In the study of Blockers vs. Inactives (Table 3.8b), CBC, CBM and AL drastically 
improved the prediction accuracy for the minority class (Blockers) – True Positive (TP) Rate 
or sensitivity, for both training and tests, as compared with almost zero prediction for 
minority class by the same algorithms (Table 3.7b). Areas under ROC curve were also 
improved greatly. Prediction accuracies for the majority class (Inactives) – True Negative 
(TN) Rate or specificity were comparable. The performance of Naïve Bayesian was 
demonstrated fair and stable – it was improved the least by any of the three approaches in 
performance comparing with other algorithms; while the improvement of SVM, AdaBoost, 
MLP, and kNN were impressive, especially for the minority class in test sets.  
In the study of Activators vs. Inactives (Table 3.8c), the class imbalance ratio was the 
highest among all studies. In decreasing order, CBM, AL and CBC improved the 
performance of each classifier in terms of prediction accuracy for the minority class 
(Activators) – True Positive (TP) Rate or sensitivity, and prediction accuracy for the majority 
class (Inactives) – True Negative (TN) Rate or specificity, area under ROC for both training 
and tests, as compared with the results of untreated data (Table 3.7c). This was the only case 
where CBC performed worse than the other two approaches, probably because the boundary 
between activators and inactives was way too complicated compared to those in other 
scenarios; while current implemented CBC was not sophisticated enough to clean up class 
boundaries that messy. Among all algorithms, Naïve Bayesian and CVC were the most 
robust and stable – they performed reasonably well; and their performance was improved 
only slightly by current three approaches. AdaBoost and kNN are the top two approaches 
whose performance was greatly improved.  
  In the study of Actives vs. Inactives (Table 3.8d), CBC significantly improved the
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Table 3.8a Performance comparison of WEKA algorithms in conjunction with CBC, CBM, and AL for study of Blockers vs. Activators 
Algorithms 
CBC CBM AL 
Training Set Test Set Training Set Test Set Training Set Test Set 
TP TN ROC TP TN ROC TP TN ROC TP TN ROC TP TN ROC TP TN ROC 
kNN 0.85 0.76 0.91 1.0 0.85 0.95 0.75 0.59 0.71 0.83 0.86 0.86 0.81 0.78 0.87 0.90 0.84 0.99 
NB 0.78 0.78 0.83 0.85 0.85 0.96 0.83 0.52 0.70 0.67 0.71 0.75 0.73 0.78 0.80 0.85 0.96 0.96 
SVM 0.85 0.66 0.76 1.0 0.62 0.97 0.78 0.72 0.70 0.58 0.71 0.76 0.83 0.84 0.84 0.89 0.91 0.90 
DT 0.81 0.54 0.71 0.85 0.54 0.69 0.71 0.61 0.63 1.0 0.71 0.81 0.75 0.67 0.77 0.94 0.98 0.97 
RF 0.89 0.56 0.89 1.0 0.77 0.96 0.76 0.54 0.70 0.67 0.71 0.79 0.81 0.82 0.88 1.0 1.0 1.0 
MLP 0.87 0.61 0.89 1.0 0.77 0.97 0.66 0.52 0.64 0.75 0.86 0.79 0.85 0.73 0.86 0.96 1.0 0.98 
AdaBoost 0.87 0.63 0.89 0.92 0.85 0.98 0.73 0.59 0.70 0.67 0.86 0.76 0.77 0.82 0.84 1.0 1.0 1.0 
CVC 0.62 0.98 0.80 0.77 0.92 0.85 0.80 0.67 0.74 0.58 0.71 0.65 0.63 0.71 0.64 0.73 0.87 0.80 
kNN: k Nearest Neighbor; NB: Naïve Bayesian; SVM: Support Vector Machine; DT: Decision Tree; MLP: multilayer perceptron; AdaBoost: adaptive  
boosting; CVC: classification via clustering; TP Rate: true positive rate; FP Rate: False positive rate; ROCA: area under receiving operation curve (ROC). 
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Table 3.8b Performance comparison of WEKA algorithms in conjunction with CBC, CBM, and AL for study of Blockers vs. Inactives. 
Algorithms 
CBC CBM AL 
Training Set Test Set Training Set Test Set Training Set Test Set 
TP TN ROC TP TN ROC TP TN ROC TP TN ROC TP TN ROC TP TN ROC 
kNN 0.88 0.85 0.95 0.94 0.93 0.98 0.38 0.82 0.62 0.52 0.73 0.63 0.43 0.80 0.70 0.68 0.74 0.75 
NB 0.85 0.84 0.88 0.87 0.78 0.91 0.58 0.73 0.63 0.52 0.89 0.78 0.62 0.75 0.72 0.71 0.74 0.79 
SVM 0.77 0.91 0.84 0.84 0.94 0.89 0.55 0.75 0.65 0.52 0.73 0.62 0.50 0.87 0.68 0.65 0.84 0.74 
DT 0.62 0.91 0.76 0.77 0.77 0.77 0.56 0.67 0.61 0.72 0.69 0.71 0.46 0.83 0.67 0.74 0.74 0.74 
RF 0.70 0.94 0.91 0.84 0.97 0.95 0.47 0.78 0.67 0.55 0.81 0.75 0.36 0.91 0.75 0.58 0.88 0.82 
MLP 0.78 0.92 0.91 0.87 0.97 0.94 0.57 0.73 0.72 0.59 0.77 0.70 0.51 0.85 0.78 0.58 0.88 0.84 
AdaBoost 0.74 0.85 0.86 0.74 0.93 0.92 0.54 0.70 0.62 0.52 0.77 0.70 0.44 0.83 0.71 0.61 0.88 0.82 
CVC 0.94 0.63 0.73 1.0 0.89 0.71 0.57 0.55 0.53 0.66 0.62 0.55 0.72 0.64 0.58 0.93 0.63 0.66 
kNN: k Nearest Neighbor; NB: Naïve Bayesian; SVM: Support Vector Machine; DT: Decision Tree; MLP: multilayer perceptron; AdaBoost: adaptive  
boosting; CVC: classification via clustering; TP Rate: true positive rate; FP Rate: False positive rate; ROCA: area under receiving operation curve (ROC). 
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Table 3.8c Performance comparison of WEKA algorithms in conjunction with CBC, CBM, and AL for study of Activators vs. Inactives. 
Algorithms 
CBC CBM AL 
Training Set Test Set Training Set Test Set Training Set Test Set 
TP TN ROC TP TN ROC TP TN ROC TP TN ROC TP TN ROC TP TN ROC 
kNN 0.52 0.95 0.84 0.33 0.96 0.84 0.55 0.74 0.51 0.5 0.6 0.60 0.47 0.84 0.64 0.44 0.89 0.63 
NB 0.67 0.80 0.80 0.83 0.87 0.92 0.46 0.89 0.65 0.56 0.78 0.77 0.42 0.84 0.59 0.67 1.0 0.83 
SVM 0.42 0.97 0.70 0.33 0.97 0.65 0.50 0.80 0.65 0.78 0.78 0.78 0.51 0.77 0.64 0.67 0.89 0.78 
DT 0.27 0.97 0.76 0.0 0.99 0.71 0.59 0.71 0.62 0.56 0.44 0.61 0.51 0.63 0.57 0.22 0.78 0.30 
RF 0.06 1.0 0.83 0.0  1.0 0.90 0.46 0.80 0.67 0.78 0.78 0.78 0.38 0.70 0.55 0.44 0.70 0.55 
MLP 0.37 0.91 0.70 0.0 0.89 0.57 0.63 0.73 0.70 0.78 0.89 0.88 0.53 0.68 0.64 0.56 0.44 0.58 
AdaBoost 0.15 0.99 0.82 0.33 0.98 0.92 0.52 0.84 0.67 0.67 0.67 0.74 0.40 0.66 0.51 0.33 0.56 0.54 
CVC 0.76 0.53 0.63 0.68 0.73 0.78 0.46 0.70 0.58 0.33 0.38 0.35 0.60 0.5 0.54 0.40 0.75 0.55 
kNN: k Nearest Neighbor; NB: Naïve Bayesian; SVM: Support Vector Machine; DT: Decision Tree; MLP: multilayer perceptron; AdaBoost: adaptive  
boosting; CVC: classification via clustering; TP Rate: true positive rate; FP Rate: False positive rate; ROCA: area under receiving operation curve (ROC). 
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Table 3.8d Performance comparison of WEKA algorithms in conjunction with CBC, CBM, and AL for study of Actives vs. Inactives 
Algorithms 
CBC CBM AL 
Training Set Test Set Training Set Test Set Training Set Test Set 
TP TN ROC TP TN ROC TP TN ROC TP TN ROC TP TN ROC TP TN ROC 
kNN 0.89 0.76 0.92 1.0 1.0 1.0 0.56 0.58 0.52 0.38 0.58 0.46 0.46 0.65 0.59 0.36 0.63 0.55 
NB 0.86 0.80 0.86 0.89 0.89 0.98 0.35 0.83 0.62 0.35 0.92 0.72 0.45 0.82 0.68 0.38 0.92 0.78 
SVM 0.75 0.92 0.84 0.89 0.98 0.94 0.48 0.79 0.63 0.51 0.84 0.68 0.53 0.80 0.67 0.43 0.92 0.68 
DT 0.64 0.73 0.69 0.86 0.93 0.93 0.40 0.77 0.59 0.38 0.84 0.65 0.52 0.71 0.62 0.45 0.82 0.64 
RF 0.75 0.89 0.87 1.0 1.0 1.0 0.42 0.78 0.64 0.46 0.79 0.61 0.53 0.75 0.70 0.43 0.84 0.70 
MLP 0.78 0.81 0.83 1.0 1.0 1.0 0.48 0.70 0.64 0.49 0.82 0.67 0.56 0.72 0.70 0.43 0.87 0.71 
AdaBoost 0.72 0.81 0.81 1.0 1.0 1.0 0.36 0.80 0.59 0.51 0.79 0.66 0.53 0.78 0.70 0.30 0.82 0.65 
CVC 0.90 0.70 0.73 0.90 0.70 0.70 0.64 0.52 0.53 0.67 0.50 0.53 0.56 0.53 0.52 0.57 0.68 0.56 
kNN: k Nearest Neighbor; NB: Naïve Bayesian; SVM: Support Vector Machine; DT: Decision Tree; MLP: multilayer perceptron; AdaBoost: adaptive  
boosting; CVC: classification via clustering; TP Rate: true positive rate; FP Rate: False positive rate; ROCA: area under receiving operation curve (ROC). 
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performance of each algorithm for both training and test sets in terms of prediction accuracy 
for the minority class (Actives) – True Positive rate or sensitivity, prediction accuracy for the 
majority class (Inactives) – True negative rate or specificity, area under ROC, as compared 
with the corresponding results in Table 3.7d, while the improvement through CBM and AL 
are modest. Once again Naïve Bayesian and CVC are the top two classifiers that are robust 
and stable – they performed better and their performance were improved the least by any of 
the three approaches; while the other algorithms improved significantly with respect to the 
prediction for the minority class; most likely they over-fit the majority class (Table 3.7d).  
In summary, among all WEKA implementations in comprison, Naïve Bayesian was the 
most robust algorithm -- the influence of class imbalance, and the improvement by CBC, 
CBM and AL each were moderate; the runner-up was CVC. On the other hand, performance 
of classifiers such as SVM, MLP, AdaBoost were greatly improved by CBC, AL and CBM 
in decreasing order. The possible reasons could be: class overlap had bigger impact than 
class imbalance on the performance of classifiers, and CBM was tackling the most 
challenging task among all.  
3. Knowledge discovery 
Highly predictive models can be used in virtual screening to speed up lead discovery. 
Knowledge or chemical structural patterns buried in those models have potential applications 
in lead optimization. After model building and testing by external validation set, we 
performed the frequent descriptor analysis of the models which were used in consensus 
prediction from each study. The support, confidence, p-value, and normalized frequency 
(sum of frequency of each descriptor within selected models normalized by the number of 
models) of each descriptor were calculated and reported in Table 3.9-3.12. The descriptors 
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with p-values lower than or equal to 0.05 are considered statistically significant; those with 
confidence around 0.7 or higher are regarded as promoting target activity, while around 0.4 
or lower as demoting corresponding that activity. Because working datasets (sample pool) 
are different after different preprocessing approaches, significant descriptors detected can be 
different. While the concordant descriptors confirm their significance; discrepant ones 
provide new perspective in structural features that responsible for hERG liability. In another 
put, one descriptor may not be detected by all three approaches; corresponding cells in the 
result tables (Table 3.9-3.12) were left blank on purpose if that was the case. 
 Structural features that differentiate Blockers and Activators 
Significant descriptors discriminating hERG channel blockers and openers are listed 
in Table 3.9. We found significant structural features/descriptors with p values equal to or 
less than 0.05 and confidence higher than 0.5, which imply they may promote hERG 
blockade. The features/descriptors include the following in the order of decreasing 
confidence: thiophenes/nThiophenes, benzene/nBnz, pyridine/(nPyridine, N-75), positive 
charged nitrogen/nN+, topological distance between Nitrogen and Chlorine atoms/T(N..Cl), 
topological polar surface area/TPSA(NO). The selection of thiophene is supported by reports 
that thiophene increase hERG affinity (Diller, 2009). Positively charged nitrogen, aromatic 
groups such as benzene ring, pyridine are known pharmacophores for hERG blockers 
(Cavalli, Poluzzi et al, 2002; Coi, Massarelli et al, 2008). The selection of TPSA is 
reasonable since polar interaction between uncharged ligand and residues Thr623, Ser624, 
Val625 at the binding cavity are critical for hERG channel blockade (Lagrutta, Trepakova et 
al, 2008). All three variants of benzene structure/descriptors, such as benzene ring/nBnz, 
unsubstituted benzene ring/nCbH, substituted benzene ring/nCb-, are chosen by the CBM 
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model building process; their confidences are different, which suggest that substitutions at 
the benzene ring can be an approach to convert a blocker into an activator or vice versa. 
Interestingly, molecular property descriptors such as Neoplastic-80, Psychotic-80, 
Hypertense-80, nflammat-80 were also picked up by model building and frequent descriptor 
analysis with fair confidence; this implies therapeutic potential of these compounds as 
anticancer, antipsychotic, anti-hypertension and anti-inflammatory drugs, which is consistent 
with literature reports: hERG blockers or activators have been suggested as potential 
therapeutic agents for cancer treatment (Chen, Jiang et al, 2005; Shao, Wu et al, 2005; 
Raschi, Vasina et al, 2008); hERG blockers as possible antipsychotic drugs (Shepard, 
Canavier et al, 2007); K channel openers were introduced into clinical practice in treatment 
of  hypertension (Mannhold 2004); Rofecoxib, the most widely used anti-inflammatory drug 
was withdrawn from market by Merk for high cardiovascular toxicity (Reddy, Mutyala et al,  
2007).  
We also identified significant structures/descriptors with p value no more than 0.05 
and confidence lower than 0.50, which suggests that they may demote hERG channel 
blockade. Those structures/descriptors are as follows: carboxylic acids (aliphatic)/nRCOOH, 
hydrogen bond donor/nHDon, nitriles (aliphatic)/nRCN, sulfonates/nSO3, Oxolanes/ 
nOxolanes. Carboxylic acid is a known pharmacophore demoting/decreasing hERG 
blockade, hydrogen bond acceptors are known for promoting hERG blockade (Cavalli, 
Poluzzi et al, 2002; Coi, Massarelli et al, 2008). It is reported that replacement of phenyl 
with nitrile leads to significant reduction in hERG activity (Bilodeau, Prasil et al, 2004). 
Heterocycles such as oxolanes, benzimidazole and pyrazole were reported to decrease hERG 
affinity (Jamieson, Moir et al, 2006; Diller and Hobbs 2007; Diller 2009). 
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Table 3.9: Significant frequent descriptors that discriminate hERG Blockers from Activators. 
 
Descr iptors CBC CBM AL 
 
Name Illustration Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. 
nThiophenes          0.35 0.03 1.00 0.10 
 
C-017 =CR2 0.31 0.09 0.95 0.03     0.28 0.09 0.92 0.02 
nR=Ct  
0.3 0.10 0.94 0.01 
        
nBnz 
number of  
benzene-like rings 0.23 0.51 0.91 0.00 0.25 0.80 0.55 0.00 0.43 0.79 0.72 0.00 
nCbH      1 0.77 0.68 0.00     
nCb-      0.38 0.80 0.55 0.00     
nPyridine          0.3 0.21 0.81 0.02 
 
N-075 R--N—X/R     1 0.42 0.67 0.04     
T(N..Cl) 
sum of topological 
distances between 
N..Cl 0.13 0.13 0.90 0.06         
nN+ 
number of positive  
charged N 0.23 0.15 0.89 0.07     0.24 0.14 0.75 0.05 
TPSA(NO) 
topological polar 
surface area using N, 
O polar contributions 0.12 0.38 0.70 0.01         
Neoplastic-80 
antineoplastic-like 
index at 80% 0.13 0.67 0.70 0.00         
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Descr iptors CBC CBM AL 
 
Name Illustration Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. 
Psychotic-80 
antipsychotic-like 
index at 80%     1 0.29 0.78 0.00 0.29 0.23 0.76 0.07 
Hypertens-80 
antihypertensive-like 
index at 80% 0.41 0.41 0.50 0.00         
Inflammat-80 
antiinflammatory-
like index at 80% 0.34 0.28 0.50 0.00 0.25 0.65 0.59 0.00     
BELe8 
Burden matrix / 
weighted by atomic 
Sanderson 
electronegativities 
0.32 0.88 0.72 0.04 0.25 0.92 0.51 0.01 0.32 0.89 0.68 0.01 
nHDon 
Number of  
H-bond donors     0.25 0.84 0.43 0.05     
 
N-074 R#N/R=N-         0.24 0.16 0.33 0.06 
C-040 
R-C(=X)-X 
R-C#X 
X=C=X 0.36 0.38 0.48 0.00     0.42 0.46 0.33 0.00 
 
C-030 X--CH--X 0.35 0.03 0.17 0.01     0.35 0.04 0.17 0.02 
nRCOOH          0.34 0.19 0.09 0.00 
 
C-031 X--CR--X 0.34 0.03 0.00 0.00 1 0.05 0.17 0.05 0.37 0.03 0.00 0.01 
Hypnotic-50 
hypnotic-like index  
at 50% 0.34 0.05 0.00 0.00     0.35 0.07 0.00 0.00 
nOxolanes  0.35 0.03 0.00 0.00     0.45 0.03 0.00 0.01 
 
nRCN  0.23 0.01 0.00 0.05         
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Descr iptors CBC CBM AL 
 
Name Illustration Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. 
nSO3  0.16 0.01 0.00 0.05         
Freq.: sum of frequency of each descriptor normalized by the number of selected models; Supp.: support; Conf.: Confidence; PV.: p values. 
Upper panel lists blocking descriptors for hERG channel, lower panel lists activating descriptors for hERG channel. 
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Figure 3.3 lists side by side of the chemical structural features that either promote 
hERG blockade (left) or demote blockade/promote activation (right); patterns and trends as 
options for lead optimization appear: substitution on the benzene ring seems to modulate 
hERG blockade; replacing “blocking” structure features of high confidence with those of low 
confidence, or with those “activating” structure features may decrese or remove hERG 
blockade of a lead compund. This Figure will be useful as quick refernce as options for lead 
optimization for hERG blockade reduction. Of course, lead optimization is a sophisticate 
process and more investigations are needed; nevertheless, cases confirmed by experiments 
are encouraging (Bilodeau, Prasil et al, 2004, Jamieson, Moir et al, 2006; Diller and Hobbs 
2007; Diller 2009). 
 
Figure 3.3 Structural features that discriminate hERG Blockers from Activators and  
suggest options for lead optimization.  
 
 Structural features that differentiate Blockers and Inactives  
Significant descriptors that differentiate hERG channel blockers and inactives are 
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listed in Table 3.10. We found significant structural features/descriptors with p values less 
than 0.05 and confidence higher than 0.5, which imply they may promote hERG blockade. 
The features/descriptors are as follows in the order of decreasing confidence: 
pyridines/nPyridines, thiophenes/nThiophenes, nitroarene/N-076, aryl amines/(nArNR2, 
nArNHR, nArNH2), aliphatic amines/nRNH2, basic nitrogen/nN+, hydrazones/nC=N-N<, 
azo-derivatives/nN=N, Chorine attached to C(sp2)/Cl-089, benzene rings/(nBnz, nCb-). 
Positively charged nitrogen, and aromatic center are known pharmacophores for hERG 
blockers(Cavalli, Poluzzi et al, 2002; Coi, Massarelli et al, 2008). The selection of 
TPSA(Tot) is consistent with report that polar interaction between uncharged ligand and 
residues at binding cavity are critical for hERG channel blockade(Lagrutta, Trepakova et al, 
2008). The selection of three types of aryl amines, which are tertiary, secondary and primary 
aromatic amines, and each with a different confidence, not only suggests their importance in 
discriminating hERG blockers from inactives, but also imply a way to tune out hERG 
blockade if wanted; aliphatic amine, whose confidence is comparable to primary aromatic 
amine, gives another option. Similarly, the selection of benzene ring/nBnz, and substituted 
benzene ring/nCb- with different confidence, is both a suggestion of importance and a hint 
for molecular optimization approach – making substitution at benzene ring and reducing 
hERG blockade. Once again, molecular properties descriptor Psychotic-80 was chosen by 
model building and frequent descriptor analysis with high confidence, which implies 
antipsychotic therapeutic potential for blockers and it’s consistent with literature reports 
(Shepard, Canavier et al, 2007).  
We also identified significant structures/descriptors with p value less than 0.05 and 
confidence lower than 0.50, which suggests that they may demote hERG channel blockade. 
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Table 3.10: Significant frequent descriptors that discriminate hERG Blockers from Inactives.  
 
Descr iptors CBC CBM AL 
 
Name Illustration Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. 
 
Psychotic-80 
antipsychotic-like 
index at 80% 0.21 0.12 0.94 0.00         
nPyridines  0.28 0.08 0.91 0.00         
nThiophenes          0.21 0.02 0.80 0.02 
 
C-037 Ar-CH=X         0.19 0.01 0.80 0.10 
N-076 
Ar-NO2 
R--N(--R)—O 
RO-NO 0.19 0.04 0.68 0.01     0.26 0.04 0.76 0.00 
 
N-066 Al-NH2         0.25 0.07 0.62 0.01 
nArNR2  0.17 0.05 0.89 0.00         
nArNHR  0.21 0.05 0.75 0.00         
nArNH2      0.33 0.06 0.56 0.12 0.19 0.06 0.58 0.07 
nRNH2      0.67 0.07 0.67 0.01     
 
nN+ 
number of positive  
charged N     0.33 0.10 0.74 0.00     
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Descr iptors CBC CBM AL 
 
Name Illustration Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. 
nC=N-N<  0.21 0.02 0.89 0.00         
 
nN=N  0.25 0.03 0.87 0.00         
 
Cl-089 Cl attached to C(sp2) 0.27 0.08 0.77 0.00 0.67 0.13 0.57 0.02     
 
nBnz 
number of benzene-
like rings 0.25 0.46 0.70 0.00         
nCb-  0.25 0.46 0.54 0.00         
 
nR06 
number of 6-
membered rings 0.22 0.69 0.52 0.00         
nRNR2  0.26 0.23 0.44 0.00         
 
nR05 
number of 5-
membered rings 0.3 0.35 0.44 0.01         
nOHt  0.22 0.03 0.43 0.10         
GATS5p 
Geary autocorrelation 
- lag 5 / weighted by 
atomic polarizabilities 0.18 0.93 0.40 0.00         
TPSA(Tot) 
topological polar 
surface area 
(N, O, S, P ) 0.28 0.99 0.37 0.04         
 
Neoplastic-80 
antineoplastic-like 
index at 80% 0.23 0.47 0.36 0.00     0.21 0.27 0.33 0.01 
 
nDB 
number of  
double bonds 0.22 0.69 0.23 0.00 0.33 0.68 0.36 0.00     
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Descr iptors CBC CBM AL 
 
Name Illustration Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. 
 
O-057 
phenol / enol / 
carboxyl OH         0.19 0.43 0.31 0.00 
 
nROH Al-OH 0.26 0.47 0.18 0.00     0.2 0.42 0.31 0.00 
nRCONHR  0.18 0.04 0.18 0.05     0.22 0.06 0.15 0.00 
nRCOOH      0.33 0.12 0.15 0.00 0.27 0.12 0.14 0.00 
N-072 
RCO-N< 
 >N-X=X 0.32 0.17 0.17 0.00 0.33 0.17 0.26 0.00 0.21 0.18 0.24 0.00 
nN-N  0.29 0.02 0.00 0.00         
Hypnotic-80 
hypnotic-like  
index  at 80%     0.67 0.35 0.30 0.00     
Freq.: sum of frequency of each descriptor normalized by the number of selected models; Supp.: support; Conf.: Confidence; PV.: p values. 
Upper panel lists descriptors that promoting hERG channel blockade, lower panel lists descriptors that demoting blockade. 
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Those structures/descriptors are as follows: aliphatic tertiary amines/nRNR2, 5-membered 
rings/nR05, tertiary alcohol/nOHt, topological polar surface area using N, O, S, P polar 
contributions/TPSA(tot), number of double bounds/nDB, phenol/enol/carboxyl hydroxyl 
group/O-057, aliphatic hydroxyl groups/nROH, aliphatic secondary amides/nRCONHR, 
aliphatic carboxylic acids /nRCOOH, amides/RCO-N<, hydrazines/nN-N. Carboxylic acid is 
known pharmacophore demoting/decreasing hERG blockade, hydrogen bond acceptors are 
know for promoting hERG blockade (Cavalli, Poluzzi et al, 2002; Coi, Massarelli et al, 
2008). The selection of different types of hydroxyl group suggests their significance in 
reducing hERG blockade, which was perfectly proved in experiment of reducing hERG 
liability by replacing terminal amino group with a hydroxyl group(Arena and Kass 1989; 
Wang, Salata et al, 2003; Mukaiyama, Nishimura et al, 2008). 
Figure 3.4 lists side by side of the chemical structural features that either promote 
(left) or demote (right) hERG blockade; patterns and trends as options for lead optimization 
appear: substitution on the aromatic amine group seems to modulate hERG blockade; 
replacing “blocking” structure features of high confidence with those of low confidence, or 
with those “inactive” structure features may decrese or remove hERG blockade of a lead 
compound, i.g. replacing terminal amino group with a hydroxyl group.  
This Figure will be useful as quick refernce as options for lead optimization for hERG 
blockade reduction. Of course, lead optimization is a sophisticate process and more 
investigations are needed; nevertheless, cases confirmed by experiments are encouraging 
(Arena and Kass 1989; Wang, Salata et al, 2003; Mukaiyama, Nishimura et al, 2008). 
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Figure 3.4 Structural features that descrimnate hERG Blockers from Inactives and suggest 
options for lead optimization  
 
 Structural features that differentiate Activators and Inactives 
Significant descriptors discriminating hERG channel blockers and activators are 
listed in Table 3.11. We found significant structural features/descriptors with p values lower 
than 0.05 and confidence higher than 0.5, which imply they may activate hERG channel. The 
features/descriptors include the following in the order of decreasing the confidence: C-041, 
urea (thio) derivatives/nCONN, and cynate or isocynates/N-074. These patterns are 
consistent with literature reports that cyano derivatives, such as Pinacidil and Saxitoxin, 
enhance potassium- sensitive current in heart cells (Arena and Kass 1989; Wang, Salata et al, 
2003). Interestingly, molecular properties descriptors such as Hypertense-50, Hypnotic-50, 
and Inflammat-50 were also picked up by model building and frequent descriptor analysis 
with fair confidence, which implies the therapeutic potential of these compounds as anti-
hypertension, anti-sedative and anti-inflammatory drugs. It is consistent with literature 
reports that by fact that Rofecoxib, the most widely used anti-inflammatory drug was 
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Table 3.11: Significant frequent descriptors that discriminate hERG Openers from Inactives.  
 
Descriptors CBC CBM AL 
 
Name Illustration Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. 
 
C-041 X-C(=X)-X         0.5 0.08 1.00 0.00 
nCONN  0.07 0.03 0.36 0.01 0.33 0.04 0.04 0.02 0.25 0.04 1.00 0.02 
nC(=N)N2  0.11 0.01 0.38 0.04         
 
Hypertens-50 
antihypertensive-like 
index at 50%         0.75 0.06 0.86 0.03 
 
Hypnotic-50 
hypnotic-like  
index at 50% 0.05 0.02 0.62 0.00         
 
Inflammat-50 
antiinflammatory-like 
index at 50% 0.02 0.02 0.50 0.00         
 
N-074 R#N / R=N-         0.25 0.13 0.80 0.00 
 
Neoplastic-80 
antineoplastic-like 
index at 80% 0.79 0.31 0.30 0.00     0.25 0.87 0.48 0.10 
nPyrazines  0.09 0.01 0.40 0.08         
nPyrroles  0.03 0.03 0.29 0.02         
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Descriptors CBC CBM AL 
 
Name Illustration Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. 
nOxolanes  0.07 0.03 0.29 0.02         
 
nHDon 
number of H-bond 
donors  (N and O)         0.25 0.94 0.43 0.03 
nO 
number of  
Oxygen atoms 1 0.79 0.06 0.10 0.33 0.94 0.40 0.03 0.25 0.93 0.42 0.02 
 
nROH          0.25 0.67 0.34 0.00 
nCrq  0.27 0.14 0.05 0.08     0.25 0.03 0.80 0.13 
nCrt       0.33 0.14 0.09 0.04     
 
C-028 R--CR--X     0.33 0.28 0.08 0.04 0.25 0.28 0.30 0.03 
 
C-031 X--CR--X 0.07 0.03 0.33 0.01 0.33 0.04 0.04 0.02     
 
C-041 X-C(=X)-X     0.33 0.08 0.08 0.00     
nR=Cs      0.33 0.16 0.04 0.06 0.25 0.17 0.30 0.10 
 
nR06 
number of 6-
membered rings 0.18 0.76 0.12 0.00         
 
Hypertens-50 
antihypertensive-like 
index at 50% 0.04 0.05 0.24 0.03 0.33 0.06 0.05 0.03     
Freq.: sum of frequency of each descriptor normalized by the number of selected models; Supp.: support; Conf.: Confidence; PV.: p values. 
Upper panel lists descriptors that promote hERG channel activation, lower panel lists descriptors that demoting hERG channel activation. 
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withdrawn from the market by Merck for high cardiovascular toxicity (Reddy, Mutyala et al, 
2007).  
We also identified significant structures/descriptors with p value lower than 0.05 and 
confidence lower than 0.50, which suggests that they may demote hERG channel blockade. 
Those structures/descriptors are as follows: carboxylic acids (aliphatic)/nRCOOH, hydrogen 
bond donor/nHDon, nitriles (aliphatic)/nRCN, sulfonates/nSO3, Oxolanes/nOxolanes. 
Carboxylic acid is known pharmacophore demoting/decreasing hERG blockade, hydrogen 
bond acceptors are known for promoting hERG blockade(Cavalli, Poluzzi et al, 2002; Coi, 
Massarelli et al, 2008). It is reported that replacement of phenyl with nitrile offered 
significant reduction in hERG activity (Bilodeau, Prasil et al, 2004). Heterocycles such as 
oxolanes, benzimidazole and pyrazole were reported to decrease hERG affinity (Jamieson, 
Moir et al, 2006; Diller and Hobbs 2007; Diller 2009). 
Figure 3.5 lists side by side of the chemical structural features that either promote 
(left) or demote (right) hERG activation; patterns and trend as options for lead optimization 
appear: replacing “activating” structure features of with those “inactive” structure features 
may decrese or remove hERG activation of a lead compound if needed. This Figure will be 
useful as quick refernce as options for lead optimization for hERG blockade reduction. Of 
course, lead optimization is a sophisticate process and more investigations are needed. 
 Structural features that differentiate Actives and Inactives 
Significant descriptors that discriminate hERG channel actives and inactives are listed 
in Table 3.12. We found significant structural features/descriptors with p values lower than 
0.05 and confidence higher than 0.5, which implies they may promote hERG liability. The 
features/descriptors include the following in the order of decreasing confidence:     
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     Figure 3.5 Structural features that discriminate hERG Activators from Inactives and suggest options for lead optimization  trihalomethyls/C-013, parasols/nPyrazoles, nitro or nitro oxide/N-076, thiazoles/nThiazoles, 
aromatic ethers/nArOR, aromatic hydroxyls/nArOH, azo-derivatives/nN=N, benzene/nBnz, 
6-membered rings/nR06, pyridine type structure/N-075, thiophenes/nThiophenes, primary 
aliphatic amines/nRNH2, topological distances between sulfur and chlorine/T(S..Cl), 
nitrogen and sulfur/T(N..S), nitrogen and oxygen/T(N..O). Interestingly, molecular properties 
descriptors such as Neoplastic-80 was picked up again by model building and frequent 
descriptor analysis with fair confidence, which implies antipsychotic therapeutic potential of 
these hERG blockers, which in turn is consistent with literature reports that hERG blockers 
are possible antipsychotic drugs(Shepard, Canavier et al, 2007).  
We also identified significant structures/descriptors with p value lower than 0.05 
and confidence lower than 0.50, which suggests that they may demote hERG channel 
liability. Those structures/descriptors are as follows: aromatic carboxylic acids /nArRCOOH, 
aliphatic carboxylic acids /nRCOOH, aliphatic secondary amides/nRCONHR, aliphatic 
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hydroxyl/nROH, and phenol/enol/ carboxyl hydroxyl groups/O-057. Carboxylic acid is a 
known pharmacophore demoting/decreasing hERG blockade(Jamieson, Moir et al, 2006). 
Our CBM results identified primary aliphatic amine/nRNH2 as a hERG-blockade-boosting 
feature and aliphatic hydroxyl group as a reducing one. Thus they can be used as an approach 
to tune out hERG liability, and this was perfectly demonstrated by experiment of replacing 
terminal amino group with a hydroxyl group(Mukaiyama, Nishimura et al, 2008).  
 Across different studies, we observed that hERG blockers contain structure patterns 
such as basic nitrogen/nN+, phenyl groups/(nBnz, nCb-), pyridines/nPyridines, 
thiophenes/nThiophenes, aryl or aliphatic amines/ (nArNR2, nArNHR, nArNH2, nRNH2), 
hydrazones/nC=N-N<, azo-derivatives/ nN=N, alkyl halides, while the inactive have 
structure patterns such as aliphatic tertiary amines/nRNR2, tertiary alcohol/nOHt, aliphatic 
hydroxyl groups/nROH, 5-membered rings/nR05, number of double bounds/nDB, 
amides/RCO-N<, hydrazine’s/nN-N, nitriles/nRCN, sulfonates/nSO3, Oxolanes/ nOxolanes. 
In principle, tuning out or reducing hERG blockade can be done by disrupting key 
interactions that involve structural features in the first group, or by replacing them with 
features from the second group. In practice, it has been proved that replacing the terminal 
amino group with a hydroxyl group (Mukaiyama et al, 2008), or replacing phenyl group with 
a nitrile group greatly reduced hERG blockade (Bilodeau, Prasil et al, 2004).   
Figure 3.6 lists side by side of the chemical structural features that either promote 
(left) or demote (right) hERG liability; patterns and trends as options for lead optimization 
appear: replacing “active” with those “inactive” structure features may decrese or remove 
hERG liability of a lead compound, i.g. replacing terminal amino group with a hydroxyl  
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     Table 3.12: Significant frequent descriptors that discriminate hERG Actives from Inactives.  
 
Descriptors CBC CBM AL 
 
Name Illustration Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. 
 
C-013 CRX3     0.5 0.02 0.88 0.01     
nPyrazoles  0.18 0.01 0.80 0.04         
N-076 
Ar-NO2   
R--N(--R)—O 
RO-NO     0.5 0.04 0.78 0.00     
nThiazoles  0.14 0.01 0.75 0.10         
 
nArOR  0.18 0.08 0.75 0.00         
 
nArOH  0.17 0.13 0.64 0.00         
 
nN=N  0.26 0.03 0.72 0.00         
nBnz 
number of 
benzene-like rings 0.16 0.48 0.59 0.00         
 
Neoplastic-80 
antineoplastic-like 
index at 80% 0.28 0.48 0.56 0.00         
 
nR06 
number of 6-
membered rings 0.16 0.72 0.53 0.00         
 
N-075 Pyridine-type structure 0.14 0.26 0.53 0.00         
nThiophenes  0.5 0.02 0.53 0.01 0.5 0.02 0.78 0.04     
nRNH2      1 0.08 0.65 0.00     
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Descriptors CBC CBM AL 
 
Name Illustration Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. Freq. Supp. Conf. PV. 
T(S..Cl) 
sum of topological 
distances between 
S..Cl     0.5 0.04 0.65 0.04 0.17 0.04 0.03 0.05 
T(N..S) 
sum of topological 
distances between 
N..S     0.5 0.21 0.53 0.01     
T(N..O) 
sum of topological 
distances between 
N..O 0.14 0.58 0.43 0.02 0.5 0.70 0.41 0.07     
 
Hypnotic-80 
hypnotic-like  
index at 80%     0.5 0.40 0.33 0.00 1 0.13 0.35 0 
 
O-057 
phenol / enol / 
carboxyl OH     0.5 0.49 0.33 0.00 0.17 0.59 0.23 0.00 
 
nROH      0.5 0.49 0.33 0.00 0.5 0.47 0.16 0.00 
nRCONHR  0.21 0.05 0.15 0.03 0.5 0.06 0.27 0.04 0.17 0.06 0.02 0.02 
nRCOOH  0.33 0.20 0.07 0.00 0.5 0.20 0.26 0.00     
nArCOOH          0.17 0.07 0.02 0.04 
 
C-031 X--CR--X             
     Freq.: sum of frequency of each descriptor normalized by the number of selected models; Supp.: support; Conf.: Confidence; PV.: p values.   
Upper panel lists descriptors that promoting hERG channel activation, lower panel lists descriptors that demoting hERG channel activation. 
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Figure 3.6 Structural features that discriminate hERG Actives from Inactives and suggest 
options for lead optimization 
 
group. This Figure will be useful as quick refernce as options for lead optimization for hERG 
blockade reduction. Of course, lead optimization is a sophisticate process and more 
investigations are needed; nevertheless, cases confirmed by experiments are encouraging 
(Arena and Kass 1989; Wang, Salata et al, 2003; Mukaiyama, Nishimura et al, 2008). 
 
4. CBC U CBM U AL should they cover  the entire data set? 
The purpose of the original design is to improve imbalanced dataset mining and 
knowledge discovery and application. For the hERG imbalanced dataset, the goal is to 
predicit hERG liability accurately, screent out the blockers and activators at early stage of 
drug discovery, and more importantly, discover patterns for lead optimization. That 
information is more likely locate at class boundary, the region in high dimensional chemical 
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descriptor space where compounds from different classes are similar to each other but have 
different activities. By exploreing class boundary, we may find out fine difference in 
chemical structures between two classes of compunds; that can be used to fne tune 
compound’s activity. For this popuse, class boundary is more informative thus more 
important than rest of the dataset; covering the whole data base is not necessarily the first 
priority. On the other hand, since the algorithms sample different distance thresholds, 
sufficient space shall be covered and learned given appropriate steps. As another point of 
view, the regions that covered by CBC and CBM do complement each other, and cover the 
entire data set. The concern of ‘loosing information’ is understandable but not necessary.  
Conclusions  
In mining the hERG dataset, we have built highly predictive and discriminatin models 
for hERG blockers, activators and inactives. We successfully identified structural features 
that either promote or demote hERG blockade, which were consistent with literature reports. 
These patterns can be used for mechanism explanation, drug screening, and lead optimization 
as well as tuning down the undesired hERG liability. This work shall benefit the 
pharmaceutical industry and governmental regulatory agencies, as well as academic research. 
We have demonstrated that CBC, CBM and AL are effective in reducing class imbalance, 
class overlap and improving performance of classifiers by many algorithms. We confirmed 
that data domain analysis is necessary to identify hidden data structures, thus a classifier can 
be designed to address those deteriorating data structure features, and make it possible to 
improve performance. 
  
 
 
 
 
CHAPTER IV  
Pattern Classification and Knowledge Discovery for Mutagenicity and  
Carcinogenicity in Carcinogenic Potency Database (CPDB) 
INTRODUCTION  
Accurate prediction of chemical carcinogenicity is a scientific issue of unquestionable 
importance. Cancer is the most feared disease in the modern world, and the second largest 
cause of death after heart disease. It affects one person in three at all ages, and causes 22.8% 
of all deaths in the United States in year 2006. According to the American Cancer Society, 
7.6 million people died from cancer in the world during 2007 (American Cancer Society, 
December 2007). In addition, cancer costs hundreds of billions of dollars in medical 
expenses each year. Besides threatening human health, it poses a huge economic burden on 
individuals and society. Cancer can be caused by chemical carcinogens, ionizing radiation, 
infectious diseases, hormonal imbalance, immunity system dysfunction, heredity, etc. Among 
all of the above causes, environmental and chemical carcinogenesis account for 85% (WHO, 
February 2006). Chemical carcinogenesis has been under intensive research for decades. 
Accurate prediction of chemical carcinogenicity is crucial for the prevention of chemically-
induced cancer.  
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It becomes more and more challenging to cope with numerous chemicals released to 
the environment each year that may cause potentially adverse effects on human health. As 
the gold standard for testing chemical carcinogenicity, rodent carcinogenicity bioassay is 
known to be expensive in terms of labor, animals, compounds and time consumed (Zeiger et 
al, 2004). As an alternative, fast and cost-effective short term genotoxicity tests that have 
been designed and routinely used include the following: Ames Salmonella mutagenicity 
assay (Ames et al, 1973), mouse lymphoma tk assay (MLA), in vivo mouse bone marrow 
chromosome aberration (CA), sister chromatid exchanges (SCEs), etc (Zeiger et al, 2004). 
Later studies showed lower sensitivity and predictivity values of Salmonella and other tests 
(Tennant et al, 1987; Zeiger et al, 1990), and high false negative rate (Brambilla and 
Martellli, 2004; Snyder et al, 2001) or low specificity in mammalian cells (Kirkland et al, 
2005; Kirkland et al, 2006). Standard three-test battery has been designed to avoid the risk of 
false negative results for compounds with genotoxic potential, but the risk cannot be 
eliminated completely for the following reasons: (i) these tests do not address all types of 
genetic damages that may be relevant to carcinogenicity, nor are they complementary in 
mechanisms (Zeiger et al, 1990; Zeiger et al, 2004); (ii) in vitro, rat liver S9 homogenate – 
the metabolic activation system – is artificial, while the biotransformation of chemicals is 
species-, sex- and tissue-specific (Ku et al, 1994); (iii) in vivo, the pharmacokinetic behaviors 
of the test compound are different (Brambilla and Martellli, 2004). On the other hand, the 
relatively high specificity of the Salmonella mutagenicity assay (Ames test) was offset by the 
low specificity of the established mammalian cell assays, which led to difficulties in the 
interpretation of the biological relevance of the results. In other words, sensitivity was 
improved at the price of specificity. This problem highlighted the deficiencies of using such 
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in vitro results to predict in vivo toxicity (Hastwell et al, 2006; Kirkland et al, 2005). In cases 
of high false positive rate (Kirkland et al, 2005), weight of evidence (WoE)(Weed et al, 2005) 
or mode of action (MoA) (Kirkland et al, 2007) arguments should be developed to determine, 
whether a positive in vitro genotoxicity result would be relevant for humans (Kasper et al, 
2005; Kirkland et al, 2005; Kirkland et al, 2007). Hastwell and colleagues reported the high 
specificity and high sensitivity of the Green Fluorescent Protein (GFP) test recently (Benigni 
and Richard, 1998), and Tice reported a fast, simple, and sensitive technique called Comet 
Assay to detect multiple classes of DNA damage in mammalian cells (Hartmann et al, 2003; 
Tice et al, 2000; Witte et al, 2007). It appears that the information available from short-term 
studies is currently insufficient to accurately and reliably predict the outcome of long-term 
carcinogenicity studies (Jacobs, 2005). Mayer and colleagues demonstrated that the SAR 
methods overall produced a higher concordance frequency and a lower percentage of false 
negatives than the overall genetic toxicity test methods (Mayer et al, 2008). 
Structural alerts (SAs) qualitatively points to the potential of a compound to induce 
cancer by direct DNA damage. Ashby and Tennant’s pioneering and influential work (Ashby, 
1985; Ashby and Tennant, 1988) on identification of SAs has been a great advancement in 
the understanding of chemical carcinogenesis and offers the possibility of designing safer 
compounds (Benigni and Richard, 1998). In spite of many successful cases (Benigni, 1997; 
Benigni, 2004), valid application of SAs demands expertise, caution, and awareness of the 
limitations. SAs illustrate key features of potential carcinogens which act through genotoxic 
mechanisms, but not by epigenetic mechanisms, which are not yet fully understood and the 
identification of the corresponding SAs has fallen far behind; likewise, the SAs for genotoxic 
non-carcinogens (false positives) are lacking. The SA list is far from exhaustive – it includes 
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mainly DNA reactive electrophilic groups, while non-genotoxic SAs are rarely identified and 
enlisted. Thus, the absence of known SAs does not gurrantee the safety of a compound: 
either it contains a new SA that has not yet been identified (Benigni, 1997; Benigni and 
Bossa, 2006), or it may become carcinogenic after metabolic activation. On the other hand, 
presence of SAs does not necessarily assure carcinogenicity either: a metabolic enzyme can 
detoxify the compound; other modulators co-presented in the same compound, including SAs 
from same category, may interfere with each other’s ability to induce carcinogenicity 
(Benigni, 1997; Benigni and Bossa, 2006; Klopman et al, 1994); or DNA repair mechanisms 
may fix the damage, etc. Thus, in many cases SAs can only function as warnings rather than 
predictors. Another obvious limitation is that SAs are identified by a human expert system. In 
the case of screening huge diverse databases to meet the needs of regulation, risk assessment 
and drug design etc, more powerful, efficient and reproducible methods such as virtual 
screening using QSAR models could be more appropriate. In fact, many computer programs 
have been developed because of this inspiring concept (Benigni and Richard, 1998; Witte et 
al, 2007), which includes knowledge-based systems such as DEREK, OncoLogic and 
HazardExpert, and statistics-based systems such as TOPKAT, and MultiCASE  etc. 
As for predictive performance of aformentioned software, wonderful reviews (Gold et 
al, 1984) and original research work (Greene, 2002) have been published. In their review, 
Benigni and Richard emphasized that expert systems are better at predicting toxicity than 
lack of toxicity, which implies high sensitivity and low specificity (Benigni, 1997; Richard et 
al, 2002b). DEREK suffers from a relatively low sensitivity and predictivity arising from 
insufficient structural coverage and limited understanding of genotoxic mechanisms (Snyder 
et al, 2001). OncoLogic employs hierarchy and decision tree structure with 40,000 rules over 
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10,000 compounds in 50 classes to provide carcinogenicity prediction with mechanism-based 
justification (Benigni and Giuliani, 2003). It has the largest training set and high concordance 
rate, but it does not take structural queries directly; Mayer and colleagues demonstrated 
(Mayer et al, 2008) that MCASE showed similar concordance degree with OncoLogic but 
broader applicability, relatively lower sensitivity and notably better specificity. OncoLogic 
revealed lower false negative rate, but false positive rates of both were high. MCASE built 
‘congeneric’ species-, sex-, gender- specific models; it got better concordance and specificity 
in local models than DEREK, but at expense of coverage and sensitivity (Greene, 2002). 
Cariello and coworkers reported that TOPKAT showed higher concordance than DEREK but 
higher false negative rate in bacteria mutagenicity prediction (Gariello and Wilson, 2002). 
Benigni reported that for the first NTP comparative exercise, most of the prediction systems 
showed high concordance in identification of powerful carcinogens, but high false positive 
rate for potential ones (Benigni, 1997; Benigni and Zito, 2004). Cariello and coworkers 
demonstrated high discordance, high false negative rate and high false positive rate in 
performance of DEREK and TOPKAT, respectively (Gariello and Wilson, 2002). As far as 
we can see, high false negative rate and false positive rate have always been problems for in 
silico toxicity prediction. Most of the commercial software demonstrated impressive 
predictivity for built-in training sets, but high false negative rate or false positive rate for 
external test sets, probably because not all compounds were within the optimal prediction 
space of the software (Golbraikh et al, 2003; Kazius et al, 2005; Kirkland et al, 2005). 
Many studies have been carried out to reduce false positive and false negative rates. 
For example, in 1998 Matthews and group (Matthews et al, 1998) optimized MCASE by 
adding more pharmaceuticals to the training set, optimizing assay evaluation criteria, 
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incorporating WoE in biophore carcinogenicity scaling, etc. As a result, more SAs have been 
found; concordance, coverage, sensitivity and specificity have been improved; false positive 
rate and, to some extent, false negative rates have been reduced. In 2006, they (Matthews et 
al, 2006) pooled in silico and experimental data which composed ~70% and ~30% of all the 
data, respectively, then ran MC4PC (Multicase Inc., 2006) to predict rodent carcinogenicity, 
and achieved up to 88% concordance. Recently, our group (Zhu et al, 2008) published work, 
in which NTP-HTS cell viability assay data and physicochemical descriptors were combined, 
and the overall animal carcinogenicity prediction improved. Votano and colleagues 
collaborated with our group and demonstrated that consensus prediction (Votano et al, 2004) 
by highly predictive models improved the overall predictive power for datasets which were 
not in the optimal prediction space of commercial software. Mayer stressed (Mayer et al, 
2008) that the use of multiple SAR programs and expert analysis often increases the 
robustness of the results and the percentage of concordance, while false positive and false 
negative rates are decreased. For the foreseeable future, the consensus approach would 
appear to hold out the best promise of being able to make acceptable predictions of chemical 
toxicity (Dearden, 2003).  
Previously, false negatives and false positives were mainly treated as statistical 
prediction errors for carcinogenicity. Not much systematic research has been done to 
elucidate the chemical mechanistic information behind the phenomenon, and thus to 
differentiate false negatives and false positives from genotoxic carcinogens better. 
Consequently, method development ended up improving sensitivity at the price of specificity 
or vice versa. To solve the problem, we need to look deeper into the chemical patterns that 
make a compound with SAs a false negative (non-genotoxic carcinogen) or a false positive 
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(genotoxic non-carcinogen). We expect that our approach will be useful for reducing the risk 
of hidden hazards, undue concerns and expense for animal toxicity tests.  
To achieve this goal, we used a novel approach for examining the dataset and model 
building. By using mutagenicity and carcinogenicity at the same time, we dissected the 
dataset into four groups: genotoxic carcinogens, non-genotoxic carcinogens (false negatives), 
genotoxic non-carcinogens (false positives) and non-genotoxic non-carcinogens. Then we 
carried out the kNN QSAR modeling. Highly predictive models were subjected to frequent 
descriptor profiling in order to characterize these four groups of compounds and the 
differences between them. The results were compared with those obtained by using the 
Leadscope (Roberts et al 2000) and Lazar (Helma, 2000) software. Besides, high 
classification accuracy of our models built for mutagenicity and carcinogenicity was 
corroborated by predictions for 28 novel CPDB compounds which were not included in 
training, test and external evaluation sets.  
We believe that our work will improve the understanding of chemical mechanisms of 
mutagenicity, carcinogenicity, epigenicity and genotoxic non-carcinogenicity, and improve 
the prediction for those toxicities. It also will be helpful in prioritizing comound toxicity 
screening, drug design and discovery, and govermental regulatory work.  
METHODS  
Data Source: 
Berkeley Carcinogenic Potency Database (CPDB). The CPDB provides a 
systematic and unifying source of outcomes from in vivo animal chemical carcinogenicity 
studies. The most recent release of the CPDB includes experimental data for 1,481 diverse 
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chemicals obtained for one or both sexes of rats and mice and other species, and reports 
outcomes for 35 possible target organ/tissue sites.  
A chemical structure-annotated version of the CPDB summary tables with additional 
summary activity categorization (CPDBAS_v3a_1481_22Oct2005, for latest update please 
see http://www. epa.gov/ncct/dsstox/sdf_cpdbas.html) was used in this study. Endpoints used 
for category modeling are "Salmonella Mutagenicity” and "ActivityCategory_Single 
CellCall" Carcinogenicity data from the summary table. We preprocessed the data by 
excluding those entries that had missing structures or Salmonella Mutagenicity readings, and 
inorganic chemicals (salts and metals). For isomers, duplicates and triplicates, we kept a copy 
with positive mutagenicity and/or carcinogenicity, if any. Chiral compounds were removed 
as well. Thus, we have created a working set of 693 compounds, which included 252 
mutagenic carcinogens, 172 non-mutagenic carcinogens, 85 mutagenic non-carcinogens 
(false positives), and 184 non-mutagenic non-carcinogenic compounds (Table 1). Combining 
these four categories of compounds, we had created working datasets of 337 mutagens vs. 
356 non-mutagens for Mutagenicity study, 424 carcinogens vs. 269 non-carcinogens for 
Carcinogenicity modeling, 252 mutagenic carcinogens vs 184 non-genotoxic non-
carcinogens for Genotoxic Carcinogenicity study, 252 mutagenic carcinogens vs. 172 non-
mutagenic carcinogens for  study I and 172 non-mutagenic carcinogens vs. 184 non-
genotoxic non-carcinogens for False Negative Carcinogenicity study II, 252 mutagenic 
carcinogens vs. 85 mutagenic non-carcinogens for  study I and 85 mutagenic non-
carcinogens vs. 184 non-mutagenic non-carcinogens for False Positive Carcinogenicity study 
II. 
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Molconn-Z Chemical Descriptors  The Molconn-Z software (eduSoft LC, Ashland, 
VA USA) enables the computation of a wide range of topological indices for molecular 
structures. These indices include, but are not limited to, the following descriptors: simple and 
valence path, cluster, path/cluster and chain molecular connectivity indices, kappa molecular 
shape indices, topological and electrotopological state indices, differential connectivity 
indices, graph’s radius and diameter, Wiener and Platt indices, Shannon and Bonchev-
Trinajstić information indices, counts of different vertices, counts of paths and edges between 
different kinds of vertices (Hall et al, 1991; Kier and Hall, 1991). Overall, Molconn-Z 
(eduSoft LC) produces more than 800 different descriptors. Those with zero variance were 
removed. The remaining descriptors were range-scaled since the non-scaled Molconn-Z 
(eduSoft LC) descriptors are in different units and can differ by orders of magnitude. 
Therefore, descriptors with significantly higher ranges will not be weighted disproportionally 
upon distance calculations in multidimensional descriptor space as well as in feature 
selection during kNN model building procedure. 
Dragon Descr iptors  A set of 843 theoretical molecular descriptors was computed 
using DRAGON software (Talete s.r.l. Dragon, 2007). The descriptors were generated from 
the SMILES strings available for each compound. The descriptors included following types: 
0D constitutional (atom and group counts); 1D functional groups; 1D atom centered 
fragments; 2D topological descriptors; 2D walk and path counts; 2D autocorrelations; 2D 
connectivity indices; 2D information indices; 2D topological charge indices; 2D Eigenvalue-
based indices; 2D edge adjacency indices; 2D Burden eigenvalues; molecular properties. 
Dragon descriptors were range-scaled. Variables which had the same value for all 
compounds were deleted. If two descriptors were at least 98% correlated one of them was 
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deleted. The final sets used in QSAR studies included about 350 descriptors. The definition 
of these descriptors and related literature references are reported elsewhere (Todeschini et al, 
2007). 
Frequent Subgraph Descr iptors Frequent Subgraph Descriptors is an algorithm 
recently developed in the lab (R. Khashan dissertation, 2007). The principle of this method is 
to represent molecules by graphs, then use subgraph mining tools to facilitate exploring the 
information encoded in data. This method can be used to find the frequent subgraphs 
(chemical fragments) that occur in at least a certain percentage of the ligands in the dataset. 
These chemical fragments will be used as molecular descriptors for the quantitative structure-
activity relationship (QSAR) studies. They will also be used for identifying the 
pharmacophores responsible for the activity as well as the toxicophores responsible for the 
toxicity of a datasets of molecules. Compared with descriptors with fixed types and sizes in 
built-in functional group library in commercial software, descriptors generated by this 
method will be more dataset specific; thus it will be more likely to find novel structure 
features that are responsible for particular activity. 
Applicability Domain (AD) of kNN QSAR Models      Theoretically, a QSAR model 
can predict the target property for any compound, for which chemical descriptors can be 
calculated. However, this compound can be very far from all compounds of the training set in 
the descriptor space, i.e. it can be dissimilar from all compounds of the training set. In this 
case, reliable prediction for this compound is impossible. Thus, a model AD (i.e. the 
dissimilarity threshold) should be introduced to avoid making predictions for compounds that 
differ substantially from the training set molecules. Suppose that a model includes M 
descriptors, i.e. each compound can be represented by a point in the M-dimensional 
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descriptor space with the coordinates Xi1, Xi2,..., XiM, where Xis are the values of individual 
descriptors. The molecular dissimilarity between any two molecules is characterized by the 
Euclidean distance between their representative points. The Euclidean distance d,ij between 
two points i and j (which correspond to compounds i and j) in M-dimensional space is 
calculated as follows (Eq. 4): 
    ( )∑
=
−=
M
k
jkikij XXd
1
2      [4] 
Compounds with the smallest distance between one another are considered to have the 
highest similarity. Let y and σ be the mean and standard deviation of distances between 
compounds and their K nearest neighbors in the training set, then the applicability domain 
threshold, ADT, is defined as follows (Eq. 5): 
    ADT = y +  Zσ        [5] 
Here, Z is an arbitrary parameter called Z-cutoff. Based on previous studies (Shen et al, 
2002), we set the default value of this parameter to 0.5. Thus, if the distance of the external 
compound from the closest of its k nearest neighbors in the training set exceeds this 
threshold, the prediction is not done.  
Robustness of QSAR models         Y-randomization (randomization of response) is a 
widely used approach to establish the model robustness. It consists of rebuilding the models 
using randomized activities of the training set and subsequent assessment of the model 
statistics. It is expected that models obtained for the training set with randomized activities 
should have significantly lower predictive accuracy for the test and external evaluation sets 
than the models built using training set with real activities, or the total number of 
"acceptable" models based on the randomized training set satisfying the same cutoff criteria 
(CCR (train)>0.7 and CCR (test)>0.7) should be much lower (at least one order) than that 
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based on the training set with real activities. If this condition is not satisfied, models built 
with real activities for this training set are not reliable and should be discarded. This test was 
applied to all data divisions considered in this study. 
Outline of research 
 
We started the studies by dissecting the dataset of compounds with known 
mutagenicity and carcinogenicity into four groups (Table 4.1). In contrast with most of the 
QSAR studies targeting one endpoint at a time, we built QSAR category models using 
combinations of different groups of compounds to address various issues outlined below.  
1. Mutagenicity models (337 mutagens vs. 356 non-mutagens) 
2. Carcinogenicity models (424 carcinogens vs. 269 non-carcinogens)   
3. Genotoxic carcinogenicity models (252 genotoxic carcinogens vs. 184 non-genotoxic 
non- carcinogens) 
4. False negative carcinogenicity models I (252 genotoxic carcinogens vs. 172 non-
genotoxic carcinogens) 
5. False negative carcinogenicity models II (172 non-genotoxic carcinogens vs. 184 non-
genotoxic non- carcinogens) 
6. False positive carcinogenicity models I (252 genotoxic carcinogens vs. 85 genotoxic 
non-carcinogens) 
7. False positive carcinogenicity models II (85 genotoxic non-carcinogens vs. 184 non-
genotoxic non-carcinogens) 
(The following pairs of terms, mutagenic and genotoxic, genotoxic non-carcinogens and false 
positives, nongenotoxic/epigenetic carcinogens and false negatives are used 
interchangeably.) 
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By analyzing our models, we were able to characterize the chemical features of false 
positive and false negative carcinogens, and differentiate them from genotoxic carcinogens 
instead of treating them only as modeling errors for carcinogenicity. Thus, the models built 
have improved predictivity, reduced false negative rate or false positive rate of potential  
 
Table 4.1: Statistics of working datasets in mutagenicity and carcinogenicity of compounds. 
 
Observations Mut+ Mut- Total 
Car+ 252 172 424 
Car - 85 184 269 
Total 337 356 693 
Mut+: mutagenic; Mut-: not mutagenic; Car+: carcinogenic; Car-: not carcinogenic;  
Mut+Car+: mutagenic and carcinogenic; Mut+Car-: mutagenic but not carcinogenic;  
Mut-Car+: not mutagenic but carcinogenic; Mut-Car-: neither carcinogenic nor mutagenic 
 
carcinogens; and the patterns found would explain why compounds which contain SAs only 
turned out to be false negatives or false positives. Thus, we are trying to address some 
important questions that have impeded carcinogenicity studies for a long time.  
 
Results I: Pattern Recognition and Knowledge Discovery Modeling with Dragon, FSG 
Descr iptors  
1) Mutagenicity Models ( mutagens vs. non-mutagens) 
For mutagenicity modeling, 105 out of 693 compounds were randomly selected as the 
external evaluation set; the remaining 588 compounds were used as a modeling set. The 
modeling set was then partitioned into pairs of training and test sets using sphere exclusion 
software for consequent kNN QSAR category model building. Feature selection was done by 
selecting descriptors ranging from 20 to 100 at step of 5. For each number of descriptors 
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selected and each division into training and test sets 10 models have been built and validated 
using the corresponding training and test sets (See Table 4.2 for result). The whole procedure 
was repeated three times, each time with a different external evaluation set, to prove that the 
model predictivity was not influenced by the way the dataset was split into external 
evaluation, training and test sets. Corresponding Y-randomization tests were performed (data 
not shown) to verify that the predictivity of models were not due to chance correlation.  
For one study using MolConnZ descriptors, 55 models with both CCR (train) and CCR 
(test) higher than 0.80 were attained then employed in the consensus prediction of the 
external evaluation set. CCR (external), sensitivity and specificity for consensus prediction  
 Table 4.2: Performance of kNN QSAR classification studies for Mutagenicity modeling 
(mutagens vs. non- mutagens)  
Descriptors Train. CCR 
Test 
CCR 
Val.  Consensus Prediction 
CCR Sens. Spec. CR Cutoff Mod. # 
MolConnZ 0.92 0.85 0.88 0.92 0.84 48/57 0.80 55 
Dragon 
FG 0.86 0.82 0.80 0.94 0.66 54/51 0.80 20 
Default 0.92 0.91 0.80 0.78 0.82 49/56 0.80 220 
Cust. 0.91 0.87 0.84 0.89 0.79 64/41 0.80 64 
FSG S20 0.88 0.81 0.78 0.85 0.70 54/51 0.80 3 
CCR: Correct Classification Rate; Sens.: sensitivity  TP/(TP+FN); Spec.: specificity TN/(TN+FP);     
FSG : Frequent Sub-graph Descriptor, S:  support;   FG: functional group ;   Cust.: customized 
 
were 0.92, 0.85 and 0.89, respectively; For one study using only functional group of Dragon 
descriptors set, 20 models with both CCR (train) and CCR (test) higher than 0.80 were 
obtained then used in the consensus prediction of the external evaluation set. CCR (external), 
sensitivity and specificity for consensus prediction were 0.80, 0.94 and 0.66, respectively; 
For one study using default setting of Dragon descriptors, 220 models with both CCR (train) 
and CCR (test) higher than 0.80 were attained then used in the consensus prediction of the 
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external evaluation set. CCR (external), sensitivity and specificity for consensus prediction 
were 0.80, 0.78 and 0.82, respectively; For one study using customized setting of Dragon 
descriptors set, 64 models with both CCR (train) and CCR (test) higher than 0.80 were 
obtained then used in the consensus prediction of the external evaluation set. CCR (external), 
sensitivity and specificity for consensus prediction were 0.84, 0.89 and 0.79, respectively; 
For one study using Frequent Subgraph descriptors, 3 models with both CCR (train) and 
CCR (test) higher than 0.80 were attained then used in the consensus prediction of the 
external evaluation set. CCR (external), sensitivity and specificity for consensus prediction 
were 0.78, 0.85 and 0.70, respectively. As shown by these results, the predictivity of models 
using MolConnZ descriptors, Default and Customized setting of Dragon descriptors are 
comparable, while those using Dragon functional group descriptors and Frequent Subgraph 
descriptors show slightly lower specificity in consensus prediction of external evaluation set. 
This suggests that physicochemical descriptors are critical in predicting mutagenicity more 
accurately than using functional group or frequent subgraph alone. 
2) Carcinogenicity Models (carcinogens vs. non-carcinogens) 
For carcinogenicity modeling, we used the same workflow, and the same dataset as for 
the mutagenicity study, but with the carcinogenicity endpoint. 105 out of 693 compounds 
were randomly selected as the external evaluation set, and the remaining 588 compounds 
were used as a modeling set. The modeling set was then partitioned into pairs of training sets 
and test sets using sphere exclusion software for consequent kNN QSAR category model 
building (See Table 4.3 for result). For one study using MolConnZ descriptors, 29 models 
with both CCR (train) and CCR (test) higher than 0.70 were attained then used in the 
consensus prediction of the external evaluation set. CCR (external), sensitivity and specificity 
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for consensus prediction were 0.78, 0.85 and 0.70, respectively; For one study using only 
functional group of Dragon descriptors set, 119 models with both CCR (train) and CCR 
(test) higher than 0.70 were obtained then employed in the consensus prediction of the 
external evaluation set. CCR (external), sensitivity and specificity for consensus prediction 
were 0.73, 0.83 and 0.63, respectively; For one study using default setting of Dragon 
descriptors, 17 models with both CCR (train) and CCR (test) higher than 0.70 were gained 
then used in the consensus prediction of the external evaluation set. CCR (external), 
sensitivity and specificity for consensus prediction were 0.82, 0.89 and 0.75, respectively; 
For one study using customized setting of Dragon descriptors set, 13 models with both CCR 
(train) and CCR (test) higher than 0.70 were achieved then used in the consensus prediction 
of the external evaluation set. CCR (external), sensitivity and specificity for consensus 
prediction were 0.76, 0.85 and 0.76, respectively; For one study using Frequent Subgraph 
descriptors, 31 models with both CCR (train) and CCR (test) higher than 0.80 were obtained 
then employed in the consensus prediction of the external evaluation set. CCR (external), 
sensitivity and specificity for consensus prediction were 0.68, 0.70 and 0.46, respectively. 
Results show that predictivity of models using MolConnZ descriptors, Default and 
Customized setting of Dragon descriptors are comparable, while those using Dragon 
functional group descriptors show slightly lower specificity in consensus prediction of 
external evaluation sets, and Frequent Subgraph descriptors show even lower specificity.  
This suggests that physicochemical descriptors are critical in predicting mutagenicity more 
accurately than using functional group or frequent subgraph alone. The reason that Frequent 
subgraph descriptor did not perform as well was probably because the support used was too 
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high, thus models detained contain too many house keeping descriptros/structures rather than 
critical structural features in carcinogenicity prediction. 
Table 4.3: Performance of kNN QSAR classification studies for Carcinogenicity modeling 
(carcinogens vs. non-carcinogens)  
 
Descriptors 
Train. 
CCR 
Test 
CCR 
Val.  Consensus Prediction 
CCR Sens. Spec. CR Cutoff Mod. # 
MolConnZ 0.82 0.70 0.78 0.85 0.70 65/40    0.70 29 
Dragon 
FG 0.79 0.69 0.73 0.83 0.63 58/47 0.70 119 
Default 0.83 0.70 0.82 0.89 0.75 70/35 0.70 17 
Cust. 0.85 0.77 0.76 0.85 0.76 60/45 0.75 13 
FSG S20 0.83 0.73 0.68 0.70 0.46 58/47 0.70 31 
CCR: Correct Classification Rate; Sens.: sensitivity, TP/(TP+FN); Spec.: specificity TN/(TN+FP);     
FSG : Frequent Sub-graph Descriptor, S:  support;   FG: functional group ;   Cust.: customized 
 
3) Genotoxic Carcinogenicity Models (genotoxic carcinogens vs. non-genotoxic non-
carcinogens) 
In genotoxic carcinogenicity modeling, we used 252 genotoxic carcinogens and 184 non-
genotoxic non-carcinogens as our working dataset. We put aside 65 compounds as an 
external evaluation set, the remaining 371 compounds as modeling set, then built models 
using the workflow described above (See Table 4.4 for result). For one study using 
MolConnZ descriptors, 29 models with both CCR (train) and CCR (test) higher than 0.70 
were attained then employed in the consensus prediction of the external evaluation set. CCR 
(external), sensitivity and specificity for consensus prediction were 0.78, 0.85 and 0.70, 
respectively; For one study using only functional group of Dragon descriptors set, 119 
models with both CCR (train) and CCR (test) higher than 0.70 were obtained and used in the 
consensus prediction of the external evaluation set. CCR (external), sensitivity and specificity 
for consensus prediction were 0.73, 0.83 and 0.63, respectively; For one study using default  
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Table 4.4: Performance of kNN QSAR classification studies for Carcinogenicity modeling 
(genotoxic vs. non-genotoxic carcinogens) 
Descriptors Train. CCR 
Test 
CCR 
Val.  Consensus Prediction 
CCR Sens. Spec. CR Cutoff Mod. # 
MolConnZ 0.94 0.89 0.84 0.85 0.83 56/24 0.80 55 
Dragon 
FG 0.92 0.86 0.84 0.80 0.88 28/37 0.8 17 
Default 0.96 0.90 0.83 0.80 0.88 39/26 0.85 13 
Cust. 0.95 0.97 0.82 0.88 0.76 33/32 0.85 120 
FSG S20 0.92 0.81 0.80 0.86 0.73 43/22 0.75 101 
CCR: Correct Classification Rate; Sens.: sensitivity  TP/(TP+FN); Spec.: specificity TN/(TN+FP);     
FSG : Frequent Sub-graph Descriptor, S:  support;   FG: functional group ;   Cust.: customized 
 
setting of Dragon descriptors, 17 models with both CCR (train) and CCR (test) higher than 
0.70 were achieved and used in the consensus prediction of the external evaluation set. CCR 
(external), sensitivity and specificity for consensus prediction were 0.82, 0.89 and 0.75, 
respectively; For one study using customized setting of Dragon descriptors set, 13 models 
with both CCR (train) and CCR (test) higher than 0.70 were attained then employed in the 
consensus prediction of the external evaluation set. CCR (external), sensitivity and specificity 
for consensus prediction were 0.76, 0.85 and 0.76, respectively; For one study using 
Frequent Subgraph descriptors, 31 models with both CCR (train) and CCR (test) higher 
than 0.80 were obtained then used in the consensus prediction of the external evaluation set. 
CCR (external), sensitivity and specificity for consensus prediction were 0.68, 0.70 and 0.46, 
respectively. Results show that predictivity of models using MolConnZ descriptors, Default 
and Customized setting of Dragon descriptors are comparable, while those using Dragon 
functional group show slightly lower specificity in consensus prediction of external 
evaluation set, and Frequent Subgraph descriptors show even lower specificity. This suggests 
that physicochemical descriptors are critical in predicting the mutagenicity more accurately 
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than using functional group or frequent subgraph alone. The reason that Frequent subgraph 
descriptor did not perform as well was probably because the support used is too high, thus 
models detained contain too many house keeping descriptors/structures rather than critical 
structural features in carcinogenicity prediction. 
4)  False Negative Carcinogenicity Models I (genotoxic carcinogens vs. non-genotoxic 
carcinogens) 
In this study we had 252 genotoxic carcinogens and 172 non-genotoxic carcinogens in 
the working dataset. 63 compounds were put aside as an external evaluation set. The 
remaining 361 compounds were used as the modeling set. The same workflow (see above) 
was used to build and validate models for the modeling set (See Table 4.5 for result).  
Table 4.5: Performance of kNN QSAR classification studies for Epigenicity modeling I 
(genotoxic carcinogens vs. non-genotoxic carcinogens). 
Descriptors Train. CCR 
Test 
CCR 
Val.  Consensus Prediction 
CCR Sens. Spec. CR Cutoff Mod. # 
MolConnZ 0.94 0.89 0.86 0.84 0.87 35/29 0.80 59 
Dragon 
FG 0.88 0.87 0.83 0.85 0.80 39/25 0.80 112 
Default 0.94 0.89 0.83 0.83 0.83 35/29 0.80 98 
Cust. 0.95 0.92 0.82 0.83 0.82 42/22 0.80 158 
FSG S20 0.90 0.86 0.84 0.86 0.82 44/22 0.80 11 
CCR: Correct Classification Rate; Sens.: sensitivity  TP/(TP+FN); Spec.: specificity TN/(TN+FP);     
FSG : Frequent Sub-graph Descriptor, S:  support;   FG: functional group ;   Cust.: customized 
 
For one study using MolConnZ descriptors, 59 models with both CCR (train) and CCR 
(test) higher than 0.80 were attained then employed in the consensus prediction of the 
external evaluation set. CCR (external), sensitivity and specificity for consensus prediction 
were 0.86, 0.84 and 0.87, respectively; For one study using only functional group of Dragon 
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descriptors set, 112 models with both CCR (train) and CCR (test) higher than 0.80 were 
obtained then used in the consensus prediction of the external evaluation set. CCR (external), 
sensitivity and specificity for consensus prediction were 0.83, 0.85 and 0.80, respectively; 
For one study using default setting of Dragon descriptors, 98 models with both CCR (train) 
and CCR (test) higher than 0.85 were attained then employed in the consensus prediction of 
the external evaluation set. CCR (external), sensitivity and specificity for consensus 
prediction were 0.83, 0.83 and 0.83, respectively; For one study using customized setting of 
Dragon descriptors set, 158 models with both CCR (train) and CCR (test) higher than 0.80 
were obtained then used in the consensus prediction of the external evaluation set. CCR 
(external), sensitivity and specificity for consensus prediction were 0.82, 0.83 and 0.82, 
respectively; For one study using Frequent Subgraph descriptors, 101 models with both 
CCR (train) and CCR (test) higher than 0.80 were attained then employed in the consensus 
prediction of the external evaluation set. CCR (external), sensitivity and specificity for 
consensus prediction were 0.84, 0.86 and 0.82, respectively. Results show that the 
predictivity of models using different types of descriptors are comparable.  
5) False Negative Carcinogenicity Models II (non-genotoxic carcinogens vs. non-
genotoxic non-carcinogens) 
In this study we had 172 genotoxic non-carcinogens and 184 non-genotoxic non-
carcinogens in the working dataset. 53 compounds were put aside as external evaluation set. 
The remaining 303 compounds were used as the modeling set. The same workflow (see 
above) was used to build and validate models for the modeling set (See Table 4.6 for result).  
For one study using MolConnZ descriptors, 33 models with both CCR (train) and 
CCR (test) higher than 0.80 were attained and employed in the consensus prediction of the 
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external evaluation set. CCR (external), sensitivity and specificity for consensus prediction 
were 0.79, 0.75 and 0.83, respectively; For one study using only functional group of Dragon 
descriptors set, 4 models with both CCR (train) and CCR (test) higher than 0.70 were 
obtained and used in the consensus prediction of the external evaluation set. CCR (external), 
sensitivity and specificity for consensus prediction were 0.61, 0.68 and 0.53, respectively; 
For one study using default setting of Dragon descriptors, 25 models with both CCR (train)  
Table 4.6: Performance of kNN QSAR classification studies for Epigenicity modeling II 
(genotoxic carcinogens vs. non-genotoxic non-carcinogens). 
Descriptors Train. CCR 
Test 
CCR 
Val.  Consensus Prediction 
CCR Sens. Spec. CR Cutoff Mod. # 
MolConnZ 0.94 0.89 0.86 0.84 0.87 35/29 0.80 59 
Dragon 
FG 0.88 0.87 0.83 0.85 0.80 39/25 0.75 212 
Default 0.94 0.89 0.83 0.83 0.83 35/29 0.80 98 
Cust. 0.95 0.92 0.82 0.83 0.82 42/22 0.80 158 
FSG S20 0.90 0.86 0.84 0.86 0.82 44/22 0.80 11 
CCR: Correct Classification Rate; Sens.: sensitivity, TP/(TP+FN); Spec.: specificity TN/(TN+FP);     
FSG : Frequent Sub-graph Descriptor, S:  support;   FG: functional group ;   Cust.: customized 
 
and CCR (test) higher than 0.70 were attained and employed in the consensus prediction of 
the external evaluation set. CCR (external), sensitivity and specificity for consensus 
prediction were 0.68, 0.68 and 0.68, respectively; For one of study using customized setting 
of Dragon descriptors set, 2 models with both CCR (train) and CCR (test) higher than 0.70 
were obtained and used in the consensus prediction of the external evaluation set. CCR 
(external), sensitivity and specificity for consensus prediction were 0.73, 0.79 and 0.66, 
respectively; For one study using Frequent Subgraph descriptors, 8 models with both CCR 
(train) and CCR (test) higher than 0.70 were attained and employed in the consensus 
prediction of the external evaluation set. CCR (external), sensitivity and specificity for 
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consensus prediction were 0.61, 0.64 and 0.57, respectively. Results show that predictivity of 
models using MolConnZ descriptors, Customized of Dragon descriptors are comparable, 
followed by Default setting Dragon descriptors. Models used Dragon functional group 
descriptors or Frequent Subgraph descriptors show lower specificity in consensus prediction 
of external evaluation set. This suggests that physicochemical descriptors are critical in 
predicting the mutagenicity more accurately than using functional group or frequent 
subgraph alone.  
6) False Positive Carcinogenicity Modeling I (genotoxic carcinogens vs. (genotoxic 
non-carcinogens) 
A combination of 252 genotoxic carcinogens and 85 non-genotoxic non-carcinogens 
comprised our working dataset for this study. We put aside 50 compounds as an external 
evaluation set. The remaining 287 compounds were used as a modeling set, for which kNN 
QSAR models were built and validated using the workflow described above (See Table 4.7 
for result).  
Table 4.7: Performance of kNN QSAR classification studies for Genotoxic Carcinogenicity 
Modeling I (genotoxic carcinogens vs. genotoxic non-carcinogens). 
Descriptors Train. CCR 
Test 
CCR 
Val.  Consensus Prediction 
CCR Sens. Spec. CR Cutoff Mod. # 
MolConnZ 0.92 0.88 0.85 0.91 0.79 34/16 0.70 56 
Dragon 
FG 0.86 0.81 0.56 0.76 0.35 33/17 0.70 2 
Default 0.92 0.81 0.62 0.84 0.40 33/17 0.75 1 
Cust. 0.90 0.80 0.84 0.92 0.54 39/11 0.75 10 
FSG S20 0.88 0.76 0.70 0.83 0.56 33/17 0.75 1 
CCR: Correct Classification Rate; Sens.: sensitivity  TP/(TP+FN); Spec.: specificity TN/(TN+FP);     
FSG : Frequent Sub-graph Descriptor, S:  support;   FG: functional group ;   Cust.: customized 
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For one study using MolConnZ descriptors, 56 models with both CCR (train) and CCR 
(test) higher than 0.70 were attained and employed in the consensus prediction of the external 
evaluation set. CCR (external), sensitivity and specificity for consensus prediction were 0.85, 
0.91 and 0.79, respectively; For one study using only functional group of Dragon 
descriptors set, 2 models with both CCR (train) and CCR (test) higher than 0.70 were 
obtained and used in the consensus prediction of the external evaluation set. CCR (external), 
sensitivity and specificity for consensus prediction were 0.56, 0.76 and 0.35, respectively; 
For one study using default setting of Dragon descriptors, 1 model with both CCR (train) 
and CCR (test) higher than 0.75 were attained and employed in the consensus prediction of 
the external evaluation set. CCR (external), sensitivity and specificity for consensus 
prediction were 0.62, 0.84 and 0.40, respectively; For one  study using Customized setting of 
Dragon descriptors set, 10 models with both CCR (train) and CCR (test) higher than 0.75 
were attained and employed in the consensus prediction of the external evaluation set. CCR 
(external), sensitivity and specificity for consensus prediction were 0.84, 0.92 and 0.54, 
respectively; For one study using Frequent Subgraph descriptors, 1 model with both CCR 
(train) and CCR (test) higher than 0.75 were obtained and used in the consensus prediction of 
the external evaluation set. CCR (external), sensitivity and specificity for consensus 
prediction were 0.70, 0.83 and 0.56, respectively. Results show that predictivity of models 
using MolConnZ descriptors is the highest, followed by those of using Customized setting of 
Dragon descriptors or Frequent Subgraph descriptors, while those using Dragon functional 
group descriptors performed in consensus prediction of external evaluation set. This suggests 
that physicochemical descriptors are critical in predicting complicated toxicity such as 
genotoxic carcinogenicity more accurately than using functional group or frequent subgraph 
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alone. The reason functional group performed worse than Frequent Subgraph descriptor 
suggests that novel structural feature that involved genotoxic noncarcinogenicity might not 
be included in ready-made built-in functional group library, thus models generate with those 
library will not predict the toxicity accurately.   
7) False Positives Carcinogenicity Modeling II (genotoxic non-carcinogens vs. non-
genotoxic non-carcinogens) 
In this genotoxicity/mutagenicity modeling, we used 85 genotoxic non-carcinogens and 
184 non- genotoxic non-carcinogens as working dataset. We put aside 40 compounds as an 
external evaluation set. The remaining 229 compounds were used as the modeling set to 
build kNN QSAR models. The same workflow as described above was implemented (See 
Table 4.8 for result).  
For one study using MolConnZ descriptors, 36 models with both CCR (train) and CCR 
(test) higher than 0.80 were attained and employed in the consensus prediction of the external 
evaluation set. CCR (external), sensitivity and specificity for consensus prediction were 0.86, 
0.78 and 0.94, respectively; For one study using only functional group of Dragon 
descriptors set, 3 models with both CCR (train) and CCR (test) higher than 0.70 were 
obtained and used in the consensus prediction of the external evaluation set. CCR (external), 
sensitivity and specificity for consensus prediction were 0.54, 0.33 and 0.75, respectively; 
For one study using default setting of Dragon descriptors, 2 models with both CCR (train) 
and CCR (test) higher than 0.80 were attained and employed in the consensus prediction of 
the external evaluation set. CCR (external), sensitivity and specificity for consensus 
prediction were 0.84, 0.79 and 0.89, respectively; For one study using Customized setting of 
Dragon descriptors set, 85 models with both CCR (train) and CCR (test) higher than 0.80   
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Table 4.8: Performance of kNN QSAR classification studies for Genotoxic Carcinogenicity 
Modeling II (genotoxic non-carcinogens vs. non-genotoxic non-carcinogens). 
Descriptors 
Train. 
CCR 
Test 
CCR 
Val.  Consensus Prediction 
CCR Sens. Spec. CR Cutoff 
Mod. 
# 
MolConnZ 0.95 0.94 0.86 0.78 0.94 15/25 0.80 36 
Dragon 
FG 0.86 0.74 0.54 0.33 0.75 10/30 0.70 3 
Default 0.91 0.87 0.84 0.79 0.89 10/30 0.80 2 
Cust. 0.97 0.97 0.95 0.94 0.95 18/22 0.80 85 
FSG S20 0.93 0.75 0.58 0.20 0.95 16/22 0.70 8 
CCR: Correct Classification Rate; Sens.: sensitivity  TP/(TP+FN); Spec.: specificity TN/(TN+FP);     
FSG : Frequent Sub-graph Descriptor, S:  support;   FG: functional group ;   Cust.: customized 
 
were obtained and used in the consensus prediction of the external evaluation set. CCR 
(external), sensitivity and specificity for consensus prediction were 0.95, 0.94 and 0.95, 
respectively; For one study using Frequent Subgraph descriptors, 8 models with both CCR 
(train) and CCR (test) higher than 0.70 were attained and employed in the consensus 
prediction of the external evaluation set. CCR (external), sensitivity and specificity for 
consensus prediction were 0.58, 0.20 and 0.95, respectively. Results show that predictivity of 
models using MolConnZ descriptors, Default and Customized setting of Dragon descriptors 
are comparable, while those using Dragon functional group descriptors show slightly lower 
specificity in consensus prediction of external evaluation set, and Frequent Subgraph 
descriptors show even lower specificity. This suggests that physicochemical descriptors are 
critical in predicting mutagenicity more accurately than using functional group or frequent 
subgraph alone.  
In summary, we have built highly predictive models. Our best models have prediction 
accuracy of 0.92, 0.85 and 0.88 for training, test and external evaluation sets in Mutagenicity 
study respectively; 0.83, 0.70, 0.82 for training, test and external evaluation sets in 
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Carcinogenicity study; 0.96, 0.90, 0.83 for training, test and external evaluation sets in 
Genotoxic Carcinogenicity study; 0.94, 0.89, 0.96 for training, test and external evaluation 
sets in Epigenicity Study I (Genotoxic carcinogen vs. Non-genotoxic carcinogens), 0.89, 
0.79, 0.79 for training, test and external evaluation sets in Epigenicity Study II (Non-
genotoxic carcinogen vs. Non-genotoxic non-carcinogens); 0.92, 0.88, 0.85 for training, test 
and external evaluation sets in Genotoxic Carcinogenicity Study I (Genotoxic carcinogen vs. 
genotoxic non-carcinogens); 0.95, 0.94, 0.86 for training, test and external evaluation sets in 
Epigenicity in Genotoxic Carcinogenicity Study II (Genotoxic non-carcinogen vs. Non-
genotoxic non-carcinogens). We noticed that models built with functional groups or frequent 
subgrpha descriptors alone have lower predictivity than models included physicochemical 
descriptors. We observed the limitation of using ready-made built-in functional group library 
to detect novel feature that are responsible for specific toxicity; we also realized that the 
support value for frequent subgraph descriptors need to be optimized to catch novel, 
significant and meaningful structural feature which will explain complicated toxicity; 
otherwise, eature selection during modeling building will face the risk of being traped in 
house-keeping scaffolds, which has hight support rate in database, but are too general and 
useless in explaining structure and toxicity relationship.  
Toxicohore and Toxicophobes Identification by Frequent Descr iptor  Analysis 
After model building and evaluations, we took the best models which passed certain 
predictivity thresholds (see above) from each study of mutagenicity, carcinogenicity, false 
negatives, and false positives, then performed frequent descriptor analysis over those models. 
We then took the significant descriptors detected and used them for association rule analysis. 
The support, confidence and p-value will show whether the descriptors are interesting 
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patterns that either promote (toxicophores) or demote (toxicophobes) specific toxicities. First, 
we calculated the frequency of each descriptor among all selected models in each study, and 
then we counted respectively the instance of active or inactive compounds that contain 
structural features described by each descriptor. Finally, for each working set we calculated 
the confidence of these descriptors and the corresponding p-value.(Tennant et al, 1987) 
Combing all the information on frequency, confidence and p-value, we identified the most 
important and discriminative SA-like descriptor patterns for mutagens, carcinogens, false 
negatives and false positives (Figure 4.1-3).  
 Toxicophores and Toxicophobes for  Mutagenicity and Carcinogenicity  
Figure 4.1 illustrates significant structural features that either promote (toxicophores) 
or demote (toxicophobes) mutagenicity/carcinogenicity by structure, name, confidence and P 
values. The upper panels contain features that promote mutagenicity (right) or 
carcinogenicity (left), the lower panels include features that demote mutagenicity (right) or 
carcinogenicity (left). The structures in the middle are common structures that either promote 
(Toxicophores) or demote (toxicophobes) both mutagenicity and carcinogenicity.  
We identified common toxicophores that promote both mutagenicity and 
carcinogenicity, such as funrane/nFuranes, azo derivatives/nN=N, diazole/ nThiazoles, N-
nitroso group/nRNNOx, aryl-nitroso group/nArNO2, hydrazine/nN-N, aromatic primary 
amines/nArNH2 etc, which are consistent with known structural alerts for 
mutagenicity/carcinogenicity that have been published (Ashby, 1985; Ashby & Tennant, 
1988; Kazius et al, 2005; Mazzatorta et al, 2008); We also discovered unique structures that 
promote mutagenicity, such as basic Nitrogen/nN+, guanidine/nC(=N)N2, 
imidazole/nImidazole, hydrogen bond/nHBonds etc, as well as unique structures that 
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promote carcinogenicity, such as unsubstituted benzene/nCbH, vinyl/nR=CHX, ethers/nROR, 
urea derivatives/nCONN etc.  
We identified common structures such as quaternary N/nNq, hydrogen donors/nHDon, 
secondary alcohols/nOHs that demote both mutagenicity and carcinogenicity. These patterns  
•nHDon 0.41/0.05
•nR=Cs   0.36/0.05
•nCb 0.35/0.05
•nROH 0.34/0.02
•nArOH 0.32/0.04
•nArX 0.31/0.05
•nR=Ct 0.30/0.03
•nRCOOR 0.29/0.01
•nCrt 0.28/0.03
•nNq 0.27/0.00
•nCt 0.23/0.00
•nCq 0.21/0.04
•nOHs 0.18/0.00
•nRCO 0.13/0.02
•nArCOOR 0.00/0.00
•nHDon 0.53/0.04
•nNq 0.40/0.00
•nArCO 0.36/0.05
•nArNHR 0.33/0.01
•nRSR 0.33/0.05
•nPO4 0.29/0.01
•nOHs 0.25/0.00
•nRCONR2  0.14/0.02
•nRNO2   0.14/0.02
•nS(=O)2   0.13/0.01
•nC(=N)N2   1.00/0.03
•nRNNOx 0.96/0.00
•nThiazoles 0.91/0.00
•nArNO2    0.90/0.00
•nFuranes 0.87/0.03
•nImidazole 0.86/0.00
•nN=N    0.82/0.03
•nArNH2    0.77/0.01
•nCrs 0.71 /0.01
•nN-N    0.71/0.05
•nHBonds 0.67/0.00
•nN+ 0.60/0.00
•nSO2N 1.00/0.02
•nCbH 1.00/0.05
•nR=CHX  1.00/0.05
•nFuranes 0.91/0.00
•nN=N   0.91/0.03
•nThiazoles 0.91/0.03
•nRNNOx 0.89/0.00
•nN-N   0.82/0.05
•nROR 0.79/0.01
•nCONN 0.79/0.01
•nArNH2   0.77/0.01
•nArNO2   0.76/0.00 Car+ Mut+
Mut-Car-
 
Figure 4.1: Toxicophores (promoting features) and toxicophobes (demoting features) for 
mutagenicity & carcinogenicity reported by name, confidence, and P value. 
 
correspond well with known detoxifying features for genotoxic carcinogenicity (Tennant et 
al, 1987); We found unique features such as secondary aromatic amine/nArNHR, 
sulfides/nRSR, aliphatic tertiary amides/nRCONR2, aliphatic nitroso/nRNO2, sulfones/nSO2 
that demote carcinogenicity; as well as unique structures such as substituted benzene/nCb, 
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aromatic or aliphatic hydroxyl groups/nArOH, nROH, steric structures/nCrt, nCq, nNq, 
nR=Ct, ketone/nRCO, aromatic ester/nArCOOR that demote mutagenicity. 
The above data suggest ways to modulate mutagenicity or carcinogenicity, such as 
replacing toxicophores with toxicophobes, substituting primary amine, replacing terminal 
amine with hydroxyl group, replacing ether to a thio ether, an aromatic nitroso to an aliphatic 
nitroso; introduce steric hindrance etc. Of course these rules warrant further investigation. 
Toxicophores and Toxicophobes for  False Negatives/Nongenotoxic Carcinogens. 
Figure 4.2 illustrates significant (p-value <= 0.05) structures/descriptors from pair wise  
modeling, frequent descriptor analysis and association rule learning. We identified the 
following structures/ descriptors as promoting (confidence > 0.8) genotoxic carcinogenicity, 
such as imidazoles/nImidazole, aliphatic N-nitroso/nRNNOx, aromatic nitro 
groups/nArNO2, thiazoles/ nThiazoles, furanes/nFuranes, aromatic amines/nArNH2, ring 
secondary C(SP3)/nCrs etc; We found the following structures/descriptors promoting 
nongenotoxic carcinogenicity, such as vinyl/nR=Cs, halide substitute on aromatic ring/nArX, 
ring tertiary C(sp3)/nCrt, tertiary C(sp3)/nCt, aliphatic ketones/nRCO, tertiary 
alcohols/nOHt, aromatic esters/nArCOOR and sulfonamide/nSO2N; We discovered the 
following structures/descriptors demoting carcinogenicity, genotoxic or non-genotoxic, such 
as hydrogen bond donor/nHDon, quaternary nitrogen/nNq, secondary alcohol/nOHs, 
secondary aromatic amines/nArNHR and sulfides/nRSR.  
The above data suggest steric hindrance is critical in demoting mutagenicity, as well 
as ways to modulate genotoxic or nongenotoxic carcinogenicity, such as replacing 
toxicophores with toxicophobes, or substituting primary aromatics amines, or replacing 
primary amines with primary alcohols. This observation warrants more investigation. 
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Mut-Car+
Mut-Car-
Mut+Car+
nImidazoles 1.00/0.00
nRNNOx 0.95/0l00
nArNO2 0.94/0.00
nThiazoles 0.90/0.04
nFuranes 0.86/0.01
nArNH2 0.84/0.00
nCrs 0.80/0.02
nHDon 0.37/0.03
nNq 0.26/0.00
nOHs 0.22/0.01
nS(=O)2   0.13/0.04 
nArNHR 0.11/0.02
nRSR 0.11/0.02
nR=Cs 0.40/0.02
nArX 0.31/0.02
nCrt 0.31/0.03
nCt 0.23/0.00
nRCO 0.14/0.02
nOHt 0.14/0.02
nArCOOR 0.00/0.01
nSO2N   0.25/0.05 
Y= O or S
 
Figure 4.2.  Discriminating toxicophores among genotoxic / nongenotoxic carcinogens, 
nongenotoxic non-carcinogens reported by name, confidence, and P value. 
 
Identifing Toxicophores and Toxicophobes for  False Positives/Genotoxic 
Noncarcinogens 
Figure 4.3 illustrates significant (p-value <= 0.05) structures/descriptors from pair-wise 
modeling, frequent descriptor analysis and association rule learning. We identified the 
following structures /descriptors as promoting (confidence > 0.8) genotoxic carcinogenicity, 
such as aliphatic ethers/nROR, furanes/nRuranes, aliphatic N-nitroso/nRNNOx, urea(-thio) 
derivatives/nCONN, aromatic amines/ nArNH2 etc; We found the following structures/ 
descriptors promoting genotoxic non-carcinogenicity or false positives, such as tertiary C 
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Mut+Car-
Mut-Car-
Mut+Car+
nROR 0.91/0.04
nFuranes 0.90/0.08
nRNNOx 0.89/0.01
nCONN 0.89/0.10
nArNH2   0.84/0.09
nNq 0.13/0.01
nRCOOR 0.12/0.05
nRSR 0.00/0.04
nCt 0.23/0.00
nPO4 0.33/0.04
nOHt 0.14/0.02
nRSSR 0.00/0.01
nRNO2 0.25/0.05
nArCOOR 1.00/0.03
nRCONHR 0.83/0.01
nCH2RX   0.78/0.00 
Y = Al or Ar  
Figure 4.3.  Discriminating toxicophores among genotoxic carcinogens/non-carcinogens, 
nongenotoxic non-carcinogens reported by name, confidence, and P value. 
 
(sp3)/nCt, phosphates/nPO4, tertiary alcohols/nOHt, disulfides/nRSSR, aliphatic nitro 
groups/nRNO2 etc; we discovered the following structures/descriptors demoting genotoxic 
carcinogenicity or noncarcinogenicity such as quaternary nitrogen/nNq, aliphatic esters/ 
nRCOOR and sulfides/nRSR. 
The above data suggest ways to modulate genotoxic carcinogenicity or genotoxic 
non-carcinogenicity, such as replacing Toxicophores with toxicophobes, or substituting 
primary aromatics amines, or replacing primary amines with primary alcohols. This 
observation warrants more investigation. 
Potential applications and limitations  
The patterns we found will be very helpful in many aspects. First, they made the 
chemical structure-activity relationships contained in our highly predictive models more 
transparent and more straightforward for potential applications such as regulations, priority 
setting for animal toxicity tests, drug design, etc. We characterized ‘alerting’ chemical 
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features for false negative and false positive carcinogens, and then differentiated the features 
from SAs for genotoxic carcinogens; we therefore addressed the problem of high false 
negative rate and high false positive rate in carcinogenicity prediction from the perspective of 
chemical structure, rather than treating them simply as statistical errors. Consequently, our 
methodology can make more accurate and reliable predictions for carcinogenicity, and 
contribute to the understanding of chemical mechanisms of mutagenicity and 
carcinogenicity, including epigenetic carcinogenicity.  
SAs were identified and applied differently in this work comparing with those in 
other people’s work (Ashby, 1985; Ashby & Tennant, 1988; Kazius et al, 2005; Mazzatorta 
et al, 2008). Ashby & Tennant SAs function as warnings, yet prediction of toxicity depends 
on investigators’ judgment, knowledge and experience; they are qualitative indications for 
carcinogenicity potential, either activating or deactivating. Since neither of promoting nor 
demoting potential of SAs was scaled, compounds with mixed SA features are less 
predictable. The practice of canceling out a deactivating feature with one or more activating 
features is an approximation, which is not acceptable as a fine-tuned SAR for drug screening. 
On the other hand, the co-presence of SAs of the same type may not increase or decrease 
carcinogenicity potential either, since each SA fragment could interfere with the ability of 
another to induce electronphilic ceneter (a known mechanism of chemical carcinogenicity), 
thus making the carcinogenicity potential less predictable. 
In contrast with this approach, our QSAR models contain many descriptors 
characterizing multiple SAs that either activate or deactivate mutagenicity or carcinogenicity 
in ensemble. The predictivity of our models is proven by rigorous validation including 
different test sets. However, it would be incorrect to use our models out of their applicability 
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domain (AD), or use significant frequent descriptors individually out of the models. Useful 
as they are, their limitations need to be kept in mind for better application.  
Chemical descriptors can be too general, so they fail to catch unique structural 
features of different compounds, which may be critical in modulation of the carcinogenicity 
potential of compounds. For example, ntsC and StsC are two corresponding descriptors for 
the count and the electrotopological state indices (E-State) of C triple bond, which can 
present in an alkyne – a likely non-carcinogen, or a cynate – a potential carcinogen. So 
without the context, it is impossible to predict correctly the carcinogenicity of a compound. 
Another example is ndsN and SdsN, which are count and E-State for nitrogen atoms that 
have a double bond and a single bond, respectively. This feature can present in imines, azo, 
isocynate, isothiocynate, nitrite or nitroso; without context of other modulators in the 
compound, it is impossible to predict carcinogenicity of a compound containing these 
features.  
On the other hand, the working dataset contains 693 compounds from CPDB, which 
have both mutagenicity and carcinogenicity data. It covers only a limited chemical space for 
mutagens and carcinogens, thus patterns derived are not exhaustive, neither can they account 
for all the chemical mutagenicity and carcinogenicity mechanisms. The patterns are not 
supposed to be used out of the AD of the working dataset. A larger database definitely will 
be helpful for us to enrich and fine-tune patterns we already found. What’s more, the patterns 
or descriptors were retrieved from models which have high, but not perfect prediction power, 
thus exceptions always exist.  
On the other hand, carcinogenesis is a complex and multistage process. For instance, 
DNA repair and apoptosis during carcinogenesis are controlled by complicated signaling 
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pathways within cells, which are beyond explanation in frames of QSAR studies present 
herein.  
Nevertheless, our work filled the gap of characterizing false negatives and false 
positives carcinogens; our work improved prediction accuracy for carcinogenicity and 
molecular optimization. However, we recommend using with caution of the patterns we 
discovered for false negatives and false positives carcinogens, considering the limited size of 
dataset from which the patterns were derived. We acknowledge that the possible structures of 
false negatives and false positives are more abundant and diverse than we have in this study; 
however, the intent of this study is not to find exhaustive patterns but to find those chemical 
structural patterns that modulate a seemingly genotoxic carcinogens into false negatives or 
false positives; therefore our work have potential application in molecule or lead 
optimization, which is a more important issue and has significant beneficial consequence to 
human life. Rather than overwhelmed by the daunting idea of finding exhaustive patterns, we 
chosed a method that’s more feasible, practical and productive. Of course, a more extensive 
dataset definitely can be helpful for us to enrich, fine-tune and validate the patterns we found 
in this study. 
CONCLUSIONS 
 
We built highly predictive kNN QSAR classification models for prediction of 
mutagenicity, carcinogenicity, non-genotoxic carcinogenicity (false negatives) and genotoxic 
non-carcinogenicity, and we identified Toxicophores and toxicophobes for each 
aforementioned type of toxicity. The patterns found would be helpful in understanding 
chemical mechanisms underlying mutagenicity and carcinogenicity, and will benefit not only 
risk assessment, hazard test prioritization, regulatory work from governmental agencies, as 
well as the lead optimization stage of drug discovery in the pharmaceutical industry.  
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Results II:  Modeling with MolConnZ Descriptors, LeadScope, LAZAR 
   1) Mutagenicity Models (mutagens vs. non-mutagens) 
For mutagenicity modeling, 105 out of 693 compounds were randomly selected as the 
external evaluation set. The remaining 588 compounds were used as a modeling set in kNN 
QSAR category model building. The modeling set was divided into 40 pairs of training and 
test sets. The number of descriptors selected was varied from 20 to 100 with a step of 5. For 
each number of descriptors selected and each pair of training and test sets, 10 models have 
been built and validated using the corresponding training and test sets. Thus, in total 8400 
models were built. The whole procedure was repeated three times, each time with a different 
external evaluation set. For one of the cases, 55 models with both CCR (train) and CCR (test) 
higher than 0.85 were employed in the consensus prediction of the external evaluation set. 
CCR (external), sensitivity and specificity for the consensus prediction were 0.92, 0.85 and 
0.89, respectively. The entire process was repeated three times, and each time similar results 
were obtained. Thus, the model predictivity was demonstrated not influenced by the way the 
dataset was split into external evaluation, training and test sets. The corresponding Y-
randomization tests showed that the high predictivity of our models were not due to chance 
correlation. (See Table 4.9 for summary and supplementary Table 4.S1 for details). 
2) Carcinogenicity Models (carcinogens vs. non-carcinogens) 
For carcinogenicity modeling, we used the same workflow and the same dataset as for 
the mutagenicity study, but took carcinogenicity as endpoint. 105 out of 693 compounds 
were randomly selected as the external evaluation set, and the remaining 588 compounds 
were used as a modeling set in kNN QSAR category model building. 29 models which had 
CCR (train) higher than 0.70 and CCR (test) higher than 0.65 were selected and employed in 
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the consensus prediction of the external evaluation set. CCR (external), sensitivity and 
specificity for the consensus prediction were 0.78, 0.85 and 0.70, respectively. The entire 
process was repeated three times, and each time similar results were obtained. Thus, the 
model predictivity was proved not influenced by the way the dataset was split into external 
evaluation, training and test sets. The corresponding Y-randomization tests showed that high 
predictivity of the models was not due to chance correlation. (See Table 4.9 for summary and 
supplementary Table 4.S1 for details.) 
3) Genotoxic Carcinogenicity Models (genotoxic carcinogens vs. non-genotoxic non-
carcinogens) 
In genotoxic carcinogenicity modeling, we used 252 genotoxic carcinogens and 184 
non-genotoxic non-carcinogens as the working dataset. We put aside 65 compounds as an 
external evaluation set, then built models using a subset of the remaining 371 compounds 
(the modeling set) following the workflow described above. 59 models, which had prediction 
accuracy higher than 0.80 for both training set and test set, were employed in the consensus  
Table 4.9: Performance of kNN QSAR classification studies for Mutagenicity, 
Carcinogenicity, False Negatives and False Positives. 
Observation 
 
 
Models 
Models for Consensus Prediction External Validation 
Numbers CCR (Train.) 
CCR 
(Test) 
CCR 
(Val.) Sensitivity Specificity 
1 55 0.92 0.85 0.88 0.92 0.84 
2 29 0.82 0.70 0.78 0.85 0.70 
3 30 0.94 0.89 0.84 0.85 0.83 
4 59 0.94 0.89 0.86 0.84 0.87 
5 33 0.89 0.79 0.79 0.75 0.83 
6 56 0.92 0.88 0.85 0.91 0.79 
7 36 0.95 0.94 0.86 0.78 0.94 
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prediction of the external evaluation set. CCR (external), sensitivity and specificity for the 
consensus prediction were 0.84, 0.85 and 0.83, respectively. The entire process was repeated 
three times, and each time similar results were obtained. Thus, the model predictivity was 
shown not influenced by the way the dataset was split into external evaluation, training and 
test sets. The corresponding Y-randomization tests showed that high predictivity of the 
models was not due to chance correlation. (See Table 4.9 for summary and supplementary 
Table 4.S1 for details.) 
4) False Negative Carcinogenicity Models I (genotoxic carcinogens vs. non-genotoxic 
carcinogens) 
In this study we had 252 genotoxic carcinogens and 172 non-genotoxic carcinogens in 
the working dataset. 63 compounds were put aside as an external evaluation set. The 
remaining 361 compounds were used as the modeling set. The same workflow (see above) 
was used to build and validate models for the modeling set. 59 models, which had prediction 
accuracy higher than 0.80 for both training set and test set were employed in the consensus 
prediction of external evaluation set. CCR (external), sensitivity and specificity for the 
consensus predction were 0.86, 0.84 and 0.87, respectively. The entire process was repeated 
three times, and each time similar results were obtained. Thus, the model predictivity was 
demonstrated not influenced by the way the dataset was split into external evaluation, 
training and test sets. The corresponding Y-randomization tests showed that high predictivity 
of the models was not due to chance correlation. (See Table 4.9 for summary and 
supplementary Table 4.S1 for details.) 
5) False Negative Carcinogenicity Models II (non-genotoxic carcinogens vs. non-
genotoxic non-carcinogens) 
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In this study we had 172 genotoxic non-carcinogens and 184 non-genotoxic non-
carcinogens in the working dataset. 53 compounds were put aside as an external evaluation 
set. The remaining 303 compounds were used as the modeling set. The same workflow (see 
above) was used to build and validate models for the modeling set. 33 models which had 
prediction accuracy higher than 0.80 for training set and 0.70 for test set were employed in 
consensus prediction of the external evaluation set. CCR (external), sensitivity and specificity 
for the consensus prediction were 0.79, 0.75 and 0.83, respectively. The entire process was 
repeated three times, and each time comparable results were obtained. Thus, the model 
predictivity was proved not influenced by the way the dataset was split into external 
evaluation, training and test sets. The corresponding Y-randomization tests showed that the 
high predictivity of the models built with real activities of the training sets were not due to 
chance correlation. (See Table 4.9 for summary and supplementary Table 4.S1 for details.) 
6) False Positive Carcinogenicity Models I (genotoxic carcinogens vs. (genotoxic non-
carcinogens) 
The combination of 252 genotoxic carcinogens and 85 non-genotoxic non-carcinogens 
made up our working dataset for this study. We put aside 50 compounds as an external 
evaluation set. The remaining 287 compounds were used as a modeling set, for which kNN 
QSAR models were built and validated using the workflow described above. 56 models 
which had prediction accuracy higher than 0.80 for both training and test sets were selected 
and used in the consensus prediction of the external evaluation set. CCR (external), 
sensitivity and specificity for the consensus prediction were 0.85, 0.91 and 0.79, respectively. 
The entire process was repeated three times, and in each case comparable results were 
obtained. Thus, the model predictivity was shown not influenced by the way the dataset was 
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split into external evaluation, training and test sets. The corresponding Y-randomization tests 
showed that high predictivity of our models was not due to chance correlation. (See Table 4.9 
for summary and supplementary Table 4.S1 for details.) 
7) False Positives Carcinogenicity Models II (genotoxic non-carcinogens vs. non-
genotoxic non-carcinogens) 
In this genotoxicity/mutagenicity modeling, we used 85 genotoxic non-carcinogens and 
184 non- genotoxic non-carcinogens as our working dataset. We put aside 40 compounds as 
an external evaluation set. The remaining 229 compounds were used as the modeling set to 
build kNN QSAR models. The same workflow as described above was implemented. 36 
models, which had prediction accuracy higher than 0.80 for both training and test set, were 
selected and employed in the consensus prediction of the external evaluation set. CCR 
(external), sensitivity and specificity for the consensus prediction were 0.84, 0.78 and 0.94, 
respectively. The entire process was repeated three times, and each time similar results were 
obtained. Thus, the model predictivity was demonstrated not influenced by the way the 
dataset was split into external evaluation, training and test sets. The corresponding Y-
randomization tests showed that the high predictivity of the models built with real activities 
of the training sets were not due to chance correlation. (See Table 4.9 for summary and 
supplementary Table 4.S1 for details.) 
Comparative Studies of kNN QSAR and Lazar  
Comparative studies between kNN QSAR and Lazar included two parts. In the first 
part, we compared consensus prediction of mutagenicity and carcinogenicity for 70 
compounds of one of the external evaluation sets with kNN QSAR and Lazar. The 
performance of each software for each endpoint was summarized in confusion matrices (See 
 128 
 
  
     
Tables 4.10a and 4.10b; the detailed information is given in supplementary Table 4.S2.) 
From the confusion matrices for both endpoints (Tables 4.10a and 4.10b), we can see that 
kNN QSAR models demonstrated better prediction than Lazar: kNN QSAR gave higher 
sensitivity and specificity, lower number of incorrect predictions and better coverage. On the 
other hand, Lazar made many unreliable predictions. Eventhough sometimes the predicitons  
Table 4.10a: Comparative study of Lazar and kNN QSAR on prediction of Mutagenicity for 
external evaluation sets of 70 compounds. 
 
Observed. 
 
 
Predict. 
Inactive(37) Active(33) NCOAD* Total 
K L K L K L K L 
Inactive 33 8+17? 6       1+7? 0  2 37 35 
Active 4  5+5? 27 6+19? 0 0 33  35 
Total 37  35 33 33 0  2 70 70 
K: in-house program kNN QSAR; L: Lazar 
Predictions were made as Inactive, Active, UI (unreliable inactive) and UA (unreliable Active) 
NCOAD* : number of compound out of the applicability domain 
?: number with question mark are unreliable predictions for CPDB Salmonella mutagenicity made by Lazar 
 
Table 4.10b: Comparative study of Lazar and kNN QSAR on prediction of Carcinogenicity 
for external evaluation sets of 70 compounds. 
 
Observ.    
 
 
Predict. 
Inactive(24) Active(46) NCOAD* Total 
K L K L K L K L 
Inactive 19 4+10? 3     3+12? 0 0 0 29 
Active 5 3+7? 43 9+21? 0 1 0 41 
Total 24 24 46 45 0 1 70 70 
K: in-house program kNN QSAR; L: Lazar 
Prediction were made as Inactive, Active, UI (unreliable inactive) and UA (unreliable Active) 
NCOAD* : number of compound out of the applicability domain 
?: number with question mark are unreliable predictions for Carcinogenicity Single made by Lazar 
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maybe correct, since compounds are out side of the AD of Lazar, there is no gurantee that the 
prediction is trustworthy. Possible reasons may attribute the difference of methods used in 
each program. Lazar used linear fragment descriptors, while it is well known that 
heterocyclic structures are critical for mutagenicity and carcinogenicity (Kazius et al, 2005), 
which agreed with our observation in this study as well. Lazar used fragment descriptors 
only, while kNN QSAR studies used Molconn-Z descriptors, which include both fragments 
and their electrotopological states. Electrophilicity is a known feature responsible for 
chemical cancinogenicity. Presence or absence of certain fragments alone is insufficient to 
explain the interference of adjunct electrophilic groups which induce carcinogenicity. Lazar 
first selected descriptors relevant to certain bioactivity, based on which nearest neighbors 
were defined, and then calculated activities of query compounds. However, this ‘relevant 
descriptor selection’ approach can be a double-edged sward. Indeed, the sensitivity can be 
increased for prediction of activities of those compounds which contain statistically 
significant fragments, but specificity may be decreased due to compounds containing less 
significant or novel fragments, or they can often fall out of ADs of training sets. That’s 
exactly shown in the unreliable result.  
In the second part, consensus prediction of mutagenicity and carcinogenicity was 
carried out for two compounds, eugenol (CAS 97-53-0) and methyleugenol (CAS 93-15-2), 
using best models from each study. Based on the NTP technical report (http://ntp-
server.niehs.nih.gov/index.cfm?objectid=BCBEB6A2-123F-7908-16655550DEAE6D; http: 
//ntp.niehs.nih.gov/index.cfm?objectid=BCADD2D9-123F-7908-7B5C8180FE80B22F), 
both compounds are negative in Salmonella mutagenicity assay; methyleugenol showed clear 
evidence of carcinogenicity while eugenol is considered negative or equivocal. kNN QSAR 
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predicted mutagenicity and carcinogenicity for both compounds correctly, while LAZAR 
made correct prediction for mutagenicity for the two compounds, but unreliable predictions 
for carcinogenicity.  
Comparative Study of kNN QSAR and Leadscope 
Results for comparative studies of kNN QSAR and Leadscope for mutagenicity and 
carcinogenicity endpoints are reported in Tables 4.11a and 4.11b. In Table 4.11a, Nitro, Misc 
N group and Nitroso have Z-scores significantly higher than 3.0, which indicate those 
structure features are significant in contributing to mutagenicity; uinones and Amines have 
Z-scores close to 3.0, which mean they are statistically less significant than the former three. 
Frequent descriptor analysis of best mutagenicity models built with kNN QSAR picked nitro,  
Table 4.11a: Mutagenicity structural alerts identified using Leadscope 
 
Class Name Mean Activity Z Score Frequency 
Nitro 0.84 7.4 90 
Misca N Group 0.82 6.9 93 
Nitroso 0.91 6.8 57 
Quinones 0.91 2.9 11 
Amines 0.54 2.6 263 
a: miscellaneous N group 
 
Table 4.11b: Carcinogenicity structural alerts identified using Leadscope 
 
Class Name Mean Activity Z Score Frequency 
Nitroso 0.85 8.2 139 
Misc N Group 0.76 7.4 202 
Hydrazine 0.76 4.7 85 
Nitro 0.64 2.9 131 
Halide 0.59 2.8 308 
 
 131 
 
  
     
amine, Misc N such as nssssNp and naaN, as Leadscope did, and also hydrazine, carbonyl, 
peroxide and aldehyde, etc. More results can be found in frequent descriptor analysis (Table  
4.12a and 4.12b). Quinone was picked up by Leadsope but not by kNN QSAR, since it is not 
in the built-in functional group library in Molconn-Z. In Table 4.11b, Nitroso, Misc N group 
and Hydrazine were picked out with Z-score much higher than 3.0, thus making a strong 
argument that these features contribute to carcinogenicity. Nitro and Halide with Z-scores 
close to 3.0 might also be SAs for carcinogenicity. Frequent descriptor analysis of kNN 
QSAR models identified amide, phosphate, sulfonate and thiocarbonyl in conjunction to 
those groups for carcinogenicity. 
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Table 4.12a: Mutagenicity structural alerts identified by frequent descriptor analysis. 
Descr iptors Model Types 
Name Descr iptions Structure Mut. Car . FN FP 
Naldehyde Group type count 
 
 33 7 30 33 
SdsCH group type EState  
 
21 6 18 30 
SHdsCH atom type EState 21 6 22 52 
naasC atom type count 
 
31 8 24 32 
SaasC atom type EState 28 8 26 42 
naaaC atom type count 46 7 27 36 
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Descr iptors Model Types 
Name Descr iptions Structure Mut. Car . FN FP 
SaaaC atom type EState 27 9 38 42 
nsNH2 group type count 
 
 61 10 69 62 
nsssN atom type count 
 
 25 8 20 40 
SsssN atom type EState 23 5 19 33 
Hhydrazine group type H EState sum 
 
 42 12 14 34 
nhydrazine group type count 10 13 11 28 
Shydrazine group type EState sum 36 10 15 38 
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Descr iptors Model Types 
Name Descr iptions Structure Mut. Car . FN FP 
Nazo group type count 
 
 23 8 19 19 
ntN atom type count 
 
 
13 5 9 39 
Nnitr ite group type count 
 
 
17 8 15 31 
Snitro group type EState sum 
 
 
68 7 55 48 
Nnitroso group type count 
 
 52 11 42 37 
Nsulfonate group type count 
 
 
74 5 40 23 
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Descr iptors Model Types 
Name Descr iptions Structure Mut. Car . FN FP 
Nester  group type count 
 
 11 13 26 60 
nphosphate group type count 
 
 
23 5 41 39 
nphosphonate group type count 
 
 15 4 24 39 
Hphosphonate group type H EState sum 22 8 27 34 
SsF atom type EState 
 
 
16 10 18 39 
nsCl atom type count 
 
 
41 10 55 29 
nsI atom type count 
 
 
34 10 33 36 
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Table 4.12b: Structural features that not induce carcinogenicity or mutagenicity identified by frequent descriptor analysis 
Descr iptors Frequency Model Types 
Names Descr iptions Structure Mut. Car . FN FP 
Nketone group type count 
 
 35 5 19 62 
Ncarbonyl group type count 
 
 20 3 18 51 
Scarbonyl group type EState sum 28 5 12 36 
Scarboxylicacid group type EState sum 
 
 32 4 25 36 
Nurea group type count  
 
18 14 28 55 
Hurea group type H EState sum 17 7 26 44 
nsNH3p group type count 
 
 20 3 31 37 
  
  
      
137 
Descr iptors Frequency Model Types 
Names Descr iptions Structure Mut. Car . FN FP 
nssssNp atom type count 
 
 56 7 36 35 
nsOH group type count 
 
 28 5 24 42 
speroxide group type EState count  21 11 24 34 
Namide group type count 
 
 20 5 28 48 
Hamide group type H EState sum 25 8 35 35 
ntr ifluoromethyl group type count 
 
 4 9 12 55 
nsulfonamide 
 
group type count 
  
44 
 
13 
 
24 
 
36 
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Descr iptors Frequency Model Types 
Names Descr iptions Structure Mut. Car . FN FP 
Hsulfonamide group type H E-state sum 21 10 16 42 
Ssulfonicacid group type EState sum 
 
 
20 9 19 35 
Ssulfuricaicd group type EState sum 
 
 27 3 21 39 
nddssS atom count 
 
 36 2 56 26 
naaS atom type count 
 
12 7 16 24 
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Descr iptors Frequency Model Types 
Names Descr iptions Structure Mut. Car . FN FP 
SaaS atom type Estate 10 8 16 24 
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Frequent descr iptor  analysis/profiling 
After model building and evaluations, we took best models, which passed certain 
predictivity thresholds (see above) from each study of mutagenicity, carcinogenicity, false 
negatives, and false positives, to perform frequent descriptor analysis. First, we calculated the 
frequency of each descriptor among all selected models in each study, and then we counted 
the instance of active or inactive compounds which contain structural features described by 
each descriptor. Finally, for each working set we calculated the confidence of these 
descriptors and the corresponding p-value (Kazius et al, 2005). After combing all the 
information of frequency, confidence and p-value, we identified the most important and 
discriminative SA-like descriptor2
To see how well the above method worked, a comparative study has been performed 
for known structural alerts that have been published (Ashby, 1985; Ashyby & Tennant, 1991; 
Kazius et al, 2005; Mazzatorta et al, 2007), and frequent descriptor patterns we retrieved 
from different types of models. As illustrated in Tables 5a and 5b, those patterns fall into one 
of the following two categories: 
 patterns for mutagens, carcinogens, false negatives and 
false positives (supplementary Table 4.S3).  
                                                 
2 Matching corresponding structural features with Molconn-Z descriptor names can be done 
easily by following a simple rule: descriptor names are composed of (i) descriptor type, (ii) 
bond type and (iii) atom/function group type; descriptor type can be n/S, these are the count 
of appearance or a sum of electroptopological state of a fragment; bond type can be s/d/t/a, 
which stand for a single, double, triple or aromatic bond. For example, nsNH3p represents 
count of ammoniums, while SsNH3p of E-States, p stands for protonated state. More 
examples and comprehensive definition of Molconn-Z descritors can be found at 
http://www.edusoft-lc.com/molconn/manuals/400/appI.html. Relavent descriptors in this 
study are illustrated in Tables 5a and b, and explained in more detail when mentioned for the 
frst time. 
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a. Concordant with known SAs for genotoxic carcinogens (Ashby, 1985; 
Ashyby & Tennant, 1991; Kazius et al, 2005; Mazzatorta et al, 2007), such as 
aldehyde, vinyl, amine, hydrazine, azo, diazonium, nitrite, nitro, nitroso, 
sulfonate and phosphonate ester, halide etc.  
b. Concordant with known SAs not likely to be involved in mutagenicity, such 
as carboxylic, sulfonic, or sulfuric acids; metabolic precursors like ketones, 
quaternary ammonium, sulphonamide, urea, hydroxyl, thiophene etc. 
In addition, we found that rarely mentioned SAs such as imine group, thiazole and 
hydrogen bonds contribute to mutagenicity and carcinogenicity, while disulfide is an SA for 
non-mutagenicity. 
We did not list all frequent descriptors in our lists, e.g. nXch3, Xvch4, nHCHnX, 
n2Pag33. Although they were found to be present with high frequency in highly predictive 
models, they are not easily interpretable since they do not uniquely describe any specific 
structural feature. So their direct application to risk assessment and drug design could be 
limited, and their correspondence with the published SAs is difficult to establish. We thus left 
them out to avoid confusion or over extrapolation. 
Both modeling and clustering are important methods for pattern discovery and 
recognition, thus in this study we performed descriptor profiling and used a clustering and 
visualization method implemented in R (heatmap.2) (Liaw, Gentleman, et al, http://www.r-
project.org/). The resulting heatmap (Fig. 4.4) shows interesting patterns which agree well 
with known SAs for mutagenicity, and those patterns we retrieved from modeling. n/SaaaC 
(count/E-state of aromatic carbon), n/SaasC (count/E-state of carbon with two aromatic 
bonds and one single bond), Gmin/Gmax/Hmaxpos/Hmin (hydrogen bond E-states) 
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Figure 4.4 Significant descriptors detected by descriptor profiling 
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correspond to aromaticity and electrophilicity properties, which are known to contribute to 
carcinogenicity. Other familiar features/descriptors included nitroso (nnitroso), nitro (nnitro), 
hydroxyl (nsOH), aromatic amine (naaN, S/naas), primary amine (nsNH2), tertiary amine 
(S/nsssN), ammonium (nsNH3p), azo (nazo), hydrazine (n/H/SHydrazine), aldehyde 
(naldehyde), ketone (nketone), ester (nester), peroxide (nssO), furan (naaO), halogen (SsF, 
nsCl, nsI), sulfoxide (ndS), sulfonamide (n/Hsulfonamide), sulfonyl (ndssS), carboxylic acid 
(Scarboxylicacid), etc. Relatively less mentioned features included hydrogen bonding 
(S/nwHBa, nHBa, nHBd, S/nHBint[2-8]), imine (SHdNH, n/H/Simine),  thiophene and 
thiazole (naaS). 
Discussion  
1. CPDB Modeling: Frequent Descriptor Profiling 
a. Most impor tant frequent descr iptors for each endpoint – Mutagenicity, 
Carcinogenicity, False Negatives, and False Positives 
Descr iptor  Profiling for  Mutagens     From the statistical point of view (Fig. 4.5a), 
we found that the following frequent descriptors/features significantly ( 05.0≤p ) favor 
mutagenicity in order of decreasing confidence ( 50.0≥c ), such as nitroso, SHdNH (primary 
imine), nsOm, Snitro (nitro), ndsN & SdsN (azo/nitro/nitroso amine/hydrazine/azoxy/oxime), 
nssssNp (ammonium), naaS & SaaS (aromatic sulfur,  such as thiophene/thiazole), naaO 
(furan), naaaC (aromatic carbon), nsNH2 (primary amine), SsssN & nsssN (tertiary amine). 
Relatively less significant descriptors/features ( 05.0≈p ) that promote mutagenicity include 
aromatic amine and hydrazine. The patterns agree well with known SAs for mutagenicity 
(Kazius et al, 2005). Imine is a new feature we found that favor mutagenicity with slightly 
lower significance ( 07.0=p ). We would like to clarify the misconception on mutagenicity 
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of thiophene based on another discovery: we found three (CAS 33389-33-2, 33389-36-5, 
58139-48-3) out of six thiophenes in the current dataset are genotoxic/mutagenic, and 
another three (CAS 33372-39-3, 58139-47-2, 135-23-9) are non-genotoxic/mutagenic. 
Therefore, Ashby’s statement (Ashby, 1985) that thiophene is an unlike feature to eliciate 
carcinogenic or mutagenic response in vivo has exceptions; it should be applied with caution. 
Figure 4.5a: Significant descriptors profiling for mutagenicity. 
Significant Descriptors for Mutagenicity
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
nn
itro
so
ns
Om
Sn
itrond
sN
Sd
sN
ns
ss
sN
p
na
aO
na
aa
C
ns
NH
2
Ss
ss
N
ns
ss
N
nH
Cs
atu
SH
Cs
atu
ns
OH
ne
ste
r
Sc
arb
ox
ylic
ac
id
nd
ds
sS
ns
ulf
on
am
ide
Hs
ulf
on
am
ide
na
aS
Sa
aS
SH
dN
H
SH
Bin
t2
nH
Bin
t2
ns
sO
Hm
ax
po
s
Hm
in
nH
Cs
ats
SH
Cs
atsns
Cl
nw
HB
d
nw
HB
a
Descriptors
C
on
fid
en
ce
0.00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
P
-V
al
ue Confidence
P-Value
 
 
Figure 4.5b: Confidence and P-Values of frequent descriptor for mutagenicity. 
Confident Descriptors for Mutagenicity
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We also found that the following descriptors/features significantly deactivate 
mutagenicity in the order of decreasing confidence: n/Hsulfonamide (sulfonamide), nddssS 
(sulfonyl), Scarboxylicacid (carboxyl acid), nester (ester), nwHBd (weak hydrogen bond), 
nsOH (hydroxyl group), S/nHCsatu (unsaturated carbon hydrogen), n/SHBint2 (internal 
hydrogen bond with two interval edges), nsCl (single bond chloride), nssO (peroxide bond), 
nHCsats (saturated carbon hydrogen), SHCsats (saturated carbon hydrogen E-state), nwHBa 
(weak hydrogen bond acceptor) and ketone, etc. Majority of the patterns agree well with 
known facts that sulfonamide, sulfonyl, carboxylic acid, ester, OH, sulfonamide are 
detoxifying feature alerts for mutagenicity (Tennant et al, 1987). However, to the best of our 
knowledge, hydrogen bonding has not been explicitly mentioned as an SA for mutagenicity.  
From the perspective of pattern confidence (Fig. 4.5b), we found that sulfonate, 
iodine, hydrogen phosphite, nitrite, protonated ammonia(nNH3p) and amidine group always 
present in mutagens with 100% accuracy, while on the contrary, tCH, carbonyl, sulfone, 
quaternary ammonium cations (nHsssNHp), sulfoxide (dssS & Ssulfoxide), sulfuric acid, 
sulfonic acid, thiol (SsSH), peroxide and sssssP (phosphate) consistently present in non-
mutagens. However, the p-values for these two groups imply they are not statistically 
significant. It is simply due to the low occurrence of compounds containing those features in 
the current database, so their status as toxicophores or toxicophobes need more investigation.  
Descr iptor  Profiling for  Carcinogens. From a statistical perspective (Fig. 4.6a), 
we discovered that the following frequent descriptors/features significantly (p-value <= 0.05) 
favor carcinogenicity in order of decreasing confidence (>0.50): nnitroso, n/SaaS, n/SdsN 
(azo/nitro/nitroso  amine/hydrazine/azoxy /oxime), naaO (furan), n/SsssN (tertiary amine), 
nsNH2 (primary amine), etc. A majority of represented structural features, such as nitroso, 
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azo/nitroso amine/hydrazine, furan, tertiary and primary amines, etc., agree well with known 
SAs for genotoxic carcinogenicity (Kazius et al, 2005). Again, we would like to emphasize 
the case of thiophene (naaS & SaaS) and its analogues. We found that except for one non-
carcinogenic compound (CAS 135-23-9), five out of six thiophenes in the current dataset are 
carcinogenic, which include three genotoxic carcinogens (CAS 33389-33-2, 33389-36-5, 
58139-48-3) and two non-genotoxic carcinogens (CAS 33372-39-3, 58139-47-2). Therefore,  
Figure 4.6a: Frequent descriptors profiling for carcinogenicity. 
Significant Descriptors for Carcinogenicity
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Figure 4.6b: Frequent descriptors profiling for carcinogenicity. 
Confident Descriptors for Carcinogenicity
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we should refrain from overstreching Ashby’s statement on noncarcinogencity of thiophene. 
As for thiazole, we found ten out of thirteen are genotoxic carcinogens (data not shown), two 
are false positives (CAS 120-78-5, 148-79-8), and one is false negative (CAS 149-30-4).  
We also found the following significant descriptors/features do not favor 
carcinogenicity in the order of increasing degree of confidence: nHBd, S/nHCsatu 
(unsaturated carbon hydrogen), Scarboxylicacid, nsOH, nketone, n/SHBint3 (internal 
hydrogen bond with 3 interval bonds), n/SHBint6, ndS, S/nssS and ndisulfide. These patterns 
correspond well to known detoxifying features for genotoxic carcinogenicity (Mazzatorta et 
al, 2007), such as OH and carboxylic acid. Although relatively less well known, the low p-
value and low confidence of n/SHBint3, nHBint3 n/SHBint6 and nHBd suggest that 
Hydrogen bonds could also be involved in deactivating carcinogenicity.   
From the perspective of pattern confidence (Fig. 4.6b), we noticed that nitrite, 
hydrogen phosphite, sSH, sNH3p consistently present in carcinogens only, while HsssNHp 
(protonated ammonium), amidine, disulfide, sssssP, sulfuricacid, sulfonicacid, and peroxide 
consistently appear in non-carcinogens. However, the corresponding p-values do not indicate 
statistical significance for them as toxicophores or toxicophobes because of the low 
occurrence of host compounds in the dataset. Hydrazine, aromatic amine (aasN) and urea 
present in carcinogens with decent occurrence and confidence, the deviation from strong 
carcinogens is probably due to the interference by adjunct structural features within same 
compounds. It is also the case for detoxifying features for carcinogenicity such as 
sulfonamide, sulfonyl, imine, secondary amine, saturated carbon, and fluoride (See 
supplementary Table 4S.3 for details.). 
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Comparing the patterns in mutagenicity and carcinogenicity models, we see both 
overlap and differences: for example, nitroso, nitrite, azo, thiazole, furan, amine and 
hydrazine, etc seem to be responsible for both mutagenicity and carcinogenicity; while 
carboxylic acid, sulfonamide, sulfonic/sulfuric acid, hydroxyl group, ketone seem to 
deactivate both end points; whereas amidine appears to contribute to mutagenicity but not 
carcinogenicity, and thiol (sSH) is just the opposite.  
Descr iptor  Profiling for  False Negatives From the statistical point of view (Fig. 
4.7a), we observed significant (p-value <= 0.05) frequent descriptors/features, which 
included those favoring genotoxic carcinogenicity (confidence > 0.6), such as nnitroso, 
nsOm, Snitro, nssssNp, ndsN, SdsN, Himine, naaO, SaaS, SaaS, SsssN, nsssN, nsNH2, naaaC  
Figure 4.7a: Frequent descriptors profiling for false negatives (non-genotoxic carcinogens) 
Significant Descriptors for Carcinogenicity 
(Genotoxic vs. Epigenetic)
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and ndO, nHBd, etc; as well as those descriptors/features that favor epigenicity, such as 
H/nsulfonamide (sulfonamide), nddssS (sulfonyl), Scarboxylicacid, nwHBd, ndS, nester, 
nsOH, nsCl, n/SHCsatu, etc.   
With regard to pattern confidence (Fig. 4.7b), we found H/nBint10, SHdNH (imine), 
sulfonate, sI, hydrogen phosphite, nitrite, protonated NH3 present only in genotoxic carcino-  
 
gens, while tCH, sulfone, sulfoxide, carbonyl, sulfoxide and thiol occur only in the false 
 
Figure 4.7b: Top frequent descriptors and corresponding confidence and support to false 
negatives (non-genotoxic carcinogens) 
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negative. However, the p-values of patterns in each group are higher than 0.05, thus they are 
not significant patterns for genotoxic carcinogens or epigenetic carcinogens. One possible 
reason is the low number of compounds that have those features in the dataset. Interestingly, 
we found the following descriptors/features, such as nHBa, SHBa, nwHBa, nHBint2, 
SHBint2 have high occurrence with confidence for genotoxic carcinogenicity around 52 ~ 
62% and p-value about 0.08, which implies hydrogen bonding is likely to be involved in 
variation from genotoxic carcinogenicity to epigenetic carcinogenicity. Comparing with 
frequent descriptor patterns for carcinogenicity models, we observed the increased 
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importance of hydrogen bonds of different strengths and intervals. In addition, sCl and sOH 
seem to be involved in changing compounds from genotoxic carcinogen to a false negative. 
When a larger dataset with more instances of compounds containing these structural features 
becomes available, we will be able to validate and refine these patterns better.   
Descr iptor  Profiling for  False Positives. From the statistical point of view (Fig. 
4.8a), we observed significant descriptors/features that favor genotoxic carcinogenicity 
(confidence > 0.75), such as Urea, Urea, ndsN, SdsN, Nitrous, naaO, SsssN, nsssN, and ndO, 
etc., and those that favor genotoxic non-carcinogenicity, such as naaaC, SHBint3, nHBint3, 
ndS, and ndisulfide. In view of the pattern confidence, SHBint10, nHBint10, ntrifluoromethyl, 
Hphosphonate, nnitrite and nsNH3p are present only in genotoxic carcinogens, while 
ndisulfide and namidine occurred only in false positives. However, descriptors/features in  
Figure 4.8a: Frequent descriptor profiling for false positives (genotoxic non-carcinogens) 
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both groups do not have sufficiently small p-values, thus they are not qualified as significant 
features for genotoxic carcinogens and false positives, respectively. The obvious reason for 
low significance is low occurrence of parent compounds in the current dataset. On the 
contrary, hydrazine (n/S/Hhydrazine), nester, S/naaS, SaasN, n/SHBint5, Himine, nHCsats, 
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H/namide, SwHBd, nssO, nsNH2, naaN, nHBa, SHBa, n/SHBint8, nHBd, SwHBa, n/SaasC, 
SaaaC and S/nHCsatu have relatively higher occurrence and confidence. More complex 
scenarios are reported in Fig. 4.8b. We can see that nurea, azo/nitro/nitroso/(ndsN), furan 
(naaO), hydrazine, tertiary amine (S/nsssN), tiophene/thiazole (S/naaS), imine, and internal 
hydrogen bond formed between atoms with 5 intervals appear to contribute to genotoxic 
Figure 4.8b: Top frequent descriptors and corresponding confidence and support to false 
positives (genotoxic non-carcinogens) 
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carcinogenicity with high confidence; ndS, thiocarbonyl, aldehyde, azo, phosphonate may be 
involved in genotoxic carcinogenicity. 
b. Potential applications and limitations  
The patterns we found will be very helpful in many aspects. First, they made the 
chemical structure-activity relationships contained in our highly predictive models more 
transparent, and thus more straightforward for potential applications such as regulations, 
prioritization of animal toxicity tests, molecule optimization, drug design, etc. We 
characterized ‘alerting’ chemical features for false negative and false positive carcinogens 
and differentiated them from SAs for genotoxic carcinogens, thus attacked the problem of 
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high false negative rate and high false positive rate in carcinogenicity prediction from the 
perspective of chemical structure, rather than treating them simply as statistic errors. 
Therefore, our methodology can make more accurate and reliable prediction for 
carcinogenicity; it will contribute to the understanding of chemical mechanisms of 
mutagenicity and carcinogenicity, including epigenetic carcinogenicity.  
SAs were identified and applied differently in this work and in those of Ashby & 
Tennant et al (Ashby, 1985; Ashby & Tennrant, 1991). Ashby & Tennant SAs function as 
warnings, yet prediction of toxicity depends on investigators’ judgment, knowledge and 
experience. SAs are qualitative indications for carcinogenicity potential, either activating or 
deactivating. Since neither promoting nor demoting potential of SAs was scaled, compounds 
with mixed features are less predictable. The practice of canceling out a deactivating feature 
with one or more activating features is an approximation, which is not acceptable to a fine-
tuned SAR for drug screening. On the other hand, the co-presence of SAs of same type may 
not increase or decrease carcinogenicity potential either, since each SA fragment could 
interfere with the ability of another one to induce carcinogenicity, thus making the 
carcinogenicity potential less predictable. 
In contrast with this approach, our QSAR models contain many descriptors 
characterizing multiple SAs that either activate or deactivate mutagenicity or carcinogenicity 
in ensemble. The predictivity of our models is proven by rigorous validation including 
different test sets. However, it’s not recommended to use our models out of their applicability 
domain (AD), or use frequent descriptors individually out of the models, as in the Ashby & 
Tennant et al. Useful as these models are, they have some limitations to be kept in mind for 
better application for the following reasons.  
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First, chemical descriptors can be too general, so they fail to catch unique structural 
features of different compounds, which may be critical in modulation of the carcinogenicity 
potential of compounds. For example, ntsC and StsC are two corresponding descriptors for 
the count and electrotopological state indices (E-State) of C triple bond which can present in 
an alkyne, which is non-carcinogenic, or a cynate, which is carcinogenic. So without the 
context, it is impossible to predict correctly the carcinogenicity of a compound. Another 
example is ndsN and SdsN which are count and E-State for nitrogen atoms that have a double 
bond and a single bond, which can present in imine, azo, isocynate, isothiocynate, nitrite or 
nitroso. Without context of modulators in the compound, it is impossible to predict 
carcinogenicity of a compound containing this feature.  
Secondly, the working dataset contains 693 compounds from CPDB, which have both 
mutagenicity and carcinogenicity data. It covers only a limited chemical space for mutagens 
and carcinogens, thus patterns derived are not exhaustive, neither can they account for all the 
chemical mutagenicity and carcinogenicity mechanisms. The patterns should not be used out 
of the AD of the working dataset. A larger database definitely can enrich and fine-tune the 
patterns we found here. On the orther hand, the descriptors were retrieved from models 
which have high, but not perfect prediction power, thus exceptions always exist. What’s 
more, descriptors generated automatically can be too general and certain characteristics of 
some compounds could be poorly presented and differentiated. In consequence, the modeling 
task becomes challenging. For example, descriptor naaS, aromatic sulfur, was used to present 
thiophene and thiazole, which have quite different propensities for mutagenicity and 
carcinogenicity. Among six thiophenes in the dataset, three (CAS 33389-33-2, 33389-36-5, 
58139-48-3) are mutagenic, another three (CAS 33372-39-3, 58139-47-2, 135-23-9) are non-
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mutagenic, they all are carcinogenic except for (CAS 58139-47-2); while for 13 thiazoles in 
the dataset, 10 (CAS 38514-71-5, 121-66-4, 26049-69-4, 3570-75-0, 139-94-6, 2578-75-8, 
53757-28-1, 531-82-8, 24554-26-5, 75-69-4) are genotoxic carcinogens, one (CAS 149-30-4) 
is false negative, and two (CAS 120-78-5, 148-79-8) are false positives. Another example are 
descriptors ndsN and SdsN, count and electrotopological state of nitrogens with one double 
bond and one single bond, which were referred to the structure shared by following 
compounds in the working dataset: 15 azos that composed of 11 genotoxic carcinogens, 2 
false negatives, one false positive, one safe compound; two azoxy that are genotoxic 
carcinogens; one azide that is genotoxic carcinogen; 46 nitrosamines which include 42 
genotoxic carcinogens, one false negative, one false positive, two non-genotoxic non-
carcinogens, etc. Obviously more specific descriptors are needed to characterize each 
category of compounds and better differentiate them from each other and other compounds. 
On the other hand, carcinogenesis is a complex and multistage process. In framework 
of QSAR studies presented herein such stages of carcinogenesis as DNA repair and 
apoptosis, etc. which are controlled by complicated signaling pathways within cells, are 
beyond explanation.  
Nevertheless, our work fills the gap of characterizing false negatives and false 
positives, and contributes to prediction accuracy for carcinogenicity. We understand that our 
results will raise a reasonable doubt about the patterns for false negatives and false positives 
we found from the limited pool of compounds used in this study. We acknowledge that 
structures of false negatives and false positives are numerous and diverse; however, finding 
exhaustive patterns for those is not the intent of this study. Finding the patterns in how 
modulators turn seemingly genotoxic carcinogens into false negatives or false positives is. 
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Rather than surrendering to the daunting idea of finding exhaustive patterns for those, our 
method is more feasible and practical. Of course, employing our method to an extensive 
dataset would definitely enrich, fine-tune and validate the patterns we found. 
2. Test Study: Mutagenicity and Carcinogenicity prediction for 28 novel CPDB 
compounds 
To test the high classification accuracy of our kNN QSAR models built for 
mutagenicity and carcinogenicity, we used compounds newly added to CPDB dataset 
(CPDBAS_v5b_1547_10Feb2008) that were not involved in any step of model building or 
validation. After the same preprocessing step as mentioned in the Methods section, we got 28 
compounds that suit the purpose of this study, which included 5 genotoxic carcinogens, 3 
genotoxic non-carcinogens, 12 non-genotoxic carcinogens, and 8 non-genotoxic non-
carcinogens. The 28 compounds were subjected to the consensus predictions by the best 
mutagenicity and carcinogenicity models (see above). Results are reported in Table 4. 13.  
Among five genotoxic carcinogens, three (CAS 23246-96-0, 13674-87-8, 501-30-4) 
were predicted correctly by both routes. For the remaining two compounds, CAS 125-33-7 
was predicted as a nongenotoxic carcinogen. NTP report showed this compound is true 
positive only in one strain of Salmonella, no positive results from MLA and SCE assays; 
CAS 57018-52-7 was predicted as non-genotoxic non-carcinogen, which was not concordant 
with CPDB and DSSTox record, but concordant with IARC reviewed in 2004 and NTP 
report.  
Two genotoxic carcinogens (CAS 518-82-1 and 87-62-7) were predicted correctly, 
and one (CAS 111-30-8) was incorrectly predicted by both models (i.e. it was predicted as 
non-genotoxic carcinogen).  
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Table 4.13: kNN QSAR models for mutagenicity and carcinogenicity showed high classification accuracy for external validation set 
DssTox 
CID CAS 
CPDB 
Mutagenicity 
CPDB 
Carcinogenicity 
Mutagenicity by 
consensus prediction of 
Models 1* 
Carcinogenicity by 
consensus prediction of 
Models 2** 
510 125-33-7 1 1 0 1 
5967 57018-52-7 1 1 0 0 
6006 23246-96-0 1 1 1 1 
6261 13674-87-8 1 1 1 1 
20236 501-30-4 1 1 1 1 
5231 518-82-1 1 0 1 0 
5355 111-30-8 1 0 0 1 
6307 87-62-7 1 0 1 0 
1917 110-54-3 0 1 0 1 
1924 110-86-1 0 1 0 1 
1986 126-73-8 0 1 0 1 
2107 693-98-1 0 1 0 1 
2521 68515-48-0 0 1 0 1 
3792 99-99-0 0 1 1 1 
3794 434-07-1 0 1 0 1 
4097 111-76-2 0 1 0 1 
5347 98-00-0 0 1 0 1 
5607 93-15-2 0 1 0 1 
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DssTox 
CID CAS 
CPDB 
Mutagenicity 
CPDB 
Carcinogenicity 
Mutagenicity by 
consensus prediction of 
Models 1* 
Carcinogenicity by 
consensus prediction of 
Models 2** 
5791 88-72-2 0 1 1 1 
20239 61445-55-4 0 1 1 1 
699 136-77-6 0 0 0 0 
1635 78-84-2 0 0 0 0 
1995 134-62-3 0 0 0 0 
4176 126-98-7 0 0 0 0 
4834 14371-10-9 0 0 0 0 
4836 5392-40-5 0 0 0 0 
4986 80-07-9 0 0 0 0 
5186 25265-71-8 0 0 0 0 
*55 models were used in consensus prediction (see Results section) 
**29 models were used in consensus prediction (see Results section) 
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Regarding 12 non-genotoxic carcinogens, nine compounds (CAS 110-54-3, 110-86-1, 
126-73-8, 693-98-1, 68515-48-0, 434-07-1, 111-76-2, 98-00-0, and 93-15-2) were predicted 
correctly by both models. Two other compounds (CAS 99-99-0 and 88-72-2) are isomers, p- 
nitrotoluene and o-nitrotoluene, and their mutagenicity was predicted incorrectly, while 
carcinogenicity correctly. However, for these compounds NTP (NTP Tech Report Ser. 2002 
May; (498):1-277) reported positive response in mouse lymphoma cell assay and increased 
sister chromatid exchange frequencies in cultured Chinese hamster ovary cells. So, our 
mutagenicity predictions for these compounds might be, in fact, correct. For the similar 
reason, our prediction for compound (CAS 61445-55-4) as genotoxic carcinogen might also 
be correct, since no other genotoxic tests except for salmonella showed negative result. 
Among eight non-genotoxic non-carcinogens, five compounds (CAS 136-77-6, 134-
62-3, 14371-10-9, 5392-40-5, 25265-71-8) were correctly predicted by both models. The 
remaining three compounds (CAS 78-84-2, 126-98-7, and 80-07-9) were correctly predicted 
as non-mutagens by model 1, but incorrectly predicted as carcinogens by model 2. As a 
follow up, we checked the structure features of these compounds. Interestingly we found that 
both compounds (CAS 126-98-7: 2-methylacrylonitrile and CAS 80-07-9: 1,1'-sulfonylbis(4-
chlorobenzene)) contain known alerting features for carcinogenicity, however eletrophiles 
cannot be formed. We have also developed a tiered scheme for mutagenicity and 
carcinogenicity prediction which utilizes QSAR models built for smaller groups of 
compounds (Fig. 4.9). For example, if a compound is classified as mutagenic using 
consensus prediction by model 1, we can use consensus prediction by model 6 to predict its 
carcinogenicity. If a compound is classified as non-mutagenic by model 1, we can use model 
5 to predict its carcinogenicity. At the same time, if a compound is predicted as carcinogenic 
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by model 2, we can use model 7 to predict its mutagenicity. However, if a compound is 
predicted as non-carcinogenic by model 2, we can use model 4 to predict its mutagenicity. 
Thus, we can find if a compound is predicted in the same way by both routes on the scheme. 
In this case, we can say that the scheme increases WoE for the predictions. It is also possible     
Figure 4.9: Scheme of tiered application of models to prediction 
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Model 1: Mutagenicity models (mutagens vs. non-mutagens);   
Model 2: Carcinogenicity models (carcinogens vs. non-carcinogens) 
Model 4: False negative carcinogenicity models I: (genotoxic carcinogens vs. non-genotoxic carcinogens) 
Model 5: False negative carcinogenicity models II (non-genotoxic carcinogens vs. non-genotoxic on-
carcinogens) 
Model 6: False positive carcinogenicity models I: (genotoxic carcinogens vs. genotoxic non-carcinogens) 
Model 7: False positive carcinogenicity models II (genotoxic non-carcinogens vs. non-genotoxic non-
carcinogens) 
Model index were kept consistent with study results. 
 
that predictions by both routes contradict each other, or a compound is out of the AD of some 
sets of models. In this case, that prediction for the compound is unreliable. All 28 compounds 
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were predicted by both routes on the scheme in the same way as by models 1 and 2, thus 
corroborating our predictions.   
In summary, the models we derived are highly predictive and discriminative. 
Mutagenicity of 22 and carcinogenicity of 23 out of 28 compounds were predicted correctly.  
Conclusions 
Mutagenicity and carcinogenicity QSAR studies of the Carcinogenic Potency 
Database (CPDB) (Gold, et al, 1984; Richard, et al, 2002) have been carried out using 
classification k Nearest Neighbor QSAR (kNN-QSAR) (Golbraikh et al, 2002) software 
developed in our laboratory. The analysis of the relationships between chemical structures 
and mutagenicity and carcinogenicity has been performed. Besides QSAR modeling for 
mutagenicity and carcinogenicity endpoints, particular attention has been paid to structural 
features and ‘alerts’ which could be responsible for genotoxic carcinogenicity, epigenic 
carcinogenicity (false negative), genotoxic non-carcinogenicity (false positive) and non-
toxicity as regards to mutagenicity and carcinogenicity. In this respect, the following QSAR 
studies have been performed: (i) mutagenicity studies (337 mutagens vs. 356 non-mutagens); 
(ii) carcinogenicity studies (424 carcinogens vs. 269 non-carcinogens); (iii) genotoxic 
carcinogenicity studies (252 genotoxic carcinogens vs. 184 non-genotoxic non- carcinogens); 
(iv) false negative carcinogenicity studies I (252 genotoxic carcinogens vs. 172 non-
genotoxic carcinogens); (v) false negative carcinogenicity studies II (172 non-genotoxic 
carcinogens vs. 184 non-genotoxic non- carcinogens); (vi) false positive carcinogenicity 
studies I (252 genotoxic carcinogens vs. 85 genotoxic non-carcinogens); (vii) false positive 
carcinogenicity studies II (85 genotoxic non-carcinogens vs. 184 non-genotoxic non-
carcinogens).  
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 A standard kNN QSAR protocol developed in our laboratory has been implemented in all 
studies. All datasets have been randomly divided into modeling and external evaluation sets. 
All modeling sets were divided into multiple training and test sets using a sphere-exclusion 
algorithm. Training sets were used to build models, test sets were used to validate them. 
Models with high correct classification rate (CCR) for both training and test sets (higher than 
0.7-0.8 in all analyses, except for the test sets of carcinogenicity models for which it was 
higher than 0.65) were used in consensus prediction of the external evaluation sets. Models 
built for all studies demonstrated high classification accuracy for the external evaluation sets 
with CCR values equal or higher than 0.78, sensitivity  values were 0.75 and higher and 
specificity values were equal to or higher than 0.70. As a comparison, we have built models 
with the external evaluation set of 70 compounds using the commercial predictive toxicology 
software Lazar (Helma, 2006); the accuracy of prediction of this set by Lazar was much 
lower than that obtained by the consensus prediction by the best kNN QSAR models. 
Structural alerts for mutagenicity and carcinogenicity, which we detected using software 
Leadscope (Robert et al, 2000), were reported as complementary to those found from kNN 
QSAR studies. High classification accuracy of the kNN QSAR models built for mutagenicity 
and carcinogenicity endpoints was corroborated for 28 novel CPDB compounds which were 
not included in model building and validation. We performed systematic descriptor profiling 
for highly predictive models for mutagens, carcinogens, epigenetic carcinogens, and 
genotoxic non-carcinogens. The patterns we found make the chemical information buried in 
highly predictive models more transparent and thus more straightforward for potential 
applications. The ‘structural alerts’ like descriptor profiles for carcinogens, epigenetic 
carcinogens, and genotoxic non-carcinogens fill the gap in the carcinogenicity prediction 
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research. The high false negative rate and high false positive rate for carcinogenicity 
prediction were explained from the chemical structural perspective rather than as statistical 
errors. We are closer to the solution of accurate and reliable prediction for carcinogenicity 
and molecular optimization. Our models have high prediction accuracy since they were 
rigorously validated using different test sets of compounds which were not used in model 
development. We have also demonstrated high prediction accuracy of our models on a new 
dataset of 28 compounds.  We expect that the computational approach presented herein could 
significantly reduce the cost and time of the drug discovery and development process, and 
the number of animals sacrificed in experimental studies. 
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Table 4.S1: Summary of kNN QSAR Modeling Result 
 
Model # 
Studies 
Training Set Models CCR Test Set Models CCR External Validation Set CCR 
0.65-
0.70 
0.70-
0.75 
0.75-
0.80 Max 
0.65-
0.70 
0.70-
0.75 
0.75-
0.80 Max CPMN Sensitivity Specificity CCR 
Carcinogenicit
y 
(Car+ vs. Car-) 
1 1579 4487 812 0.82 1085 0 0 0.70 29 0.85 0.70 0.78 
2 980 3858 1304 0.80 640 10 0 0.68 15 0.80 0.70 0.75 
3 1132 4207 1294 0.82 920 7 0 0.69 18 0.78 0.67 0.73 
Model # 
Studies 
Number of Models with CCR (train) Number of Models with CCR (test) External evaluation Set 
0.70-
0.75 0.75-0.80 0.80-1.0 Max 0.70-0.75 0.75-0.80 0.80-1.0 Max CPMN Sensitivity Specificity CCR 
Mutagenicity 
(Mut+ vs. Mut-
) 
1 23 1351 5067 0.92 3183 772 69 0.85 55 0.92 0.84 0.88 
2 13 1196 4401 0.89 2312 348 48 0.87 33 0.86 0.84 0.85 
3 6 366 2721 0.89 1265 176 16 0.85 24 0.83 0.82 0.83 
 
Carcinogenicit
y 
(TP vs. TN) 
1 2 225 6403 0.93 2386 1236 289 0.94 20 0.83 0.72 0.78 
2 10 266 6183 0.94 2189 856 120 0.89 30 0.85 0.83 0.84 
3 3 199 6428 0.94 2307 984 202 0.92 33 0.93 0.70 0.82 
False 
Negatives 
(TP vs. FN) 
1 40 729 6029 0.94 1921 481 66 0.89 59 0.84 0.87 0.86 
2 13 614 6513 0.93 1249 210 16 0.85 26 0.78 0.76 0.77 
3 6 361 6433 0.95 1732 380 29 0.84 29 0.75 0.80 0.78 
False 
Negatives 
(FN vs TN) 
1 1696 1619 253 0.89 2459 59 0 0.79 33 0.75 0.83 0.79 
2 1003 1900 178 0.86 2715 45 0 0.73 27 0.69 0.78 0.74 
3 1117 1968 388 0.88 2434 44 0 0.79 28 0.72 0.81 0.77 
False Positives 
(TP vs. FP) 
1 1563 2470 1577 0.92 1433 627 94 0.88 56 0.91 0.79 0.85 
2 2359 1987 650 0.90 1271 265 51 0.75 35 0.93 0.77 0.85 
3 2488 1945 519 0.89 1492 565 47 0.74 32 0.90 0.75 0.83 
False Positives 1 617 1451 393 0.95 756 244 112 0.94 36 0.78 0.94 0.86 
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(FP vs. TN) 2 950 1185 398 0.90 675 267 80 0.88 25 0.73 0.88 0.81 
3 775 1779 607 0.93 421 312 101 0.85 20 0.78 0.94 0.84 
To keep information in the table concise, the following abbreviations are used: 
Mut+/-: mutages/non-mutages; Car+/-: carcinogens/non-carcinogens; 
TP: true positives a.k.a. genotoxic carcinogens; FP: false positives, a.k.a. genotoxic non-carcinogens;  
TN: true negatives a.k.a. non-genotoxic non-carcinogens; FN: false negatives, a.k.a. non-genotoxic carcinogens 
CPMN: consensus prediction models number 
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Table 4.S2: Comparative Studies of Lazar and kNN QSAR for external evaluation set of 70 compounds. 
 
DSSTox_ 
SID Structure_Formula 
TestSubstance_ 
CASRN 
Mutagenicity_ 
CPDB 
MutPred_ 
kNNQSAR 
MutPred_ 
Lazar 
Carcinogenicity_
CPDB 
CarPred_ 
kNNQSAR 
CarPred_ 
Lazar 
1 C11H9N3 26148-68-5 positive positive active? 1 1 active? 
9 C2H3N 75-05-8 negative positive inactive? 0 0 inactive 
18 C15H13NO 53-96-3 positive positive active? 1 1 active? 
29 C3H3N 107-13-1 positive positive inactive? 1 1 inactive? 
35 C17H12O6 1162-65-8 positive positive inactive? 1 1 active? 
54 C14H15ClN2 6109-97-3 positive positive active? 1 1 active? 
57 C15H11NO2 82-28-0 positive positive active? 1 1 active? 
64 C6H6N2O3 119-34-6 positive positive active 1 1 active 
77 C11H23NO2 2432-99-7 negative negative inactive? 1 0 inactive? 
89 C9H5Cl3N4 101-05-3 negative negative active? 0 1 active? 
94 C7H7NO2 118-92-3 negative negative inactive? 0 0 inactive? 
112 C8H14ClN5 1912-24-9 negative negative inactive? 1 1 inactive? 
135 C6H6 71-43-2 negative negative N.A. 1 1 N.A. 
153 C7H7Cl 100-44-7 positive negative active? 1 1 inactive? 
253 C40H56 7235-40-7 positive negative inactive? 0 0 inactive? 
287 C7H8ClN 95-79-4 negative negative active 1 1 active 
299 C16H14Cl2O3 510-15-6 negative negative inactive? 1 1 inactive? 
333 C13H14O5 518-75-2 negative negative inactive? 1 1 inactive? 
361 C6H14ClN 4998-76-9 negative negative inactive 0 0 inactive 
404 C7H12Cl2N2 15481-70-6 positive positive active 0 0 active 
409 C22H14 53-70-3 positive positive inactive? 1 1 active? 
432 C12H10Cl2N2 91-94-1 positive positive active? 1 1 active? 
435 C12H6Cl2O2 33857-26-0 negative negative inactive? 0 1 active? 
438 C2H4Cl2 107-06-2 positive positive inactive 1 1 active 
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DSSTox_ 
SID Structure_Formula 
TestSubstance_ 
CASRN 
Mutagenicity_ 
CPDB 
MutPred_ 
kNNQSAR 
MutPred_ 
Lazar 
Carcinogenicity_
CPDB 
CarPred_ 
kNNQSAR 
CarPred_ 
Lazar 
462 C4H10O3 111-46-6 negative negative inactive 1 0 active? 
483 C8H12ClNO2 54150-69-5 positive positive active 0 0 active 
484 C16H12N2O4 91-93-0 positive positive active? 1 1 active? 
507 C8H11N 121-69-7 negative negative active 1 1 active 
520 C4H7Cl 513-37-1 positive negative inactive? 1 1 active 
565 C20H32N2O6S 134-72-5 negative negative inactive 0 0 inactive? 
566 C3H5ClO 106-89-8 positive positive active? 1 1 active 
577 C8H10N2S 536-33-4 negative negative inactive? 1 1 inactive? 
583 C5H8O2 140-88-5 negative negative inactive 1 1 inactive 
616 C10H18O 470-82-6 negative negative inactive 0 0 inactive 
628 C10H11F3N2O 2164-17-2 negative negative active? 0 0 active? 
640 C8H6N4O4S 3570-75-0 positive positive active? 1 1 active? 
662 C3H8O3 56-81-5 negative negative active 0 0 active 
741 C6H11IO3 5634-39-9 positive negative active? 1 1 active? 
861 C7H8O2 452-86-8 negative negative inactive 1 1 inactive? 
867 C15H18N2 838-88-0 positive positive active? 1 1 active? 
884 C2H3N3O 33868-17-6 positive positive active? 1 1 active? 
892 C6H9N3O3 443-48-1 positive positive active? 1 1 active? 
912 C12H12N2O3 389-08-2 negative negative N.A. 1 1 inactive? 
914 C12H11NO 86-86-2 positive positive inactive? 0 0 inactive? 
916 C10H10N2 2243-62-1 positive positive active? 1 1 active? 
939 C6H9NO6 139-13-9 negative negative inactive? 1 1 inactive 
964 C6H5NO2 98-95-3 negative positive active 1 1 active 
970 C12H7Cl2NO3 1836-75-5 positive positive active 1 1 active? 
978 C10H7NO2 86-57-7 positive positive active? 0 0 active? 
984 C9H6N2O2 613-50-3 positive positive active? 0 0 active? 
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DSSTox_ 
SID Structure_Formula 
TestSubstance_ 
CASRN 
Mutagenicity_ 
CPDB 
MutPred_ 
kNNQSAR 
MutPred_ 
Lazar 
Carcinogenicity_
CPDB 
CarPred_ 
kNNQSAR 
CarPred_ 
Lazar 
1028 C4H10N2O 55-18-5 positive positive active 1 1 active 
1031 C12H10N2O 156-10-5 positive negative active? 1 1 active? 
1036 C3H8N2O 10595-95-6 positive positive active 1 1 active 
1050 C6H7N3O 16219-98-0 positive positive active? 1 1 active? 
1051 C6H7N3O 69658-91-9 negative positive active? 0 1 active? 
1097 C22H25ClN2O9 2058-46-0 negative negative inactive? 0 0 inactive? 
1144 C8H14N2O4S 156-51-4 positive positive inactive? 1 1 inactive 
1151 C12H10O 90-43-7 positive negative active? 1 1 active? 
1158 C8H8N2O2 88-96-0 negative negative inactive? 0 1 inactive? 
1159 C8H4O3 85-44-9 negative negative inactive? 0 0 inactive? 
1217 C12H13ClN4 58-14-0 negative positive active? 0 1 active? 
1248 C23H22O6 83-79-4 negative negative inactive? 0 0 inactive? 
1328 C4H8O 109-99-9 negative negative active 1 1 active? 
1357 C28H48O2 1406-66-2 negative negative inactive? 1 0 inactive? 
1358 C14H21N3O3S 1156-19-0 negative negative inactive? 0 0 inactive? 
1386 C6H3Cl3O 88-06-2 negative negative inactive 1 1 active? 
1392 C6H15NO3 102-71-6 negative negative inactive 1 1 inactive? 
1410 C19H25ClN2O 6138-79-0 negative negative active? 0 0 inactive? 
1440 C6H9NO 88-12-0 negative negative inactive? 1 1 inactive? 
3235 C6H14O6 69-65-8 negative negative inactive? 0 0 inactive 
617 C10H12O2 97-53-0 negative negative inactive 0 0 inactive? 
N.A. C11 H14 O2 93-15-2 negative negative inactive 1 1 inactive? 
CASRN: CAS registration number; MutPred: Mutagenicity prediction; CarPred: Carcinogenicity prediction 
Mutagenicity_ CPDB: Salmonella mutagenicity in CPDB summary table;  Carcinogenicity_CPDB: Carcinogenicity single cell call in CPDB summary table 
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Table 4.S3: Significant descriptor profiling for mutagenicity, carcinogenicity, false negatives and false positives in terms of confidence, support 
and frequency. 
   Mutagenicity Carcinogenicity  False Negative False Positive  
ID Descriptors Freq. Act. Inact. Cnfid. P-value Freq. Act. Inact. Cnfid. P-value Freq. Act. Inact. Cnfid. P-value Freq. Act. Inact. Cnfid. P-value 
4 SHBint2 21 54 80 0.40 0.02 9 77 57 0.57 0.19 18 40 37 0.52 0.09 33 40 14 0.74 0.51 
5 Hmaxpos 21 334 344 0.49 0.02 9 414 264 0.61 0.44 18 251 163 0.61 0.00 60 251 83 0.75 0.16 
6 Gmax 30 337 355 0.49 0.51 14 423 269 0.61 0.61 30 252 171 0.60 0.41 62 252 85 0.75 1.00 
7 naasC 31 200 213 0.48 0.48 8 246 167 0.60 0.16 24 149 97 0.61 0.32 54 149 51 0.75 0.50 
9 nurea 18 17 12 0.59 0.18 14 22 7 0.76 0.07 28 16 6 0.73 0.14 36 16 1 0.94 0.04 
13 nHBint2 36 54 80 0.40 0.02 3 77 57 0.57 0.19 33 40 37 0.52 0.09 39 40 14 0.74 0.51 
14 nwHBa 14 270 302 0.47 0.06 4 345 227 0.60 0.18 12 199 146 0.58 0.08 33 199 71 0.74 0.23 
19 SHBint4 25 40 39 0.51 0.40 5 43 36 0.54 0.12 20 28 15 0.65 0.26 33 28 12 0.70 0.29 
27 SHBint6 11 21 26 0.45 0.34 4 21 26 0.45 0.01 16 14 7 0.67 0.33 28 14 7 0.67 0.26 
28 SHBint3 19 44 45 0.49 0.48 10 42 47 0.47 0.00 11 28 14 0.67 0.20 38 28 16 0.64 0.05 
30 nHBd 18 187 192 0.49 0.37 5 221 158 0.58 0.05 30 140 81 0.63 0.05 45 140 47 0.75 0.53 
32 nsNH2 61 104 55 0.65 0.00 10 107 52 0.67 0.04 69 79 28 0.74 0.00 35 79 25 0.76 0.42 
34 nHBint3 19 44 45 0.49 0.48 13 42 47 0.47 0.00 15 28 14 0.67 0.20 42 28 16 0.64 0.05 
36 nnitroso 52 50 5 0.91 0.00 11 48 7 0.87 0.00 42 45 3 0.94 0.00 42 45 5 0.90 0.00 
37 nHBint4 16 40 39 0.51 0.40 8 43 36 0.54 0.12 25 28 15 0.65 0.26 40 28 12 0.70 0.29 
38 nssO 31 80 110 0.42 0.02 8 112 78 0.59 0.26 18 61 51 0.54 0.13 37 61 19 0.76 0.43 
40 nhydrazine 10 9 5 0.64 0.18 13 11 3 0.79 0.14 11 8 3 0.73 0.28 41 8 1 0.89 0.29 
42 Gmin 32 336 356 0.49 0.49 8 423 269 0.61 0.61 33 251 172 0.59 0.59 63 251 85 0.75 0.75 
44 SwHBa 23 337 355 0.49 0.51 5 423 269 0.61 0.61 12 252 171 0.60 0.41 16 252 85 0.75 1.00 
45 SHBint8 6 12 15 0.44 0.40 5 14 13 0.52 0.21 23 9 5 0.64 0.47 29 9 3 0.75 0.62 
46 SHBint5 14 15 19 0.44 0.36 3 19 15 0.56 0.32 14 12 7 0.63 0.47 35 12 3 0.80 0.45 
48 nester 11 16 44 0.27 0.00 13 34 26 0.57 0.27 26 14 20 0.41 0.02 48 14 2 0.88 0.19 
49 nHssNH 21 60 55 0.52 0.23 7 63 52 0.55 0.08 23 43 20 0.68 0.08 37 43 17 0.72 0.32 
50 naaN 44 49 43 0.53 0.20 7 58 34 0.63 0.39 35 37 21 0.64 0.28 54 37 12 0.76 0.53 
51 Hurea 17 16 12 0.57 0.23 7 21 7 0.75 0.09 26 15 6 0.71 0.18 55 15 1 0.94 0.06 
55 naaO 26 27 8 0.77 0.00 6 28 7 0.80 0.01 32 24 4 0.86 0.00 58 24 3 0.89 0.06 
57 Hmin 22 334 344 0.49 0.02 6 414 264 0.61 0.44 8 251 163 0.61 0.00 57 251 83 0.75 0.16 
64 nsOH 28 55 125 0.31 0.00 5 88 92 0.49 0.00 24 38 50 0.43 0.00 40 38 17 0.69 0.19 
69 SHBint7 11 11 11 0.50 0.53 6 11 11 0.50 0.19 12 8 3 0.73 0.28 41 8 3 0.73 0.55 
70 naaaC 46 51 25 0.67 0.00 7 44 32 0.58 0.31 27 33 11 0.75 0.02 54 33 18 0.65 0.06 
71 nsCl 41 64 89 0.42 0.03 10 97 56 0.63 0.29 55 46 51 0.47 0.00 42 46 18 0.72 0.33 
74 ndS 13 11 18 0.38 0.16 9 12 17 0.41 0.02 16 4 8 0.33 0.06 47 4 7 0.36 0.01 
79 nHBint6 19 21 26 0.45 0.34 8 21 26 0.45 0.01 25 14 7 0.67 0.33 41 14 7 0.67 0.26 
80 ndsN 76 75 15 0.83 0.00 17 75 15 0.83 0.00 68 68 7 0.91 0.00 44 68 7 0.91 0.00 
82 nssS 29 12 13 0.48 0.56 8 9 16 0.36 0.01 16 7 2 0.78 0.22 39 7 5 0.58 0.16 
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   Mutagenicity Carcinogenicity  False Negative False Positive  
ID Descriptors Freq. Act. Inact. Cnfid. P-value Freq. Act. Inact. Cnfid. P-value Freq. Act. Inact. Cnfid. P-value Freq. Act. Inact. Cnfid. P-value 
86 SaasC 28 337 355 0.49 0.51 8 423 269 0.61 0.61 26 252 171 0.60 0.41 31 252 85 0.75 1.00 
89 Snitro 68 68 13 0.84 0.00 7 52 29 0.64 0.32 55 48 4 0.92 0.00 24 48 20 0.71 0.23 
90 nHBint7 13 11 11 0.50 0.53 3 11 11 0.50 0.19 13 8 3 0.73 0.28 39 8 3 0.73 0.55 
93 nHCsats 19 166 202 0.45 0.03 5 215 153 0.58 0.07 17 129 86 0.60 0.44 40 129 37 0.78 0.14 
94 Simine 22 13 7 0.65 0.10 7 11 9 0.55 0.36 21 9 2 0.82 0.11 29 9 4 0.69 0.42 
95 naldehyde 33 6 2 0.75 0.13 7 5 3 0.63 0.62 30 3 2 0.60 0.67 49 3 3 0.50 0.17 
97 Hhydrazine 42 9 4 0.69 0.11 12 10 3 0.77 0.19 14 8 2 0.80 0.16 60 8 1 0.89 0.29 
100 SdsN 54 75 15 0.83 0.00 17 75 15 0.83 0.00 48 68 7 0.91 0.00 35 68 7 0.91 0.00 
101 Shydrazine 36 9 5 0.64 0.18 10 11 3 0.79 0.14 15 8 3 0.73 0.28 35 8 1 0.89 0.29 
102 nssssNp 56 72 16 0.82 0.00 7 57 31 0.65 0.27 36 52 5 0.91 0.00 37 52 20 0.72 0.34 
105 nsOm 53 71 13 0.85 0.00 4 55 29 0.65 0.23 40 51 4 0.93 0.00 39 51 20 0.72 0.31 
106 Scarboxylicacid 32 9 38 0.19 0.00 4 23 24 0.49 0.05 25 6 17 0.26 0.00 39 6 3 0.67 0.41 
108 SsssN 23 86 50 0.63 0.00 5 100 36 0.74 0.00 19 76 24 0.76 0.00 29 76 10 0.88 0.00 
115 nphosphate 23 3 4 0.43 0.53 5 5 2 0.71 0.45 41 2 3 0.40 0.33 37 2 1 0.67 0.58 
116 nketone 35 13 23 0.36 0.08 5 17 19 0.47 0.06 19 8 9 0.47 0.21 37 8 5 0.62 0.21 
118 nHCsatu 22 111 185 0.38 0.00 7 166 130 0.56 0.01 29 83 83 0.50 0.00 37 83 28 0.75 0.55 
120 nHBint5 20 15 19 0.44 0.36 5 19 15 0.56 0.32 23 12 7 0.63 0.47 43 12 3 0.80 0.45 
121 nHBint8 25 12 15 0.44 0.40 4 14 13 0.52 0.21 24 9 5 0.64 0.47 39 9 3 0.75 0.62 
122 SssS 27 12 13 0.48 0.56 8 9 16 0.36 0.01 18 7 2 0.78 0.22 34 7 5 0.58 0.16 
125 nimine 22 13 7 0.65 0.10 4 11 9 0.55 0.36 24 9 2 0.82 0.11 39 9 4 0.69 0.42 
129 nHBa 33 328 343 0.49 0.30 6 409 262 0.61 0.33 33 246 163 0.60 0.10 43 246 82 0.75 0.41 
130 Sthiocarbonyl 16 4 9 0.31 0.15 5 7 6 0.54 0.39 36 2 5 0.29 0.10 23 2 2 0.50 0.26 
131 SHCsats 13 166 202 0.45 0.03 7 215 153 0.58 0.07 21 129 86 0.60 0.44 34 129 37 0.78 0.14 
132 nddssS 36 3 16 0.16 0.00 2 8 11 0.42 0.07 56 2 6 0.25 0.05 48 2 1 0.67 0.58 
135 SHBa 22 328 343 0.49 0.30 5 409 262 0.61 0.33 17 246 163 0.60 0.10 31 246 82 0.75 0.41 
139 naaS 12 15 4 0.79 0.01 7 16 3 0.84 0.03 16 13 3 0.81 0.06 58 13 2 0.87 0.22 
140 SaaaC 27 337 355 0.49 0.51 9 424 268 0.61 0.39 38 252 172 0.59 1.00 33 252 85 0.75 1.00 
142 nsssN 25 86 50 0.63 0.00 8 100 36 0.74 0.00 20 76 24 0.76 0.00 40 76 10 0.88 0.00 
146 SaasN 12 12 6 0.67 0.09 9 14 4 0.78 0.11 11 10 4 0.71 0.26 36 10 2 0.83 0.38 
147 ndO 28 185 181 0.51 0.16 7 228 138 0.62 0.29 22 145 83 0.64 0.04 45 145 40 0.78 0.06 
148 ntrifluoromethyl 4 2 3 0.40 0.53 9 3 2 0.60 0.64 12 2 1 0.67 0.64 42 2 0 1.00 0.56 
149 nphosphonate 15 2 3 0.40 0.53 4 3 2 0.60 0.64 24 1 2 0.33 0.36 39 1 1 0.50 0.44 
156 nHBint9 28 7 6 0.54 0.46 9 6 7 0.46 0.20 22 5 1 0.83 0.22 41 5 2 0.71 0.56 
158 StsC 14 4 5 0.44 0.53 3 5 4 0.56 0.49 15 3 2 0.60 0.67 24 3 1 0.75 0.69 
162 Hamide 25 28 27 0.51 0.42 8 34 21 0.62 0.52 35 21 13 0.62 0.46 61 21 7 0.75 0.59 
164 SwHBd 37 30 24 0.56 0.18 9 38 16 0.70 0.10 38 23 15 0.61 0.52 13 23 7 0.77 0.50 
168 Himine 32 10 4 0.71 0.07 6 9 5 0.64 0.52 28 8 1 0.89 0.06 55 8 2 0.80 0.52 
169 SHBint9 28 7 6 0.54 0.46 12 6 7 0.46 0.20 17 5 1 0.83 0.22 36 5 2 0.71 0.56 
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   Mutagenicity Carcinogenicity  False Negative False Positive  
ID Descriptors Freq. Act. Inact. Cnfid. P-value Freq. Act. Inact. Cnfid. P-value Freq. Act. Inact. Cnfid. P-value Freq. Act. Inact. Cnfid. P-value 
170 SHCsatu 17 111 185 0.38 0.00 3 166 130 0.56 0.01 21 83 83 0.50 0.00 31 83 28 0.75 0.55 
175 Hsulfonamide 21 0 11 0.00 0.00 10 4 7 0.36 0.08 16 0 4 0.00 0.03 62 0 0 N.A. 1.00 
178 SsF 16 3 6 0.33 0.28 10 4 5 0.44 0.24 18 2 2 0.50 0.53 25 2 1 0.67 0.58 
181 ntsC 12 4 5 0.44 0.53 2 5 4 0.56 0.49 12 3 2 0.60 0.67 38 3 1 0.75 0.69 
182 nsulfonamide 44 0 12 0.00 0.00 13 5 7 0.42 0.14 24 0 5 0.00 0.01 35 0 0 N.A. 1.00 
183 SHBint10 20 4 2 0.67 0.32 7 4 2 0.67 0.57 39 4 0 1.00 0.12 31 4 0 1.00 0.31 
190 SHdNH 32 8 1 0.89 0.02 12 4 5 0.44 0.24 25 4 0 1.00 0.12 30 4 4 0.50 0.11 
192 ndisulfide 13 2 1 0.67 0.48 10 0 3 0.00 0.06 25 0 0 N.A. 1.00 44 0 2 0.00 0.06 
193 ntCH 30 0 3 0.00 0.14 3 1 2 0.33 0.33 19 0 1 0.00 0.41 33 0 0 N.A. 1.00 
194 ntN 13 4 2 0.67 0.32 5 4 2 0.67 0.57 9 3 1 0.75 0.47 42 3 1 0.75 0.69 
197 SaaS 10 15 4 0.79 0.01 8 16 3 0.84 0.03 16 13 3 0.81 0.06 32 13 2 0.87 0.22 
203 namide 20 35 36 0.49 0.50 5 44 27 0.62 0.50 28 27 17 0.61 0.46 54 27 8 0.77 0.46 
205 nwHBd 28 6 15 0.29 0.05 9 14 7 0.67 0.39 30 4 10 0.29 0.02 36 4 2 0.67 0.47 
207 nHBint10 22 4 2 0.67 0.32 7 4 2 0.67 0.57 28 4 0 1.00 0.12 44 4 0 1.00 0.31 
208 nazo 23 4 2 0.67 0.32 8 3 3 0.50 0.43 19 2 1 0.67 0.64 45 2 2 0.50 0.26 
215 nsulfone 27 0 2 0.00 0.26 4 1 1 0.50 0.63 25 0 1 0.00 0.41 37 0 0 N.A. 1.00 
217 nHsssNHp 17 0 2 0.00 0.26 9 0 2 0.00 0.15 25 0 0 N.A. 1.00 36 0 0 N.A. 1.00 
218 ndssS 24 0 2 0.00 0.26 7 1 1 0.50 0.63 22 0 1 0.00 0.41 48 0 0 N.A. 1.00 
221 Scarbonyl 28 0 3 0.00 0.14 5 1 2 0.33 0.33 12 0 1 0.00 0.41 36 0 0 N.A. 1.00 
224 nsulfonate 74 3 0 1.00 0.11 5 2 1 0.67 0.67 40 2 0 1.00 0.35 34 2 1 0.67 0.58 
225 ncarbonyl 20 0 3 0.00 0.14 3 1 2 0.33 0.33 18 0 1 0.00 0.41 51 0 0 N.A. 1.00 
227 nsI 34 2 0 1.00 0.24 10 1 1 0.50 0.63 33 1 0 1.00 0.59 36 1 1 0.50 0.44 
229 Ssulfoxide 18 0 2 0.00 0.26 3 1 1 0.50 0.63 16 0 1 0.00 0.41 22 0 0 N.A. 1.00 
230 Hphosphonate 22 1 0 1.00 0.49 8 1 0 1.00 0.61 27 1 0 1.00 0.59 58 1 0 1.00 0.75 
231 Ssulfuricacid 27 0 1 0.00 0.51 3 0 1 0.00 0.39 21 0 0 N.A. 1.00 19 0 0 N.A. 1.00 
232 nnitrite 17 1 0 1.00 0.49 8 1 0 1.00 0.61 15 1 0 1.00 0.59 42 1 0 1.00 0.75 
233 SsSH 29 0 1 0.00 0.51 8 1 0 1.00 0.61 12 0 1 0.00 0.41 28 0 0 N.A. 1.00 
234 nsNH3p 20 1 0 1.00 0.49 3 1 0 1.00 0.61 31 1 0 1.00 0.59 35 1 0 1.00 0.75 
235 namidine 25 1 0 1.00 0.49 11 0 1 0.00 0.39 24 0 0 N.A. 1.00 48 0 1 0.00 0.25 
237 Speroxide 21 0 1 0.00 0.51 11 0 1 0.00 0.39 24 0 0 N.A. 1.00 26 0 0 N.A. 1.00 
238 Ssulfonicacid 20 0 1 0.00 0.51 9 0 1 0.00 0.39 19 0 0 N.A. 1.00 28 0 0 N.A. 1.00 
239 nsssssP 19 0 1 0.00 0.51 6 0 1 0.00 0.39 18 0 0 N.A. 1.00 33 0 0 N.A. 1.00 
 
Freq.: frequency; Act: count of active compounds; Inact: count of inactive compounds; Cnfid.: confidence. 
 
  
 
 
 
 
CHAPTER V  
SUMMARY AND FUTURE STUDIES 
Summary and future studies of Chapter II -- Methodology      
CBC, CBM, and AL were designed and proved effective to improve classifier’s 
performance for imbalanced datasets, particularly when class imbalance is complicated with 
other detrimental data domain characteristics such as class overlap, outliers, small clusters etc, 
which failed otherwise robust standard classification algorithms for imbalanced datasets. The 
effectiveness was demonstrated not only with in-house category kNN QSAR algorithm, but 
also with other algorithms implemented in WEKA. We observed best performance 
improvement in combination of algorithms with in-house category kNN QSAR than with 
WEKA implement in case of hERG liability dataset. Therefore, we recommended this 
combination for future studies.   
We also observed that CBC, CBM and AL showed best performance in classification 
of blockers vs. activators, which has smallest size of working dataset, lightest class 
imbalance ratio, least complicity of data structure comparing with rest of the studies such as 
blockers vs. inactives, activators vs. inactives, and actives vs. inactives. In another put, the 
performance improvement decreases when data complicity increases yet data size decreses. 
All these suggest that there is room of improvement for all three algorithm developed.  
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In addtition to effectively handling class imbalance and overlap, CBM offered unique 
eddge in knowledge discovery and application like no other algorithm. The CBM models 
from study of hERG Blockers vs. Inactives picked up fine structural difference between these 
two classes; and replacement of “blocking” features with “inactive” ones can be a way for 
lead optimization – tuning out hERG blockade. In fact, few pattern replacement options 
revealed by our models have been experimentally proved by others (Bilodeau, Prasil et al, 
2004; Arena and Kass, 1998; Wang, Salata et al, 2003; Mukaiyama, Nishimura et al, 2008). 
Glad to have this method proven, we’d like to mention its limitation – class boundary was 
defined based on similarity or distance between two classes, yet the optimal 
distance/similarity threshold need more investigation to decide. We don’t expect it to be 
arbitrated but database dependent. If the distance were not defined appropriately, the patterns 
we found might at risk of being artifact. The finding of optimal class boundary might not be 
guranteed in a diverse dataset. On the orther hand, we used eucledian distance in this study, 
while class boundary defined by other distance or similarity metrics may be different. Mining 
class boundary provides invaluable information; we just need to avoid introducing artificial 
class boundary, either by impropriate distance threhold, unsuitable distance/similarity matrics, 
or something even more fundamental – data set cleaning. 
The difference between AL and CBM that implemented in this study is the coverage 
of minority class – AL retains all compounds in minority class while CBM only cover those 
close to class boundary. Thus, AL presumed to make best of rare information while 
correcting class imbalance. 
The advantage of incorporating data mining goal in classifier design is evident. The 
pounding question in drug discovery field regarding hERG liability is how to uncouple the 
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primary target activity and hERG liability, the inadvertent anti-target activity, of a lead 
compound. Since usually when modification was made in a lead compound to reduced hERG 
inhibition, the primary efficacy was compromised as well unfortunately. Hence we need to 
know how different pharmacophores affect primary and side effects of a lead simultaneously 
but differently, and then choose one that greatly reduce hERG libility but interfering the 
primary efficacy the least if possible. These questions can only be answered by new 
algorithms. That will be an interesting subject for my future studies. 
Summary of Chapter III and future studies of hERG  
In mining the hERG dataset, we have built highly predictive and discriminating 
models for hERG blockers, activators, actives and inactives, and we have identified structural 
features that either promote or demote hERG blockade, and discovered chemical patterns for 
lead optimization. Some of these patterns and trends are new, and may need more 
investigation; others have been successuly proved by experiments (Bilodeau, Prasil et al, 
2004; Arena and Kass, 1998; Wang, Salata et al, 2003; Mukaiyama, Nishimura et al, 2008). 
Nevertherless, our work will have extensive application in drug screening and lead 
optimization. It shall benefit pharmaceutical industry and regulatory agencies, and academic 
research, now that we have demonstrated that CBC, CBM and AL are effective in reducing 
class imbalance, class overlap and in improving performance of several classifiers. We have 
confirmed that data domain analysis is necessary to identify hidden data structures, so that 
classifier can be designed to address those deteriorating data features to make it possible to 
improve the performance. 
The interesting and challenging questions in filed of hERG liability research are: how 
to reduce high false positive rate in hERG liability prediction, which was reported as high as 
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60%; how to uncouple primary therapeutic activity from hERG liability, so that we will not 
interfere primary therapeutic activity of a lead when tuning out its hERG liability. I’d like to 
seek answers for these questions in my future studies. 
 
Summary of Chapter IV and future studies of CPDB  
Mutagenicity and carcinogenicity QSAR studies of the Carcinogenic Potency 
Database (CPDB) have been carried out using classification k Nearest Neighbor QSAR 
(kNN-QSAR) software developed in our laboratory. The analysis of the relationships 
between chemical structures and mutagenicity and carcinogenicity has been performed. 
Besides QSAR modeling for mutagenicity and carcinogenicity endpoints, particular attention 
has been paid to structural features and ‘alerts’ which could be responsible for genotoxic 
carcinogenicity, epigenic carcinogenicity (false negative), genotoxic non-carcinogenicity 
(false positive) and non-toxicity as regards to mutagenicity and carcinogenicity. In these 
respects, the following QSAR studies have been performed: (i) mutagenicity studies (337 
mutagens vs. 356 non-mutagens); (ii) carcinogenicity studies (424 carcinogens vs. 269 non-
carcinogens); (iii) genotoxic carcinogenicity studies (252 genotoxic carcinogens vs. 184 non-
genotoxic non- carcinogens); (iv) false negative carcinogenicity studies I (252 genotoxic 
carcinogens vs. 172 non-genotoxic carcinogens); (v) false negative carcinogenicity studies II 
(172 non-genotoxic carcinogens vs. 184 non-genotoxic non- carcinogens); (vi) false positive 
carcinogenicity studies I (252 genotoxic carcinogens vs. 85 genotoxic non-carcinogens); (vii) 
false positive carcinogenicity studies II  (85 genotoxic non-carcinogens vs. 184 non-
genotoxic non-carcinogens).   
A standard kNN QSAR protocol developed in our laboratory has been implemented in all 
studies. In summary, we have built highly predictive models. Our best models have 
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prediction accuracy of about 0.90, 0.80 and 0.80 for training, test and external evaluation sets 
for all studies except carcinogenicity, which has 0.83, 0.70, 0.82 for training, test and 
external evaluation sets. Our models performed better in comparison study using commercial 
predictive toxicology software Lazar with external evaluation set of 70 compounds.  
We performed systematic descriptor profiling for highly predictive models for mutagens, 
carcinogens, epigenetic carcinogens, and genotoxic non-carcinogens. The patterns we found 
make the chemical information buried in highly predictive models more transparent for 
interpretation and more straightforward for potential applications. The ‘structural alerts’ like 
descriptor profiles for carcinogens, nongenotoxic carcinogens, genotoxic non-carcinogens fill 
the gap in the research field. The high false negative rate and high false positive rate for 
carcinogenicity prediction were explained from the chemical perspective rather than as 
statistical errors. We are closer to the solution of accurate and reliable prediction for 
carcinogenicity. We also expect that computational approach presented herein could 
significantly reduce cost and time of the drug discovery process, advance the development of 
safe chemicals used everywhere, and reduce the number of animals sacrificed in toxicity 
tests. 
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